Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,42137,-0.173102226928957,0.00456691969729793,-0.182053389535661,-0.164151064322253,6.98400594872749e-299
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,41843,-0.427170073653819,0.012633462376979,-0.451931659912698,-0.40240848739494,1.84067673277859e-240
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.107633697982163,0.00339905558405366,0.100971549037418,0.114295846926909,2.19515635916687e-212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,39958,-0.276984825838524,0.00877548092033086,-0.294184768442372,-0.259784883234675,1.13186053620038e-209
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C9,Complement component C9,39990,0.176932250207406,0.00589927794152409,0.165369665442019,0.188494834972793,2.75363002846998e-190
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.378313913926365,0.0130525450672589,0.352730925594537,0.403896902258192,2.58805229669778e-179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.116286543419239,0.00400785288077944,-0.124141935065567,-0.108431151772911,1.26431058180532e-178
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,42080,-0.122648704154376,0.00429673642483889,-0.131070307547061,-0.114227100761692,4.66851892893128e-174
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,42262,-0.179136255478607,0.00655813551804267,-0.19199020109397,-0.166282309863243,5.35600954119847e-160
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.157363243755624,0.00583520935038993,-0.168800254082388,-0.14592623342886,2.66774832899876e-155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,42163,-0.235479993440762,0.00877961985375945,-0.25268804835413,-0.218271938527393,1.88413750301342e-154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.087556330014477,0.00332422260636459,0.0810408537060024,0.0940718063229516,3.81507435251017e-149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PYY,Peptide YY,39575,-0.261122889809749,0.0103375458460937,-0.281384479668093,-0.240861299951406,6.88756938866555e-137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,42070,-0.228713938590704,0.00910954715740659,-0.246568651019221,-0.210859226162187,5.44276695504292e-136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,39990,0.0641669474539326,0.00268859172290464,0.0588973076770396,0.0694365872308257,6.90894431194979e-123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,42145,-0.155496331975439,0.00653352478823103,-0.168302040560372,-0.142690623390506,1.0897893579166e-122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,42296,-0.122994826033232,0.00536820130238069,-0.133516500585898,-0.112473151480566,4.88143684221238e-114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.125323542451189,0.00551975120072119,-0.136142254804602,-0.114504830097775,4.96305571215991e-112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,39990,0.110333405446674,0.00487480668469464,0.100778784344673,0.119888026548676,5.58110128621496e-111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.0679447216793524,0.00305464211593928,0.0619576231321114,0.0739318202265934,1.08871248280372e-107
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.186796757091338,0.00850646486862733,-0.203469428233847,-0.170124085948828,5.11846349745775e-105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,42137,-0.0903451310979739,0.00413900559624038,-0.0984575820666051,-0.0822326801293428,7.74033230977052e-104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,42195,-0.0767647969367877,0.00354304607383213,-0.0837091672414987,-0.0698204266320767,2.27837224183847e-102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.327047515431345,0.0151095321759082,-0.356662198496125,-0.297432832366565,3.50150782535488e-102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.121447851055852,0.0056278531437163,0.110417258894168,0.132478443217536,1.50498189341626e-101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,42145,0.108231529698827,0.0050162221026169,0.0983997343776982,0.118063325019956,1.52309638839467e-101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,39958,-0.201306199572194,0.00944929486280212,-0.219826817503286,-0.182785581641102,8.83369156653357e-99
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.264749558383071,0.012529659032519,-0.289307690086808,-0.240191426679334,1.53291669863974e-97
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.111274232730494,0.0052756797111858,-0.121614564964418,-0.10093390049657,7.57217653038483e-97
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,42089,-0.222894173389578,0.0107420288153492,-0.243948549867663,-0.201839796911494,3.62086242039185e-94
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,0.0647713536122158,0.00321217545570393,0.0584754897190361,0.0710672175053955,7.68549428669385e-89
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.177898168204257,0.00904497215747511,-0.195626313632909,-0.160170022775606,1.04298769443198e-84
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,41913,-0.169615147259315,0.00863749168024817,-0.186544630952602,-0.152685663566029,1.17078889936548e-84
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.123896860114754,0.00632263683618253,0.111504491915836,0.136289228313671,2.39775949088632e-84
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FURIN,Furin,42181,-0.0665514587273616,0.00345613873377657,-0.0733254906455637,-0.0597774268091595,1.52996638299572e-81
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,39979,0.137583027975259,0.0072006970760908,0.123469661706121,0.151696394244397,3.95167088453926e-80
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.108887842195831,0.00570583301319415,-0.120071274901691,-0.0977044094899703,4.05307687860009e-80
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,42262,0.0728663247979777,0.00384423677129245,0.0653316207262445,0.0804010288697109,4.16974907636538e-79
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GH1,Somatotropin,42129,0.351089166303876,0.0186069374364645,0.314619568928406,0.387558763679347,2.08790224992177e-78
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,42137,0.0526305500682943,0.00283028199364766,0.0470831973607449,0.0581779027758437,3.10265387540825e-76
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.164105056362793,0.0088800311767471,-0.181509917469218,-0.146700195256369,2.51591200820766e-75
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MME,Neprilysin,42070,-0.150593902002291,0.00815256274937756,-0.166572924991071,-0.134614879013511,2.94351130626209e-75
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,39966,0.110901066538057,0.00601262086203519,0.0991163296484676,0.122685803427646,7.08151665507058e-75
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,0.0741194131768183,0.00404419818005967,0.0661927847439013,0.0820460416097352,3.89021605455701e-74
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,41225,-0.0763886124770775,0.00434310696830953,-0.0849011021349642,-0.0678761228191909,1.97214087615483e-68
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.139642818217837,0.00797172981022795,-0.155267408645884,-0.12401822778979,8.25408616039081e-68
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,42296,-0.052864862913452,0.00305652556539669,-0.0588556530216296,-0.0468740728052745,2.56153894590965e-66
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,39736,-0.0511990160071728,0.00296356785382475,-0.0570076090006693,-0.0453904230136763,5.14320461554575e-66
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0347190557479957,0.0020142375876193,0.0307711500762619,0.0386669614197295,7.0677007817458e-66
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFM,Afamin,39979,-0.0364502987153322,0.00212016572984888,-0.040605823545836,-0.0322947738848284,2.03044351650193e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,-0.0545017098026887,0.00317991607661183,-0.0607343453128479,-0.0482690742925295,3.72287317769796e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.133930350816792,0.0080927359956816,-0.149792113368328,-0.118068588265256,6.59827804493184e-61
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,42047,-0.123423146642878,0.00752794881193518,-0.138177926314271,-0.108668366971485,7.8533668649212e-60
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,42224,-0.0836716968991477,0.00511280842231327,-0.0936928014068817,-0.0736505923914136,1.25642733879379e-59
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.0640312261648942,0.00391510178183795,0.0563576266724918,0.0717048256572966,1.49261714079358e-59
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.14356567007922,0.0087900607123046,-0.160794189075337,-0.126337151083103,2.18154656333022e-59
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELE,E-selectin,42310,-0.0863432807054195,0.00529977901937892,-0.0967308475834022,-0.0759557138274368,4.04623959591753e-59
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,42123,-0.0952653497008463,0.00592432610903868,-0.106877028874562,-0.0836536705271305,1.19842304973684e-57
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,42137,-0.0477914669045744,0.0029740154373417,-0.0536205371617641,-0.0419623966473846,1.41772743993472e-57
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.2448493149895,0.0153408984903523,-0.27491747603059,-0.21478115394841,8.08354487765173e-57
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0416966655928142,0.00264197757409155,0.0365183895475947,0.0468749416380336,1.26963845116899e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.0533843837104857,0.00338562147574041,-0.0600202018029369,-0.0467485656180344,1.60769341359459e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,39649,-0.137963744081296,0.00875869068124674,-0.15513077781654,-0.120796710346053,2.66937536024177e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,42194,-0.0510933322258506,0.00325858900440179,-0.0574801666744781,-0.0447064977772231,6.31257314218295e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.0530845744401846,0.0033916123913611,-0.0597321347272524,-0.0464370141531169,1.27200693338011e-54
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,-0.106635399038371,0.00684673329013363,-0.120054996287033,-0.0932158017897095,3.25813522076805e-54
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.130467824694769,0.00840565838617708,-0.146942915131676,-0.113992734257862,7.26800815193671e-54
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTR,Transthyretin,39862,-0.0403973719193654,0.00261273586019217,-0.0455183342053421,-0.0352764096333888,2.22092589750283e-53
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,39638,-0.102085108803409,0.00662961635373227,-0.115079156856724,-0.0890910607500937,5.95539842500183e-53
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0596110027163052,0.00387490092844241,0.0520161968965581,0.0672058085360524,7.17940404061504e-53
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0469659576279645,0.0030582689733803,0.0409717504401391,0.0529601648157898,8.80680509095942e-53
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,42193,-0.0532304988047643,0.00347015185881014,-0.0600319964480322,-0.0464290011614964,1.14873234526577e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.0953623653783326,0.00629793227404644,-0.107706312635464,-0.0830184181212016,2.30719189564732e-51
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,41839,-0.0837813624995915,0.00554466902764183,-0.0946489137937695,-0.0729138112054135,3.69950273512291e-51
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,42262,-0.0532214636140886,0.00354758441983064,-0.0601747290769567,-0.0462681981512206,1.79201571418548e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,42310,-0.0807026453359962,0.00539246847644569,-0.0912718835498297,-0.0701334071221626,3.0604923993107e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.049875690025378,0.00333748650200673,-0.0564171635693112,-0.0433342164814448,4.23906406638977e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0551489545946234,0.00369332423526899,-0.0623878700957506,-0.0479100390934961,5.08154886103724e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.0524029582545944,0.00352093115883758,0.0455019331832727,0.059303983325916,1.0341403722173e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,42199,-0.0286228296090158,0.00192761827929703,-0.032400961436438,-0.0248446977815936,1.72832177815805e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.101499643572447,0.00685714113471249,-0.114939640196484,-0.0880596469484107,3.51143371599725e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,42230,0.0424252693022178,0.00287135257790169,0.0367974182495305,0.0480531203549052,5.05624775107025e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,42137,0.0435577744119677,0.00295668793104964,0.0377626660671104,0.049352882756825,9.58094238843615e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.0766761923515733,0.00521661603650527,0.066451624920023,0.0869007597831236,1.8381769458715e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.0781219118454787,0.00537321865685415,-0.0886534204129128,-0.0675904032780446,1.55822672133922e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0560661782910301,0.00386975576866453,-0.0636508995976126,-0.0484814569844476,3.21553685953553e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.104618221688365,0.00723890017808781,-0.118806466037417,-0.0904299773393126,5.40810100788935e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.0732610600712404,0.00510653633931669,-0.0832698712963011,-0.0632522488461797,2.89414075850149e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,-0.077034553618465,0.0053864499249902,-0.0875919954714458,-0.0664771117654842,4.59817896046547e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,42211,-0.0911410015170695,0.00642240990866851,-0.10372892493806,-0.0785530780960792,2.19125661139138e-45
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.0720022763294202,0.00508341315370872,-0.0819657661106893,-0.0620387865481511,3.19493667199932e-45
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,39713,-0.0579529042292105,0.00412446284601161,-0.0660368514073933,-0.0498689570510278,1.82231365849587e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.112132016475473,0.00803111107639133,-0.1278729941852,-0.0963910387657455,6.21480452978169e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,39468,0.0621865332571331,0.00445596196626955,0.0534528478032447,0.0709202187110214,6.93035734827621e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.180950735162196,0.0130195119582165,-0.2064689786003,-0.155432491724092,1.28244845011703e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.0754994059507155,0.00545623405068611,-0.0861936246900603,-0.0648051872113707,2.99425998715051e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,42205,-0.0966730587848432,0.00700392544418466,-0.110400752655445,-0.0829453649142412,4.78666178956126e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,42145,-0.0904977455853684,0.00658130331292691,-0.103397100078705,-0.0775983910920317,9.76143554398147e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,42262,0.0664407608110077,0.00488182280377357,0.0568723881156115,0.0760091335064038,6.56593704577427e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,42070,-0.0806608219931441,0.00592716105249906,-0.0922780576560422,-0.0690435863302459,6.7280639511217e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.121395405605681,0.00894269645717751,-0.138923090661749,-0.103867720549613,1.06207175762136e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.0938733460982348,0.00696348373849612,-0.107521774225687,-0.0802249179707824,4.19833132699951e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,39802,-0.033230379250746,0.00246906759068915,-0.0380697517284968,-0.0283910067729953,5.69503984963098e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0491662822410412,0.0036567050159603,-0.0563334240723234,-0.041999140409759,6.71504413892731e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.0775815956284197,0.00577567021752356,-0.0889019092547659,-0.0662612820020736,7.24148597560229e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.0814690085562767,0.00606344615602863,-0.0933533630220928,-0.0695846540904606,7.77422459260409e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,39638,-0.0891038294609734,0.00663256099687773,-0.102103649014854,-0.076104009907093,7.96116615830806e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,-0.118378336747357,0.00884386719081704,-0.135712316441358,-0.101044357053355,1.35164199676965e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.0450927719291999,0.00337173174288127,0.0384841777131526,0.0517013661452471,1.55060528613944e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POSTN,Periostin,39966,0.0532823671699124,0.00398938894533255,0.0454631648370606,0.0611015695027642,2.20094469901385e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,-0.0396222222181917,0.00297137701243894,-0.0454461211625721,-0.0337983232738114,2.92113693425361e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,39930,-0.156505766467778,0.0117553361839921,-0.179546225388403,-0.133465307547154,3.86214932834871e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0389148843135622,0.00293111775720273,-0.0446598751176795,-0.0331698935094448,5.63960599861904e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.1122393261289,0.00846590784554206,-0.128832505506162,-0.0956461467516373,7.22603447394424e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,-0.0364655948942916,0.0027661493485019,-0.0418872476173553,-0.0310439421712278,2.16270794536482e-39
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,42145,-0.0875326977686284,0.00665188811628366,-0.100570398476544,-0.0744949970607124,2.62920037485821e-39
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,39934,-0.058462098584601,0.00444281593151266,-0.0671700178103658,-0.0497541793588362,2.93747707131393e-39
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,0.0639113904477348,0.00491225479197533,0.0542833710554632,0.0735394098400065,1.80338416248929e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.0273856665030914,0.00210943629695487,-0.031520161645123,-0.0232511713610599,2.60857508141224e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,-0.116315128942269,0.00899634831560629,-0.133947971640857,-0.0986822862436803,5.1868958214363e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.0997126953740897,0.00770789075291032,0.0846052294983855,0.114820161249794,5.20266161049791e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.0726426786908185,0.00562067956247936,-0.0836592106332781,-0.061626146748359,6.0967585327169e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,42185,0.0552004216707721,0.00432368220700657,0.0467260045450392,0.063674838796505,4.09545640343928e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.0668781164014159,0.0052655922376628,-0.077198677187235,-0.0565575556155968,1.04915253988822e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,42171,0.0513135853735542,0.00411065508439374,0.0432567014081424,0.0593704693389659,1.44790639811875e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,39638,-0.069975639649143,0.00564024488931087,-0.0810305196321923,-0.0589207596660937,4.12943062799401e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.0561758964567756,0.0045324403960562,0.0472923132805054,0.0650594796330457,4.34387423389065e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.0367634592638243,0.00298270355993143,-0.0426095582412899,-0.0309173602863586,1.00914681113481e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.117947381817706,0.00966378026538315,-0.136888391137857,-0.0990063724975546,4.44160206952997e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.0412012999219057,0.00338237457299866,0.0345718457588283,0.0478307540849831,5.8836573130804e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.06992269221764,0.00576308454589446,-0.0812183379275931,-0.0586270465076868,1.06525762198502e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.027030603409517,0.0022386702903022,0.0226428096405247,0.0314183971785094,2.13392046732629e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0324835939413267,0.00269132089477232,0.0272086049875729,0.0377585828950804,2.25343508779357e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.127192544704561,0.010580226889066,-0.14792978940713,-0.106455300001992,4.07571467249222e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.0564958662963903,0.00470260657195255,0.0472787574153633,0.0657129751774173,4.4291323804267e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,42123,0.0564601553539414,0.00471625127914179,0.0472163028468235,0.0657040078610593,7.35339385987026e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.0865064144155366,0.00724234740594335,-0.100701415331186,-0.0723114134998876,1.01439964129975e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.0666325059062776,0.00561205561871341,-0.0776321349189559,-0.0556328768935994,2.36329269425627e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,42119,-0.0494462023389406,0.00416543075965195,-0.0576104466278585,-0.0412819580500228,2.43519695698964e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.0332107361167654,0.00280861427622687,0.0277058521353608,0.0387156200981701,4.4874019959007e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,42296,-0.0565972119750294,0.00479311922089959,-0.0659917256479926,-0.0472026983020662,5.07354217351625e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0243408781215333,0.00206312752049512,0.0202971481813629,0.0283846080617037,5.73865726484454e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.070491674731279,0.00597206516070965,0.0587864270162881,0.0821969224462699,5.82176741366253e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0185068713705214,0.00156964488447279,0.0154303673969547,0.0215833753440881,6.70650182067553e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD248,Endosialin,39966,0.0502540748698892,0.00427566864171024,0.0418737643321372,0.0586343854076413,1.03365581713523e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,39806,-0.0333755164293304,0.00284394864517388,-0.0389496557738712,-0.0278013770847896,1.28139669250018e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,42296,-0.0378277662137348,0.00322732259718673,-0.0441533185042208,-0.0315022139232488,1.40626889523887e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEP,Leptin,42145,-0.0858745042154916,0.00734464960943191,-0.100270017449978,-0.071478990981005,1.97995782681232e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.0395311354733469,0.00338345424777186,0.0328995651477141,0.0461627057989797,2.17597167553533e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELN,Elastin,39958,-0.0428660321969329,0.00367133067740133,-0.0500618403246395,-0.0356702240692263,2.55550250708119e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,-0.131402067954734,0.0112636645604543,-0.153478850493224,-0.109325285416243,2.68850385847133e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,42181,-0.049464780069951,0.00425448146620908,-0.0578035637437208,-0.0411259963961812,4.2417760809276e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,39954,0.0436379503726267,0.00375187793109549,0.0362842696276796,0.0509916311175739,4.303618324669e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,42249,-0.0458378245623693,0.00394717298778199,-0.053574283618422,-0.0381013655063166,4.96269064844339e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.0424665833431508,0.00366134715557375,0.0352903429182262,0.0496428237680753,5.86758138042052e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,39959,-0.0356615088638656,0.00307933456881536,-0.0416970046187437,-0.0296260131089875,7.67161987348218e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.153238161194869,0.0132347657368994,-0.179178302039192,-0.127298020350546,7.97770273862942e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,-0.0263961899866261,0.00229284770995687,-0.0308901714981416,-0.0219022084751107,1.6846365741011e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.0722162525482925,0.00628968384825152,0.0598884722057195,0.0845440328908655,2.24708127683572e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.0391083103995788,0.0034112460566305,-0.0457943526705746,-0.032422268128583,2.73535669153955e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,-0.0693547924659437,0.00605832378527856,-0.0812291070850897,-0.0574804778467977,3.52783293060941e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,42070,-0.0857684645518017,0.00749704536014743,-0.100462673457691,-0.0710742556459128,3.62392635873217e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.0930265738468689,0.00813223098742804,-0.108965746582228,-0.0770874011115099,3.89526700956019e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0409513434334607,0.00358166663407887,-0.0479714100362553,-0.0339312768306661,3.90510883982887e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.0628959434590945,0.00555711943894653,-0.0737878975594297,-0.0520039893587593,1.45129772412423e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,42070,-0.07854175842272,0.00694806383632337,-0.0921599635419138,-0.0649235533035262,1.69995596224321e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,42181,-0.0646247109741063,0.0057253210299851,-0.0758463401928771,-0.0534030817553355,2.04472940273167e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,42137,-0.0662179086409166,0.00587630149067284,-0.0777354595626354,-0.0547003577191978,2.53178288891899e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREH,Trehalase,39966,-0.0896516304265182,0.00795530764787812,-0.105244033416359,-0.0740592274366771,2.65707390883805e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASN,Vasorin,41975,0.0325505157923451,0.00289275729406132,0.0268807114959849,0.0382203200887053,3.0491426398575e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),39775,0.216552282430781,0.0192499625789471,0.178822355776045,0.254282209085517,3.34272189290765e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,42153,0.0600069828110457,0.0053612797082959,0.0494988745827858,0.0705150910393057,5.93324074985698e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,-0.0354239232319244,0.00318252164941883,-0.0416616656647853,-0.0291861807990635,1.25414262549638e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,42016,0.0404816998699484,0.00364099302663486,0.0333453535377441,0.0476180462021527,1.36235031417048e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.0283553817461714,0.00255429278289897,0.0233489678916894,0.0333617956006534,1.64774707970849e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.0708816710742055,0.00642393948266045,-0.0834725924602199,-0.058290749688191,3.68319772945313e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,39736,-0.075006304231138,0.00680783922634865,-0.0883496691147813,-0.0616629393474946,4.38709133844362e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.0480825475596057,0.00436974276286617,-0.0566472433748234,-0.039517851744388,4.83791725124859e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.035997951510615,0.00327709152010704,-0.0424210508900248,-0.0295748521312052,5.93832070262506e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,39735,0.0360354745525118,0.00328285848430686,0.0296010719232703,0.0424698771817533,6.86158210848102e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,39736,-0.0318792423331879,0.00291246967005807,-0.0375876828865017,-0.0261708017798741,9.63821263179847e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,42119,-0.0607362113643343,0.00555432956332196,-0.0716226973084453,-0.0498497254202232,1.0250330456489e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.0605989893839371,0.0055693549348078,-0.0715149250561604,-0.0496830537117138,1.8532881629551e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.030924114037174,0.00284282710830477,0.0253521729048966,0.0364960551694513,1.90709271363954e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,-0.0379164123000831,0.00348591214230703,-0.0447488000990049,-0.0310840245011613,1.92008978621264e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,-0.02783604902216,0.00257799007174488,-0.0328889095627799,-0.02278318848154,4.55163652423388e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,0.0462924424428634,0.0042917912231983,0.0378805316453947,0.0547043532403321,5.15265553321084e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,-0.0256084343640048,0.00237496979602017,-0.0302633751642043,-0.0209534935638052,5.34785248825875e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAST,Gastrin,39929,-0.148498827809053,0.0138274241396804,-0.175600579122826,-0.121397076495279,8.93871204699632e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,41827,-0.0670426302019086,0.00624934498714484,-0.0792913463767125,-0.0547939140271047,9.69356695880702e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,39966,-0.128779732405975,0.0120116326813711,-0.152322532461463,-0.105236932350488,1.0851723245096e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0277168210428571,0.00258829410467406,0.022643764597696,0.0327898774880183,1.24299454364446e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,-0.0417085363695987,0.00390892658691525,-0.0493700324799526,-0.0340470402592448,1.79239585721921e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,39736,-0.0431773274411363,0.00404839297771989,-0.0511121776774672,-0.0352424772048053,1.98391341814269e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,42230,-0.07778162344851,0.00730403748515529,-0.0920975369194144,-0.0634657099776056,2.23461292307455e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0378937976986714,0.00357654023307112,-0.0449038165554908,-0.030883778841852,3.9825357810866e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,39990,-0.0324656035973058,0.00306846732534019,-0.0384797995549725,-0.026451407639639,4.85209579467114e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.037131632585296,0.00353075193341438,-0.0440519063747882,-0.0302113587958038,9.08343680010951e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.111069468947051,0.0105620840280286,-0.131771153641987,-0.0903677842521145,9.17911510238003e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,42134,0.0434112635397408,0.00413063897693465,0.0353152111449489,0.0515073159345327,9.80469498358801e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.041594692599257,0.00395640057290026,-0.0493492377221415,-0.0338401474763725,9.90384917123596e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,39958,-0.0309846102275408,0.00295323416212653,-0.0367729491853088,-0.0251962712697728,1.23453009095294e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANG,Angiogenin,42152,-0.0362819147705483,0.00346131238789799,-0.0430660870508283,-0.0294977424902682,1.30774343334748e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.0521945100681201,0.00498028654291112,-0.0619558716922259,-0.0424331484440143,1.33172407866207e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.0779562377721825,0.0074795880296577,-0.0926162303103116,-0.0632962452340534,2.44911958287686e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.0557439716443431,0.00534892866665547,-0.0662278718309878,-0.0452600714576983,2.47815022774234e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,-0.0920686770135292,0.00885237870686059,-0.109419339278976,-0.0747180147480825,3.2025773940303e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,-0.0789711189694702,0.00762374733691794,-0.0939136637498294,-0.0640285741891111,4.75694104954945e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.0417505662875989,0.00403546294750046,0.033841058910498,0.0496600736646998,5.40766396938006e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,-0.0225622999965508,0.00218296103186653,-0.0268409036190092,-0.0182836963740924,6.0583319239225e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,42267,0.0412557961923174,0.00399208131439415,0.0334313168161049,0.04908027556853,6.08393293296649e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.10647737254992,0.01032000395834,-0.126704580308267,-0.086250164791574,7.26310924673261e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.115478999645881,0.0112326374020482,-0.137494968953895,-0.0934630303378662,1.06190927291625e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.0626164314344466,0.00609333902599616,-0.0745593759253991,-0.0506734869434942,1.1135337519384e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,-0.0572350851645149,0.0055777518663642,-0.0681674788225887,-0.046302691506441,1.30143434506247e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,42310,-0.0671627429427858,0.00655181981967296,-0.0800043097893448,-0.0543211760962268,1.43641565852257e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0337598089009697,0.00331298125665761,-0.0402532521640186,-0.0272663656379208,2.68719427274054e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0628709381167781,0.00617522285681871,-0.0749743749161428,-0.0507675013174135,3.05983898253798e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.0311037552458971,0.00306568367534852,-0.0371124952495802,-0.025095015242214,4.22187185471861e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,41994,0.0293214969617837,0.00289399862163314,0.0236492596633827,0.0349937342601846,4.8723326296754e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,42274,0.0574973006754839,0.00568551100591739,0.0463536991038858,0.0686409022470819,5.87657708909324e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.0975148520468172,0.00965214943661682,-0.116433064942586,-0.0785966391510482,6.51978372997546e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.0600877818291224,0.0059604895161744,-0.0717703412808243,-0.0484052223774206,8.44661107232871e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,42217,-0.060719248317526,0.00603450591970879,-0.0725468799201552,-0.0488916167148968,9.84323345003489e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,42249,0.0397900270547699,0.00396054987482707,0.0320273493001088,0.0475527048094309,1.14925158822548e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.108737640495898,0.0108318237034856,-0.12996801495473,-0.0875072660370665,1.29273556332916e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,-0.0725589644295281,0.0072478262391273,-0.0867647038582176,-0.0583532250008386,1.71732237116471e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,41839,-0.0705720284176375,0.00706092888054601,-0.0844114490235076,-0.0567326078117673,1.94610333310328e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,-0.0445837854720535,0.0044631364983603,-0.0533315330088397,-0.0358360379352673,2.0422784804121e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,-0.120276786447727,0.0120576373843227,-0.143909755721,-0.0966438171744546,2.3594679791058e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,41697,-0.0424234867419913,0.00425315140395105,-0.0507596634937353,-0.0340873099902472,2.38512356252538e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.0214545998195467,0.00215164256482819,0.0172373803924835,0.02567181924661,2.44914276736348e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0589300723634267,0.00591800121010893,-0.0705293547352402,-0.0473307899916132,2.92712116066038e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,41830,-0.0520279625297154,0.00522715822418998,-0.0622731926491278,-0.0417827324103031,2.94214439516296e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.051245581692797,0.00517264041159797,-0.061383956899529,-0.0411072064860649,4.64872997462685e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.0724540077155139,0.0073238267208441,-0.0868087080883684,-0.0580993073426595,5.56592978559742e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELL,L-selectin,39979,0.0243262912659321,0.00246259547156823,0.0194996041416583,0.0291529783902058,6.3919934253279e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,-0.0230251435401682,0.00233207852818194,-0.0275960174554048,-0.0184542696249316,6.75269313914744e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.0762828241780088,0.00773277255061702,-0.0914390583772181,-0.0611265899787994,7.08760654417872e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,-0.0741131734614377,0.00752506105553719,-0.0888622931302906,-0.0593640537925848,8.56122653939518e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.0426353849088766,0.00433903967182305,-0.0511399026656498,-0.0341308671521034,1.07596808491217e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.0854873689939903,0.00870799160078937,-0.102555032531537,-0.0684197054564431,1.13547341771881e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,-0.0376075669737833,0.00383272469102788,-0.0451197073681979,-0.0300954265793686,1.1889529843804e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,41654,0.0325692330041281,0.00332169612011379,0.026058708608705,0.0390797573995511,1.28250656423341e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.0775884292599621,0.00792297597488377,-0.0931174621707343,-0.0620593963491899,1.43648530048222e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.0380508180740322,0.00388831895946943,-0.0456719232345923,-0.0304297129134721,1.53828459258401e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.0748063907138337,0.00771864793932055,-0.089934940674902,-0.0596778407527654,3.86732986577116e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,-0.026630563806302,0.00274820335099593,-0.032017042374254,-0.0212440852383499,3.92158473637254e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0276214956324073,0.002857357636991,0.0220210746639049,0.0332219166009096,4.9151900314709e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,42296,-0.0352364444296622,0.00364634453668708,-0.0423832797215688,-0.0280896091377555,5.06588033240172e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.0500391854437645,0.0051806223237751,-0.0601932051983637,-0.0398851656891653,5.31721752398048e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.0768984887061262,0.0079744232489376,-0.0925283582740439,-0.0612686191382085,6.17041690100149e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,42310,-0.0656764775529648,0.00683537907646951,-0.079073820542845,-0.0522791345630845,8.63735189576809e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,42070,-0.0355484661310749,0.00371845620077437,-0.0428366402845926,-0.0282602919775571,1.37861369664671e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,42262,-0.0642341017242833,0.00675478818177641,-0.0774734865605651,-0.0509947168880016,2.23266446867823e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.042019700531144,0.00441919111619149,0.0333580859434086,0.0506813151188793,2.32698584931042e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,-0.110798301443113,0.0116550394230586,-0.133642178712308,-0.087954424173918,2.36955357717809e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0330102871061083,0.00348064079786038,0.026188231142302,0.0398323430699146,2.84968215564138e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0432637312883934,0.00458336984453255,-0.0522471361836772,-0.0342803263931096,4.35704908656158e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.0834701817084099,0.00885781091743673,-0.100831491106586,-0.0661088723102339,5.08877718405964e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.0646999440878048,0.00687683545774194,-0.078178541584979,-0.0512213465906306,5.85666153864061e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,42262,-0.0259409510976368,0.00276716406143744,-0.0313645926580542,-0.0205173095372194,8.02155136430637e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,42296,-0.0258450884819929,0.00276706414231719,-0.0312685342009346,-0.0204216427630512,1.10708145660357e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,-0.0654592353496139,0.00701860734423745,-0.0792157057443193,-0.0517027649549085,1.25902758538144e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,39919,-0.0992464316195527,0.0106492177849582,-0.120118898478071,-0.0783739647610346,1.3836258276456e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,-0.0293747554435742,0.0031523381884248,-0.0355533382928868,-0.0231961725942616,1.39837843013624e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,-0.0475409544946003,0.00510309497445797,-0.0575430206445379,-0.0375388883446627,1.42939383698759e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,42239,-0.0198351061254454,0.00213139860122371,-0.0240126473838439,-0.0156575648670469,1.52482207624518e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0420088482591381,0.00451610626753664,0.0331572799747663,0.0508604165435099,1.58776819214716e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,39638,-0.0585371518788778,0.00629829740075025,-0.0708818147843483,-0.0461924889734073,1.76280290756813e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.0624736584708681,0.00672479971720888,-0.0756542659165975,-0.0492930510251387,1.82306005963257e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,42016,-0.0521194521068596,0.00561808915113714,-0.0631309068430883,-0.0411079973706307,2.00489924078141e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,-0.0751607471758311,0.00812053306217998,-0.0910769919777038,-0.0592445023739583,2.44462424327652e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,-0.0667091649958608,0.00721275068257102,-0.0808461563337,-0.0525721736580216,2.61378800547287e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSN,Gelsolin,39943,0.0185128805464913,0.00200732551396929,0.0145785225391115,0.0224472385538712,3.40916172650783e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.0844799069452559,0.00917237301769125,-0.102457758059931,-0.0665020558305811,3.72605227103244e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTD,Biotinidase,39979,-0.0199824533858715,0.0021707197951414,-0.0242370641843486,-0.0157278425873943,3.99547592614594e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,42119,0.0329117759088185,0.0035789090012286,0.0258971142664104,0.0399264375512265,4.24995279452314e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.0505676376404443,0.0055066466715182,-0.06136066511662,-0.0397746101642687,4.78695818966211e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,42119,0.0431256832615438,0.00469813317629007,0.0339173422360153,0.0523340242870724,4.95934086894195e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.0449142358776286,0.004895797926332,-0.0545099998132393,-0.0353184719420179,5.36350903450031e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,42016,-0.0848107634633697,0.00929744474074054,-0.103033755155221,-0.0665877717715182,8.41649107679131e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,42137,-0.0224072817873604,0.00245785952161787,-0.0272246864497314,-0.0175898771249893,8.83013612706829e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,-0.121362384410983,0.0133380128806173,-0.147504889656993,-0.0952198791649734,1.03811415491061e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,39736,-0.0510548075759136,0.00561264674935188,-0.0620555952046432,-0.0400540199471839,1.09221390397832e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,42181,-0.0536691835786081,0.00592331076694657,-0.0652788726818234,-0.0420594944753928,1.47140169054318e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,42119,-0.0695870235956241,0.0077083349737801,-0.0846953601442331,-0.0544786870470151,1.99080206638821e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.0646130826423221,0.00715586525685216,-0.0786385785457523,-0.0505875867388919,2.01447246536726e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.0297097800898184,0.003294194016385,0.0232531598177038,0.0361664003619331,2.15319612224316e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0762749157750802,0.00846351070568838,0.0596864347919309,0.0928633967582294,2.28665544036652e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,42070,-0.0371766813233187,0.00414075863726273,-0.0452925682523536,-0.0290607943942837,3.11198806733321e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,42025,-0.068623280121796,0.007643926778176,-0.0836053766070209,-0.053641183636571,3.13411704052634e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.0782923699087707,0.00878675187958834,-0.0955144035927638,-0.0610703362247776,5.73095601507533e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,42145,-0.0639606984548386,0.00722075591720707,-0.0781133800525644,-0.0498080168571127,9.15740535881765e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0724212440697266,0.00818964036482184,-0.0884729391847774,-0.0563695489546758,1.0738780188626e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.0333138931230171,0.003772276373577,0.0259202314308062,0.0407075548152281,1.16123590943614e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,42296,-0.0348688662604068,0.00395043386461638,-0.0426117166350549,-0.0271260158857586,1.20847612579227e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.0265894471316195,0.00301780361170439,0.0206745520526789,0.0325043422105602,1.39145404578514e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PXN,Paxillin,41839,-0.0476104607175552,0.00542758330615399,-0.058248523997617,-0.0369723974374933,1.96861890780722e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,42115,-0.0857484491169204,0.00977577237445773,-0.104908962970858,-0.0665879352629832,1.97131187325294e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0571305161087184,0.00651764086558084,-0.0699050922052568,-0.0443559400121799,2.08218290896583e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,39966,0.047588621427042,0.00542900256572942,0.0369477763982123,0.0582294664558717,2.12078178325655e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,42255,-0.0226466212362861,0.00258689036746353,-0.0277169263565147,-0.0175763161160576,2.2907295127842e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0344187910854883,0.00393874928464465,-0.0421387396833918,-0.0266988424875848,2.63603271755169e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.0262190003156979,0.00300057159659957,0.0203378799863628,0.0321001206450331,2.64507164231735e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,39657,-0.0775345090840152,0.00888665252341894,-0.0949523480299163,-0.0601166701381141,3.0476171874965e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,42119,-0.0886630170057909,0.0102045275032058,-0.108663890912074,-0.0686621430995076,4.08699536924897e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,39958,-0.0839701050571904,0.00966545713511984,-0.102914401042025,-0.0650258090723556,4.20593901301163e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,-0.0268703845287315,0.00309341745854603,-0.0329334827474817,-0.0208072863099813,4.2600879033633e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.0701025446066746,0.00807482404261294,-0.085929199730196,-0.0542758894831533,4.43354595476563e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0308843780306747,0.00356093335742146,0.0239049486501287,0.0378638074112208,4.67431433919679e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.10194082950033,0.0117981877831499,-0.125065277555304,-0.0788163814453564,6.23919505121152e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EZR,Ezrin,42249,-0.0221993496290092,0.00257090241521522,-0.0272383183628311,-0.0171603808951874,6.52613770214322e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.0947852217097541,0.0110012813796596,-0.116347733213887,-0.0732227102056212,7.70633058148388e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,-0.063708627586655,0.0073944005477074,-0.0782016526601615,-0.0492156025131485,7.86534135157948e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,42119,-0.0299559499521358,0.0034827111638081,-0.0367820638331996,-0.0231298360710719,8.73951259920549e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0388384189240067,0.00452676924885135,-0.0477108866517554,-0.0299659511962581,1.05295253922015e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,-0.0711665245655868,0.00830466062331613,-0.0874436593872864,-0.0548893897438872,1.17444206072274e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,-0.0828633432927413,0.0096786219315474,-0.101833442278574,-0.0638932443069084,1.23295613798688e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,39929,-0.035086623040088,0.00410468655633163,-0.043131808690498,-0.027041437389678,1.41349418275368e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,39958,-0.027545364780697,0.00322286986316783,-0.033862189712506,-0.0212285398488881,1.42648280025884e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0726963454895215,0.00851025213220617,-0.0893764396686456,-0.0560162513103974,1.45648617953963e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,42199,0.0255540194021647,0.00299836719505218,0.0196772196998624,0.031430819104467,1.72229871456403e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.0355511643382468,0.00417975965458916,0.027358835415252,0.0437434932612415,1.9955979266801e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.0384806981598912,0.00452488937697421,-0.0473494813387607,-0.0296119149810218,2.01692430441998e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,-0.0778467462867782,0.00919355293868537,-0.0958661100466015,-0.0598273825269549,2.76214831608407e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,39958,-0.0602458957822284,0.00713050992315272,-0.0742216952316077,-0.0462700963328491,3.29467995932634e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.0270584850531195,0.00321675920168928,0.0207536370178085,0.0333633330884305,4.52417172098985e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,-0.0344514842397753,0.00410642446686842,-0.0425000761948374,-0.0264028922847132,5.34957541498426e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,42145,0.0451297255643902,0.00538099165662704,0.0345829819174012,0.0556764692113792,5.4818990255333e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,42119,-0.0817142116256191,0.0097644791434238,-0.10085259074673,-0.0625758325045085,6.40313378161391e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,-0.0662651197153605,0.00792273993942708,-0.0817936899966376,-0.0507365494340834,6.80078338930556e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,42249,-0.0404999205400537,0.00484683004341962,-0.0499997074251561,-0.0310001336549512,7.11229956468594e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MLN,Promotilin,42119,-0.0788173603744506,0.00944649288282577,-0.0973324864247891,-0.0603022343241121,7.90241399220131e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,42286,0.0387504477344687,0.00465336224441183,0.0296298577354215,0.0478710377335159,9.04182287496747e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0319447627198384,0.00384618295223372,-0.0394832813062165,-0.0244062441334603,1.08791700531576e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,-0.100401624573442,0.0120904218652813,-0.124098851429394,-0.076704397717491,1.1206107044438e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,42145,-0.0309906650912679,0.00373430676967217,-0.0383099063598253,-0.0236714238227104,1.14942399105151e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,-0.0392104020300028,0.00472400181022603,-0.0484694455780459,-0.0299513584819598,1.15966918683576e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.0316240834190362,0.00381273413367793,-0.039097042321045,-0.0241511245170275,1.21950956409086e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,-0.0954536903718646,0.0115128047506187,-0.118018787683077,-0.0728885930606519,1.24870985072247e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.0169605220208534,0.0020496513475921,-0.020977838662134,-0.0129432053795729,1.40630793179521e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,42119,-0.0703750981018679,0.00850842991151988,-0.0870516207284468,-0.0536985754752889,1.44903153992337e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNC,Tenascin,42217,0.0421729151618832,0.0051059703917112,0.0321652131941292,0.0521806171296371,1.59643078043573e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,-0.0873177988542269,0.0105758325098944,-0.10804643057362,-0.066589167134834,1.66830753246388e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,-0.0324682851090659,0.00394042155058055,-0.0401915113482038,-0.0247450588699281,1.91477037788945e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.0512252350309985,0.0062185995999798,-0.0634136902469589,-0.0390367798150381,1.92020585967382e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,-0.0554270243346832,0.00673647649897988,-0.0686305182726838,-0.0422235303966827,2.08215506105885e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,42310,0.0210255788823685,0.0025656867271717,0.0159968328971119,0.026054324867625,2.72858903044979e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,41843,-0.055612675802469,0.00679830831346323,-0.0689373600968569,-0.042287991508081,3.08620379915756e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORT1,Sortilin,42129,-0.0329882480798459,0.00403569531570362,-0.040898210898625,-0.0250782852610668,3.24374127045391e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNST,Consortin,42145,-0.0941325903278555,0.0115281877585895,-0.116727838334691,-0.0715373423210201,3.48440735399493e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,-0.0730008346212354,0.00896050019165651,-0.0905634149968821,-0.0554382542455886,4.05623631983467e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.0279241384837099,0.0034323701546692,-0.0346515839868616,-0.0211966929805583,4.54021968063474e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,-0.0206217370471495,0.00253746611438741,-0.0255951706313488,-0.0156483034629502,4.7838038177704e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.0982852816454403,0.0121065097423459,-0.122014040740438,-0.0745565225504424,5.21316611735413e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,42145,0.0269226213037651,0.00332834895564752,0.020399057350696,0.0334461852568342,6.53055115952113e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.0294536750951503,0.00364275862369488,-0.0365934819975923,-0.0223138681927084,6.81510308056301e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,-0.0567538057403907,0.00702234290235219,-0.070517597829001,-0.0429900136517804,6.92696874434421e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,39990,0.0422024624261901,0.00523920322265868,0.0319336241097791,0.0524713007426011,8.72962222922439e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.0439659652266486,0.00546401354995694,-0.0546754317845642,-0.033256498668733,9.39335648238225e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,42119,-0.0683944894952827,0.00853695871925928,-0.0851269285850309,-0.0516620504055345,1.22471414386917e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,42016,-0.0364985669907048,0.00455627752491873,-0.0454288709395455,-0.0275682630418641,1.23505173747428e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.0587094492765089,0.00733781726603719,-0.0730915711179418,-0.044327327435076,1.3347245774383e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.0251723661028439,0.00316694928117287,0.0189651455117451,0.0313795866939427,2.07060353887445e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,42310,0.0133943131934074,0.0016887431745643,0.0100843765712614,0.0167042498155534,2.33143384054914e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.027587699635346,0.00349511756103632,0.0207372692157148,0.0344381300549772,3.21530621925571e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.0726314501381442,0.00920186866296208,-0.0906671127175499,-0.0545957875587386,3.21856307513535e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,39736,-0.0284859077219602,0.00362604350744146,-0.0355929529965455,-0.0213788624473749,4.33325620403433e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,42310,0.0252197643858292,0.00321333855858317,0.0189216208110062,0.0315179079606522,4.52255956187579e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.018283878219945,0.00233053977562591,0.0137160202597182,0.0228517361801718,4.70418883505923e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.0545566630317026,0.00695611377026749,-0.0681906460214269,-0.0409226800419783,4.72830081627054e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.0848808163002701,0.0108335881880814,-0.10611464914891,-0.0636469834516305,5.03587889659882e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0252923878510645,0.0032281882168506,-0.0316196367560917,-0.0189651389460373,5.03987321566039e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.032947155110853,0.00420608494626078,-0.0411910816055241,-0.0247032286161819,5.10383228666743e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KAZN,Kazrin,39930,-0.0870708988350978,0.0111133510630659,-0.108853066918707,-0.0652887307514887,5.11512990832246e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,42016,0.0276395981512809,0.00353288224999237,0.0207151489412959,0.034564047361266,5.51905248546593e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0269092452227095,0.00344230342258717,0.0201623305144387,0.0336561599309804,5.89027506364931e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.0334382734007916,0.00428263476094154,-0.041832237532237,-0.0250443092693461,6.24247859905526e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,42070,0.0643472886962088,0.00824551075998884,0.0481860876066307,0.0805084897857869,6.44217790865591e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,-0.0406946174411683,0.00521746374807963,-0.0509208463874044,-0.0304683884949322,6.6685876971077e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.0483512457247738,0.00619946249838366,0.0362002992279418,0.0605021922216057,6.67803785122918e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0246129767844177,0.00316689666782671,0.0184058593154774,0.0308200942533581,8.28155781487689e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.018136960698757,0.00233760123700331,0.0135552622742305,0.0227186591232835,9.19737349188973e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,0.0223033985184886,0.0028755884736497,0.0166672451101352,0.027939551926842,9.50310022987864e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.0399826013914608,0.005157756980274,-0.0500918050727979,-0.0298733977101238,9.70847818910959e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,39736,-0.0571291911034324,0.00738423405381974,-0.0716022898489191,-0.0426560923579457,1.10887292155742e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,42310,-0.0356139442805721,0.00460502539953189,-0.0446397940636546,-0.0265880944974896,1.11715301909482e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,-0.0226278438550708,0.00292685788340213,-0.028364485306539,-0.0168912024036026,1.15689888373894e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.0200395128824546,0.00259282017927716,0.0149575853310714,0.0251214404338379,1.1604868411458e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.0651690711186391,0.00843261876077132,-0.0816970038897509,-0.0486411383475274,1.18283505031752e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFI,Complement factor I,39979,-0.0158821907575448,0.0020569452370365,-0.0199138034221363,-0.0118505780929533,1.24838638375728e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,42070,0.0227258380459962,0.00294698628475544,0.0169497449278755,0.0285019311641168,1.3299364008845e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,39934,-0.0423338060573812,0.00548983213707376,-0.0530938770460457,-0.0315737350687166,1.34946348918399e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,-0.0778844062966818,0.0101062627571226,-0.0976926813006421,-0.0580761312927215,1.38164699557832e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,39638,-0.0420306362656596,0.00548210189056106,-0.0527755559711593,-0.03128571656016,1.9102078585303e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,42169,0.0221294702320914,0.00289062504431056,0.0164638451452427,0.0277950953189401,2.05383285237782e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,42016,0.0210787328973243,0.00276149160486287,0.015666209351793,0.0264912564428555,2.44627500241585e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,-0.049170883804979,0.00644298295887678,-0.0617991304043775,-0.0365426372055805,2.47500458107024e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.0190971928538894,0.00250383577503436,-0.0240047109729567,-0.014189674734822,2.55859242840432e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0417422545908839,0.00548134905306073,-0.0524856987348829,-0.0309988104468849,2.80622603530922e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,0.0223873366026696,0.00294131162273075,0.0166223658221174,0.0281523073832219,2.89105286683489e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,39929,-0.0491554184750469,0.0064690473358128,-0.0618347512532399,-0.0364760856968538,3.23046732487272e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.038950818876598,0.00512837196102774,0.0288992098329836,0.0490024279202124,3.27553374853145e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0611556301439975,0.00808455316989172,-0.0770013543569853,-0.0453099059310098,4.14430805262708e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,-0.0419615198308377,0.0055560986586326,-0.0528514732017576,-0.0310715664599178,4.55121101876721e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,-0.0410528781004591,0.00545253263253801,-0.0517398420602336,-0.0303659141406846,5.49519707842773e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,39934,0.0390342071519293,0.00518596380171385,0.0288697181005702,0.0491986962032885,5.58980338692692e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,42249,0.0230798483655514,0.00307578574723438,0.017051308300972,0.0291083884301308,6.58622523577949e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.0420948225862969,0.00561286968961335,0.0310935979946547,0.0530960471779391,6.79432022625554e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.0351418317553378,0.00468631361230475,-0.0443270064354551,-0.0259566570752205,6.84162217619974e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.0388815303297929,0.0051904365967844,-0.0490547860594903,-0.0287082746000955,7.34401689479316e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.018718590158834,0.00249910565266534,-0.0236168372380581,-0.0138203430796099,7.39091789538007e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.0497275890392613,0.00664559987850447,-0.0627529648011301,-0.0367022132773926,7.72447308290064e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,-0.0216731523074532,0.00290938244126641,-0.0273755418923354,-0.015970762722571,9.94205985907934e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.0154247351408364,0.00207765694953164,-0.0194969427619184,-0.0113525275197544,1.20256428313851e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.0706002630694551,0.00951216743956322,-0.089244111250999,-0.0519564148879112,1.2222599089172e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.0437416743003385,0.00589384114162167,-0.055293602937917,-0.03218974566276,1.22745472098533e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.0529712769748104,0.00713899367824972,-0.0669637045841799,-0.038978849365441,1.24137518681466e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,41843,-0.0772158462872369,0.010422397328959,-0.0976437450519966,-0.0567879475224772,1.3531926058224e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,-0.0323549221153388,0.00437344980174683,-0.0409268837267625,-0.023782960503915,1.47984583309086e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,39736,0.0409022453305594,0.00553074292113634,0.0300619892051322,0.0517425014559866,1.51070643924052e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.0663980109092255,0.00899494365372772,-0.0840281004705318,-0.0487679213479192,1.67518832736342e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,42137,-0.0300959420810862,0.00408535192309811,-0.0381032318503585,-0.0220886523118139,1.84891228076559e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0255193191286906,0.00347009206852812,-0.0323206995830057,-0.0187179386743755,2.03352396420066e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,-0.0415175917621315,0.00565122662863832,-0.0525939959542626,-0.0304411875700004,2.15128871493957e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,-0.048767443426426,0.00664099791659129,-0.0617837993429449,-0.035751087509907,2.22491602148083e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,0.0324500034653682,0.00442941429531,0.0237683514465606,0.0411316554841758,2.53467226759059e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,-0.0178157789051994,0.00243660005835429,-0.0225915150195738,-0.013040042790825,2.78668241452189e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,39736,-0.0358236044434809,0.00490230531697225,-0.0454321228647466,-0.0262150860222153,2.90776657150085e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,-0.021756547280359,0.00298000860738096,-0.0275973641508256,-0.0159157304098923,3.02024264465586e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.0211536439921932,0.00289963700543675,-0.0268369325228492,-0.0154703554615372,3.18451153985218e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,42296,-0.0367372039593624,0.00503727660676665,-0.046610266108625,-0.0268641418100997,3.19601497829564e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,39813,-0.0851332041288381,0.0116833169483197,-0.108032505347545,-0.0622339029101315,3.38890443314257e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.0148045318930278,0.00203467579158282,0.0108165673415255,0.0187924964445301,3.62347439834588e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,39978,-0.0430048641064781,0.00591810973401584,-0.0546043591851492,-0.0314053690278071,3.92605500899734e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,42168,-0.0247105549770016,0.0034124432150708,-0.0313989436785404,-0.0180221662754628,4.68302946893218e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0265593246763694,0.00366952009321895,-0.0337515840590786,-0.0193670652936603,4.80309754413591e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,42181,0.0210472058591558,0.00291366837373166,0.0153364158466417,0.0267579958716699,5.33216327647974e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.0556222803348383,0.00770240416252627,-0.0707189924933898,-0.0405255681762868,5.47361082625741e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,-0.0675731196240346,0.00936495566162674,-0.085928432720823,-0.0492178065272462,5.71553027851948e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0456330446644606,0.00632707798885955,-0.0580341175226254,-0.0332319718062959,5.79336791374329e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0291434376906362,0.0040414703818017,0.0212221557423048,0.0370647196389675,5.84470805767156e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASPN,Asporin,39958,0.0212875607361229,0.00295198846989605,0.0155016633351266,0.0270734581371191,5.89584995074584e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0296016165555571,0.00410714356935382,-0.0376516179514906,-0.0215516151596236,6.0037269794622e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,42119,-0.0426097168575913,0.00591440601434389,-0.0542019526457053,-0.0310174810694773,6.1388937655671e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,39966,0.0245370936283218,0.0034055336754292,0.0178622476244805,0.031211939632163,6.16870119276658e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,42250,-0.0384734545628812,0.00535110904404286,-0.0489616282892052,-0.0279852808365572,6.82555919601057e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,39826,0.0836641742584165,0.0116780662700592,0.0607751643691005,0.106553184147732,8.31337095142301e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,-0.0629444342658675,0.00878647371031007,-0.0801659227380752,-0.0457229457936598,8.34327117131353e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,-0.0440487313380293,0.00615432017404,-0.0561111988791477,-0.0319862637969109,8.65724746269766e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,-0.0560519734052306,0.00787292774388165,-0.0714829117832386,-0.0406210350272225,1.14979913122163e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.0432731928410854,0.00608280948365606,-0.0551954994290513,-0.0313508862531195,1.18332706029963e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.0929485311076544,0.0130705688505386,-0.11856684605471,-0.0673302161605987,1.22071380992847e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,39966,-0.0211808374519252,0.00297944211836257,-0.0270205440039158,-0.0153411308999345,1.23897789091433e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.0604683360746709,0.00852979504435584,-0.0771867343616084,-0.0437499377877335,1.43244798201024e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,42124,0.0432079864247735,0.00609989977038453,0.0312521828748198,0.0551637899747272,1.47621952323625e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.0192316098591732,0.00271518115639581,-0.024553364925709,-0.0139098547926375,1.48007534505396e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MENT,Protein MENT,39736,0.0178074165175184,0.00251834887148304,0.0128714527294116,0.0227433803056252,1.62955429174366e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,-0.0824540421335407,0.0116766963809614,-0.105340367040225,-0.0595677172268564,1.74478200306382e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0301725049962897,0.00430314209356035,-0.038606663499668,-0.0217383464929114,2.48760489480748e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.080141003097883,0.0114782520212464,-0.102638377059526,-0.0576436291362401,3.07309619129732e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.0397670275531904,0.00571193730247808,-0.0509624246660474,-0.0285716304403334,3.50990829303111e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,-0.0458112350592738,0.00658003565480245,-0.0587081049426866,-0.032914365175861,3.53631803188104e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,42119,-0.0637736055528261,0.00917054055042185,-0.081747865031653,-0.0457993460739993,3.70905240826066e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0196873388205644,0.00283257697371273,0.0141354879520875,0.0252391896890414,3.81205265881811e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.0424032004450569,0.00610279037603974,-0.0543646695820948,-0.030441731308019,3.8688436672306e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.0615030954689243,0.00885932871087611,-0.0788673797422415,-0.0441388111956071,4.03761964551125e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,-0.0408288245315942,0.00590104189126291,-0.0523948666384695,-0.0292627824247189,4.796355528394e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.0437147993890547,0.00633363524592259,-0.0561287244710629,-0.0313008743070464,5.3558151547283e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.0578191956298771,0.00838065913353317,-0.0742452875316022,-0.0413931037281521,5.47033956551893e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,-0.0336527479669337,0.00488498425361911,-0.0432273171040272,-0.0240781788298403,5.86456979694343e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.0425468283568948,0.00617856268062438,-0.0546568112109185,-0.030436845502871,5.98292610029669e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.0213749877771246,0.00311090488481464,-0.0274723613513613,-0.0152776142028879,6.66106231158678e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.060814885540114,0.00885347146508756,-0.0781676896116856,-0.0434620814685424,6.80188817505561e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.043633286428294,0.00636144241227356,-0.0561017135563502,-0.0311648593002378,7.23249456034469e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0433059838789478,0.00631468236935853,-0.0556827613228906,-0.0309292064350051,7.34645372006545e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,42185,-0.0306203081373879,0.00446951291865293,-0.0393805534579476,-0.0218600628168281,7.65319482982625e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.0197116274644547,0.00287826830266599,0.0140702215912294,0.0253530333376801,7.78893302762209e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REN,Renin,42145,-0.0586499948058545,0.00860050546172735,-0.0755069855108401,-0.0417930041008689,9.53199658125371e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,39930,-0.049124457966949,0.00720427326739794,-0.063244833571049,-0.035004082362849,9.64762999788991e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPTC,Opticin,42070,0.0327021090778712,0.00480516978882831,0.0232839762917677,0.0421202418639747,1.04878024293359e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0289804672276109,0.00425858073273066,-0.037327285463763,-0.0206336489914588,1.05119196478336e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,-0.0986951447597219,0.0145098064668748,-0.127134365434796,-0.0702559240846473,1.07559751215677e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,42145,-0.0191992871036193,0.00282409224828578,-0.0247345079102595,-0.0136640662969792,1.10223366144117e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.0283752865722807,0.00417637644728552,0.0201895887356011,0.0365609844089604,1.13517703506548e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.0477195000729599,0.00704312240794377,-0.0615240199925297,-0.0339149801533901,1.29368475129915e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,-0.0542387100906602,0.00801069630450217,-0.0699396748474844,-0.0385377453338359,1.334012004679e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,39736,0.0336498798559419,0.00496904575994866,0.0239105501664425,0.0433892095454413,1.33501123946929e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,42129,-0.0217965925816534,0.00322058760642782,-0.0281089442902519,-0.0154842408730549,1.36052519885612e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.0196051933065785,0.00289730863028578,-0.0252839182219387,-0.0139264683912184,1.37185454508036e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,-0.0364599039486668,0.00539899411690501,-0.0470419324178006,-0.025877875479533,1.50628685165239e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,41797,-0.0502813063697909,0.00744784439686091,-0.0648790813876383,-0.0356835313519436,1.52841446317325e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,42170,0.026450827254359,0.00391885688455959,0.0187698677606222,0.0341317867480958,1.54244469265534e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,0.0284114158253367,0.00421273755319568,0.0201544502210732,0.0366683814296002,1.60150936921897e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.0374718077182049,0.00555977355589144,0.0265746515486577,0.0483689638877521,1.65024340378942e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,39919,-0.0600216510193006,0.00890687724757757,-0.0774791304245527,-0.0425641716140486,1.67455328396781e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.0620057752891915,0.00920224945197601,-0.0800421842150645,-0.0439693663633185,1.68435088044342e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,42262,0.0118543858452583,0.00176060361685976,0.00840360275621312,0.0153051689343034,1.72675756805025e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,-0.0615249257405598,0.00914190835500121,-0.0794430661163622,-0.0436067853647574,1.77864891641946e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,39930,-0.0679966736867879,0.0101134548261526,-0.0878190451460469,-0.0481743022275289,1.86080765456725e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,-0.0548260399035167,0.00816300351037208,-0.070825526783846,-0.0388265530231875,1.95335478142665e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,-0.0263305848604721,0.00392439878834998,-0.0340224064856381,-0.0186387632353062,2.03205068532241e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.0749251793370588,0.0111716954352376,-0.0968217023901245,-0.0530286562839932,2.07028836843475e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,-0.0515883912370693,0.00772031050326042,-0.0667201998234597,-0.0364565826506789,2.46449387680084e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.053078011674109,0.00795294227051793,-0.0686657785243242,-0.0374902448238939,2.60493150576931e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.0399399895541105,0.00599476821192479,-0.0516897352494831,-0.0281902438587379,2.79574382178424e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.0199793395036185,0.00300002714250489,0.0140992863043089,0.0258593927029281,2.84939050124068e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,-0.0492422991875316,0.00739679520840873,-0.0637400177960128,-0.0347445805790505,2.89938581368119e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.0320711714331092,0.00481868253884581,0.0226265536569714,0.041515789209247,2.93295664605765e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,42310,0.0188117194177196,0.00282685851813347,0.013271076722178,0.0243523621132612,2.94786068040286e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,42181,0.0215831459356869,0.00325038465463586,0.0152123920126006,0.0279538998587732,3.2520740774965e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.033417911072782,0.00503845245763474,-0.0432932778897461,-0.0235425442558179,3.42415593298799e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.0531608878402436,0.00802135577746685,-0.0688827451640786,-0.0374390305164085,3.54385088217088e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,42299,0.031249743253551,0.00471595762675793,0.0220064663051054,0.0404930202019965,3.56868828094971e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,41843,-0.0335095687609204,0.00506313610506974,-0.043433315526857,-0.0235858219949837,3.77233113530789e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.0480862682075965,0.00728288057735394,-0.0623607141392102,-0.0338118222759828,4.22429411087088e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.0428800162989036,0.00649665656083732,-0.0556134631581447,-0.0301465694396624,4.25898314286843e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,39638,-0.0310699721721654,0.00471185210795552,-0.0403052023037582,-0.0218347420405726,4.47670578864901e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.0864727553132743,0.0131303091974396,-0.112208161340256,-0.0607373492862927,4.69355475861267e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,42137,-0.0314309151862825,0.00477298617302807,-0.0407859680854175,-0.0220758622871475,4.71139216254746e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.0193382914635896,0.00294375710115137,-0.0251080553818463,-0.0135685275453329,5.24146589206652e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.029782976239037,0.00453410100152959,-0.038669814202035,-0.020896138276039,5.2626845123732e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,-0.042649144990002,0.00649627777873333,-0.0553818494363193,-0.0299164405436847,5.38722548890103e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,39934,-0.0743166310688236,0.0113253904768284,-0.0965143964034073,-0.0521188657342399,5.54243481915196e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBIN,Erbin,42070,-0.0710642472759048,0.0108470184515105,-0.0923244034408654,-0.0498040911109443,5.90317848235058e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,0.0187607406081536,0.0028661768989133,0.0131430338862835,0.0243784473300236,6.13798250305251e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.0262262651123801,0.00400808274550988,-0.0340821072935794,-0.0183704229311807,6.28220124123907e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,39966,0.0177003751007558,0.00270664136784302,0.0123953580197835,0.0230053921817282,6.43249904873641e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,0.0234597807012464,0.00358782636587736,0.0164276410241267,0.030491920378366,6.47887178973376e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.0971972728982966,0.0148763105240816,-0.126354841525497,-0.0680397042710967,6.69171633305472e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.0388007652466161,0.00594030829660817,-0.0504437695079681,-0.0271577609852641,6.73374461537464e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,-0.0212406219218767,0.00325995792238415,-0.0276301394497496,-0.0148511043940037,7.55906828805301e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.0468593890394954,0.0072064478097633,-0.0609840267466315,-0.0327347513323593,8.17856741248406e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,42070,0.0207042366563863,0.00318558337582782,0.0144604932397638,0.0269479800730088,8.35049060174689e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,-0.0388721165725249,0.0059909873437657,-0.0506144517663057,-0.0271297813787441,8.98198320713238e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.0445140377319954,0.00686157362549843,-0.0579627220379723,-0.0310653534260185,9.03207248074724e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.0204415529279296,0.00315271525779604,-0.0266208748332098,-0.0142622310226493,9.25370775100066e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,-0.0293554033544691,0.00453517726264187,-0.0382443507892472,-0.0204664559196911,1.00291042674722e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0500252152315373,0.00773757777952152,-0.0651908676793995,-0.0348595627836751,1.05414552439615e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,42262,-0.0373315346593441,0.00577806422493822,-0.048656540540223,-0.0260065287784651,1.07604868750674e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.0340666096969269,0.00527358180875745,-0.0444028300420915,-0.0237303893517623,1.08463428461799e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.033753425886357,0.00523138795047293,-0.044006946269284,-0.0234999055034301,1.1407098344853e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,39575,-0.0269072147325925,0.00416963352482994,-0.0350796964412591,-0.0187347330239258,1.14175374900027e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,39929,-0.0470958575575474,0.00730202456519137,-0.0614078257053225,-0.0327838894097723,1.16635749760407e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,-0.0267504803419933,0.00417617546244815,-0.0349357842483917,-0.018565176435595,1.55797846559104e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,-0.0525528748719586,0.0082108679977899,-0.0686461761476268,-0.0364595735962904,1.60098915524678e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.0576329953596866,0.00901142318432286,-0.0752953848009594,-0.0399706059184138,1.65235213522463e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,0.0440187490548359,0.00688200205623757,0.0305300250246103,0.0575074730850615,1.65517279689784e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,-0.0489897131864958,0.00766510665499042,-0.0640133222302771,-0.0339661041427146,1.70986780011073e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.0522329110119913,0.00818205633628385,-0.0682697414311077,-0.036196080592875,1.79437800600568e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.0417060606273646,0.00656522248996914,-0.0545738967077041,-0.0288382245470251,2.2007498237596e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.0297450636481788,0.00469398306773385,-0.0389452704609372,-0.0205448568354205,2.41947523930742e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,-0.0555100467814292,0.0087597924371592,-0.0726792399582613,-0.0383408536045972,2.43287338504421e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,41913,-0.0316420714821558,0.0049967036049571,-0.0414356105478717,-0.0218485324164399,2.48827148535312e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,39934,-0.0444948255598891,0.00704111085562061,-0.0582954028369055,-0.0306942482828727,2.72625560289336e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.0342545063477986,0.005430576588769,-0.0448984364617859,-0.0236105762338114,2.94065399657644e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,39929,-0.0438982079445648,0.00697376835362479,-0.0575667939176694,-0.0302296219714603,3.19252156839132e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,-0.0367717190291928,0.00584610093986459,-0.0482300768713274,-0.0253133611870582,3.27545881610349e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.015918123585265,0.00253076682961287,0.0109578205992238,0.0208784265713062,3.2755808735496e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,41900,-0.037587343421816,0.00597763823867912,-0.049303514369627,-0.0258711724740049,3.3165586379183e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.0483817375163899,0.00769480216009236,-0.0634635497501709,-0.0332999252826089,3.32431916092235e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.041196825880054,0.00655837179412359,-0.0540512345965362,-0.0283424171635717,3.47470504417168e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,42262,-0.0260156218162252,0.00414389980315393,-0.0341376654304069,-0.0178935782020435,3.53208878994036e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,42296,-0.062907491100955,0.0100311718020395,-0.0825685878329525,-0.0432463943689576,3.69036934429063e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,42310,0.0195681605711972,0.00312108520309687,0.0134508335731273,0.0256854875692671,3.72671514122032e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0107007502265837,0.0017080942521804,0.00735288549231013,0.0140486149608573,3.84632187973287e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,41843,-0.0498075286755568,0.00795624130309555,-0.065401761629624,-0.0342132957214895,3.96393702103399e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.0378792126385782,0.00605879688048956,0.0260039707528187,0.0497544545243378,4.17713731829073e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,-0.0524370633698842,0.00839400317799409,-0.0688893095987526,-0.0359848171410157,4.33922965203847e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,-0.0513888191745538,0.00824380904725047,-0.0675466849071647,-0.0352309534419429,4.7195929226529e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0294922441306318,0.00473487151262515,0.0202118959658865,0.0387725922953771,4.84140443822137e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,39966,0.0328649152207883,0.00527683641206458,0.0225223158531417,0.0432075145884348,4.88650782368315e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,-0.0372077864256654,0.00598372915440182,-0.0489358955682929,-0.0254796772830378,5.18135034424617e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,-0.0355896930842202,0.00572598886687611,-0.0468126312632974,-0.024366754905143,5.29990143721698e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,42167,0.0138679464002956,0.00223376320022335,0.00948977052785787,0.0182461222727334,5.51100984467521e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.0164755445713592,0.00265608844831731,-0.0216814779300611,-0.0112696112126573,5.70275370894095e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0183013727367874,0.00295178924255757,0.0125158658213745,0.0240868796522002,5.80495235885204e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,42137,0.0161027907591162,0.00259782699564889,0.0110110498476444,0.0211945316705881,5.8635502686719e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.0420766945365329,0.00678755153203687,-0.0553802955393251,-0.0287730935337406,5.87629375403644e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OCLN,Occludin,39934,-0.0291063336081196,0.00469619608292997,-0.0383108779306624,-0.0199017892855769,5.92268468781792e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,39929,-0.0712514807125745,0.0115040069259112,-0.0937993342873605,-0.0487036271377886,6.0834660413921e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.0482881543532975,0.00780022790450637,-0.06357660104613,-0.032999707660465,6.16623604405941e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,41839,-0.0222502209557181,0.00359636009453424,-0.0292990867410052,-0.015201355170431,6.31780480906732e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.0466255747965033,0.00753977619843882,0.0318476134475632,0.0614035361454434,6.46719057134611e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.0185260950970814,0.00299602861650155,-0.0243983111854244,-0.0126538790087383,6.48336849842385e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.0153310782364797,0.00248152209120419,0.0104672949377195,0.02019486153524,6.67325483685445e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,-0.0386467108691326,0.00625844194096126,-0.0509132570734167,-0.0263801646648486,6.80433906283155e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.0376012601624495,0.00611692805757038,-0.0495904391552875,-0.0256120811696116,8.15802648814902e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,-0.0408670789138906,0.00665185266168141,-0.0539047101307861,-0.027829447696995,8.34084723917782e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,39929,-0.035310478004077,0.00574977084227242,-0.046580028854931,-0.024040927153223,8.46463210489788e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,39979,0.0196688179403398,0.00320500106450955,0.0133870158539011,0.0259506200267785,8.69388661857352e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0198944521190917,0.00324526073458686,0.0135337410793014,0.0262551631588819,9.06269998680401e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,-0.0630610188585153,0.0102882750076352,-0.0832260378734803,-0.0428959998435503,9.12142731975097e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.0493092963333058,0.0080575707340731,-0.0651021349720891,-0.0335164576945225,9.63794881730751e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.0554098804564923,0.00905902900439991,-0.0731655773051162,-0.0376541836078685,9.83094277760499e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.0263603280506147,0.00431562472823201,-0.0348189525179495,-0.01790170358328,1.04111317070196e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.0194595002845052,0.00318621381332472,-0.0257044793586216,-0.0132145212103887,1.0458344278564e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.0164414414131309,0.00269232159979648,-0.021718391748732,-0.0111644910775298,1.04971906180225e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,-0.0671417527989096,0.0110025526620156,-0.0887067560164602,-0.045576749581359,1.07342201403784e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,39919,-0.0143626743674369,0.00235407745662093,-0.018976666182414,-0.00974868255245991,1.08722558526044e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.0248914890180666,0.00408589771529259,0.0168831294960931,0.0328998485400401,1.14465294503086e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,-0.0383396501128212,0.00629401068438544,-0.0506759110542166,-0.0260033891714257,1.14976018766183e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.0612620017441389,0.0100731873785241,-0.0810054490060462,-0.0415185544822315,1.22182010749759e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.017520427224249,0.0028862204951264,0.0118634350538012,0.0231774193946967,1.31686744080215e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0367314527671517,0.0060592292265398,-0.0486075420511697,-0.0248553634831337,1.38019983234489e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,-0.0521049151642243,0.00860584149878674,-0.0689723645018463,-0.0352374658266023,1.45225746785533e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,39903,-0.0469252685865753,0.00775258469838923,-0.0621203345954182,-0.0317302025777324,1.46814591485934e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.0377693816880735,0.00624306956826192,-0.0500057980418669,-0.0255329653342802,1.48809749834294e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,42310,-0.0369733066488215,0.00612371599175963,-0.0489757899926704,-0.0249708233049727,1.60340509652008e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.0467123380924304,0.00775042180241079,-0.0619031648251555,-0.0315215113597052,1.72150592329674e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.0174429529242632,0.00289709480566017,0.0117646471051693,0.0231212587433571,1.78906841351012e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.046494720824867,0.00772705612613934,-0.0616397508321001,-0.0313496908176339,1.82086962337972e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,39930,-0.045517244275083,0.0075747353734664,-0.0603637256070771,-0.0306707629430888,1.92307131002961e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.0294244801940501,0.00489751731229968,-0.0390236141261575,-0.0198253462619427,1.92597939133102e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,41913,-0.0282015069876455,0.00469987995436603,-0.0374132716982029,-0.0189897422770881,2.01851395783994e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.0210510794845054,0.0035091191904956,-0.0279289530978768,-0.0141732058711341,2.03617968473788e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.0191790487458294,0.00319883080192221,-0.0254487571175969,-0.0129093403740619,2.07840056856098e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.0398999951802154,0.00665889767264996,-0.0529514346186093,-0.0268485557418215,2.12518712106388e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.039871090716696,0.00666878850485309,-0.0529419161862081,-0.026800265247184,2.3179918236448e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.0208738624105753,0.00349331946259848,-0.0277207685572684,-0.0140269562638823,2.36447196090463e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FST,Follistatin,42166,0.030797187387232,0.00515805485538161,0.0206873998706841,0.04090697490378,2.42142875655725e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.0165225022713462,0.00276882027398154,0.0110956145343424,0.0219493900083501,2.48540245008771e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.00516996209419876,0.000866419725514795,0.00347177943218976,0.00686814475620775,2.48907549628157e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.041742828140664,0.00700713554681296,-0.0554768138124174,-0.0280088424689106,2.64373176917502e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0391211824527096,0.00658566441077872,-0.0520290846978359,-0.0262132802075833,2.92770039864264e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,41992,-0.0316164639443375,0.00533552318305011,-0.0420740893831157,-0.0211588385055593,3.18698898684812e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,-0.0415342635608464,0.00702439987750209,-0.0553020873207505,-0.0277664398009423,3.45922043641936e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.0252902502092598,0.00427908286458384,-0.0336772526238441,-0.0169032477946755,3.49799306852205e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,-0.0332033652784013,0.00562367694620782,-0.0442257720929686,-0.0221809584638339,3.64777174861232e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.0268597518261269,0.00455147112445422,-0.0357806352300572,-0.0179388684221967,3.69274159324613e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,-0.059068392764518,0.0100194870488469,-0.078706587380258,-0.0394301981487781,3.84541923912653e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,-0.0438637905096359,0.00744152078134989,-0.0584491712410817,-0.0292784097781901,3.86881846588031e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELP,P-selectin,42217,-0.034753821103175,0.0059041151867368,-0.0463258868691792,-0.0231817553371709,4.04054093297837e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,-0.0365712514783472,0.00622413320952488,-0.0487705525690159,-0.0243719503876784,4.3113563444319e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,39990,-0.0456689313011024,0.00777349224274547,-0.0609049760968835,-0.0304328865053212,4.34785394896067e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.0529617477095565,0.00901581523896782,-0.0706327455779334,-0.0352907498411795,4.3479032132593e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,-0.0299265857679919,0.00510689980485216,-0.0399361093855021,-0.0199170621504817,4.75664655733811e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,42137,0.0307931886591406,0.00525915880774535,0.0204852373959597,0.0411011399223215,4.8761446468136e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.030084842042388,0.0051568053591731,0.0199775035384087,0.0401921805463672,5.53445332096254e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,-0.0516276598374931,0.00885483134158367,-0.0689831292669971,-0.0342721904079892,5.67865253283979e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.0604986447656344,0.0103998528547299,-0.080882356360905,-0.0401149331703639,6.11738601502318e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.0224670827350691,0.0038674400133336,0.0148869003089353,0.030047265161203,6.41611620778474e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.0584044158539938,0.0100539783328303,-0.0781102133863411,-0.0386986183216464,6.42222645931582e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.0342181107814859,0.00590590659228014,-0.045793687702355,-0.0226425338606169,7.02963128101926e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.031980551197236,0.0055210681630711,-0.0428018447968553,-0.0211592575976166,7.09399910247415e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0219026250796877,0.00378667504430835,0.0144807419928434,0.0293245081665321,7.44986952758843e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.0249619864699785,0.00431723568005806,0.0165002045370647,0.0334237684028923,7.54537900379519e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,0.0174947527415045,0.00302656910896791,0.0115626772879274,0.0234268281950816,7.61645288545266e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.0318576183909545,0.00551594503620225,-0.0426688706619109,-0.021046366119998,7.83687353648568e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,39757,-0.0330192606270848,0.00572160656467712,-0.044233609493852,-0.0218049117603177,8.09115597120633e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.0281077074118508,0.00487971830075257,-0.0376719552813258,-0.0185434595423758,8.62849923347195e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,-0.0467625251662786,0.00812125746014555,-0.0626801897881639,-0.0308448605443933,8.69451580914669e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,39919,-0.0380682586319258,0.00661454198003862,-0.0510327609128015,-0.0251037563510502,8.87661605604524e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,39713,0.0176514487441983,0.00306982277690161,0.0116345961014711,0.0236683013869254,9.16007762667066e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.0679381044730305,0.0118222259656033,-0.091109667365613,-0.044766541580448,9.30145357418323e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,39757,-0.0783799428108754,0.0136758542053276,-0.105184617053318,-0.0515752685684332,1.02267396730156e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,42081,-0.0255805876557486,0.00446935748978952,-0.0343405283357361,-0.0168206469757611,1.06542438451417e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,-0.0297451161093068,0.00520751411024851,-0.0399518437653938,-0.0195383884532197,1.14563625619035e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,-0.0348328329982546,0.00609903610142079,-0.0467869437570394,-0.0228787222394699,1.14591608610692e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLC,Galectin-10,42119,0.0406620403521113,0.0071232154641326,0.0267005380424114,0.0546235426618112,1.16451087548823e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,42185,-0.0286522815574356,0.00502311375041712,-0.0384975845082531,-0.018806978606618,1.19406157655413e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TF,Serotransferrin,39979,-0.0129510549261505,0.00227277855810471,-0.0174057009000358,-0.0084964089522653,1.23986885345661e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.0589450088813694,0.010346847999652,-0.0792248309606873,-0.0386651868020514,1.24598626122588e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,42085,-0.0503721344870173,0.00884474690708897,-0.0677078384249117,-0.0330364305491229,1.25838577076195e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,42070,-0.0323844653258185,0.00569651576004828,-0.0435496362155131,-0.0212192944361239,1.33558195868124e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.0154333354602748,0.00272519921011201,0.0100919450084552,0.0207747259120943,1.52195128908085e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.0210544919889043,0.00372782438495215,-0.0283610277834105,-0.0137479561943981,1.65704025685558e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,-0.0405981974057922,0.00718840211419697,-0.0546874655496182,-0.0265089292619661,1.66558422649667e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.0302236297676243,0.00535244984784197,-0.0407144314693945,-0.019732828065854,1.66856349462963e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0216698183972424,0.00383940567794457,-0.0291950535260137,-0.014144583268471,1.69499773491033e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,39638,-0.044368888004432,0.00786076187097871,-0.0597759812715502,-0.0289617947373137,1.69896720166541e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.0230009894369881,0.00407698659617813,0.015010095708479,0.0309918831654973,1.71837541685417e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0380991586375257,0.00675616307224869,-0.0513412382591331,-0.0248570790159183,1.74301948882072e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,39657,-0.0278495836811399,0.00493920390376803,-0.0375304233325253,-0.0181687440297546,1.75768735989513e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.0650835942093959,0.0115528430129949,-0.0877271665148658,-0.0424400219039259,1.80740255790834e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,42258,-0.0159592894391034,0.00283709642383096,-0.0215199984298121,-0.0103985804483948,1.88909816129477e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,39979,-0.0246099802038343,0.00437502516937431,-0.033185029535808,-0.0160349308718607,1.89769651779822e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.019625089351489,0.00349990258675382,-0.0264848984215265,-0.0127652802814515,2.09518273537724e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0233517826868506,0.00416767058736645,0.0151831483356124,0.0315204170380889,2.14706637924318e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.0339458046331434,0.00606658211091384,-0.0458363055705345,-0.0220553036957523,2.24167851040781e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,-0.0492598447400564,0.0088063354238166,-0.0665202621707369,-0.0319994273093758,2.26623850145691e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,39586,-0.0240988759232666,0.00430776783412381,-0.0325421008781493,-0.0156556509683839,2.26836117005206e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,42119,0.0261713938114663,0.00468127391950198,0.0169960969292424,0.0353466906936901,2.30592943968727e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,42310,-0.0270727670723633,0.00484686573078086,-0.0365726239046938,-0.0175729102400329,2.37293118990489e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,42103,-0.0391958186791006,0.00702192245626126,-0.0529587866933727,-0.0254328506648285,2.42459233827591e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.0382799227417619,0.00685921798751456,0.0248358554862334,0.0517239899972905,2.44026008401343e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,39575,-0.0390954716395346,0.00700991184452891,-0.0528348988548113,-0.0253560444242579,2.50249099086157e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,41831,-0.0233934662426423,0.00420229472016079,-0.0316299638941575,-0.0151569685911272,2.64461159207545e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.0575982108833942,0.0103508613631778,-0.0778858991552227,-0.0373105226115657,2.67713187889974e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.0462616914141444,0.00831726284711577,0.0299598562337974,0.0625635265944913,2.71542887192988e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.0479120921879555,0.00863255446385576,-0.0648318989371128,-0.0309922854387982,2.90717471807443e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0391556978717482,0.00705680003602201,-0.0529870259423514,-0.0253243698011451,2.94320551384447e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,42084,-0.0192204835548949,0.00346687330252894,-0.0260155552278516,-0.0124254118819382,3.01124562296606e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.0527729135356246,0.00952079112153129,-0.071433664133826,-0.0341121629374233,3.04137818849298e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0385467125954611,0.00698663784510249,-0.052240522771862,-0.0248529024190602,3.50766430796752e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.0387009418395259,0.00701661637123221,-0.052453509927141,-0.0249483737519108,3.55389276464353e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,39638,-0.0406439572280218,0.00737005168650913,-0.0550892585335797,-0.0261986559224639,3.57150696045628e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0402093709400893,0.00729246847569767,0.0259161327277219,0.0545026091524567,3.57588140718083e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.0201280120713153,0.00365192505279718,0.0129702389678329,0.0272857851747978,3.63499019990995e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.0162902831706533,0.00295694050550374,-0.0220858865614406,-0.0104946797798659,3.67262296927574e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0139902672651333,0.00254053488264003,0.00901081889515888,0.0189697156351078,3.71997293798123e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,42275,-0.0397032750355537,0.0072112965291983,-0.0538374162327824,-0.0255691338383251,3.74321033759817e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,39919,-0.0236643668519285,0.00429807076560965,-0.0320885855525235,-0.0152401481513336,3.75488083030913e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,42249,-0.0354731349430709,0.0064476015133545,-0.0481104339092457,-0.0228358359768961,3.82798072379859e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,39638,-0.0228052174230135,0.00414599297356161,-0.0309313636511943,-0.0146790711948328,3.87060861657504e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,41960,-0.0235299555733505,0.00428046955448202,-0.0319196759001353,-0.0151402352465658,3.93280562597883e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.0166183397678993,0.00302491207471358,-0.022547167434338,-0.0106895121014607,4.00363783715934e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,42146,-0.0328467603174361,0.00597961061458356,-0.0445667971220199,-0.0211267235128523,4.02001356335039e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,42199,-0.0186987076534016,0.00340527261911952,-0.0253730419868758,-0.0120243733199273,4.06594136944672e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,39645,-0.0162197312370935,0.00295606845724391,-0.0220136254132916,-0.0104258370608955,4.18009471923155e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,42016,0.0242766683125615,0.00443209779202692,0.0155897566401887,0.0329635799849342,4.39229256571064e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,-0.055123028290828,0.0100668629906656,-0.0748540797525326,-0.0353919768291233,4.43716802403809e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,39970,0.0206276357878938,0.00376862788854041,0.0132411251263546,0.028014146449433,4.50561919640158e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.00966284430023409,0.00176705433027787,-0.0131262707875787,-0.00619941781288946,4.63880872283111e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.0595161238656454,0.0108928005313317,-0.0808660129070556,-0.0381662348242352,4.75895249772141e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.0254130014148884,0.00465441437402832,-0.034535653587984,-0.0162903492417929,4.84729256926956e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,41839,-0.0365100611738816,0.00670240098149363,-0.0496467670976091,-0.0233733552501541,5.20506028652883e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,41740,-0.0480468450311543,0.00882700782794388,-0.0653477803739243,-0.0307459096883843,5.32819917923127e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,42145,-0.070836889001187,0.0130230149450464,-0.0963619982934779,-0.0453117797088961,5.43999894115314e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,-0.0381155361690521,0.00700987275372472,-0.0518548867663526,-0.0243761855717517,5.51828283032061e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,39929,-0.0223343584219003,0.00411199393460598,-0.030393866533728,-0.0142748503100726,5.70322648311198e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,-0.0420346031665273,0.00773984342353959,-0.0572046962766649,-0.0268645100563898,5.72465224036406e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.0362781541422827,0.0066892133697837,-0.0493890123470588,-0.0231672959375067,5.95087035577688e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.0271094975403739,0.00499856831340457,-0.0369066914346468,-0.0173123036461009,5.96905963074869e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.0286086984214968,0.00528313416137798,-0.0389636413777976,-0.0182537554651959,6.23000629996985e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,42082,-0.0501912545617503,0.00929059389758503,-0.0684008186010169,-0.0319816905224836,6.68817809857422e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.048090945720418,0.00890653077027397,-0.065547746030155,-0.030634145410681,6.82132155069088e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,-0.0581737003360886,0.0107786486554408,-0.0792998517007527,-0.0370475489714246,6.88601413047794e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.0204607594189084,0.00379724980184956,0.0130181498072833,0.0279033690305335,7.23068932881448e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,39960,-0.0213904436279098,0.0039718706186865,-0.0291753100405353,-0.0136055772152842,7.36904524908918e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.0179439174373552,0.00333195761663007,-0.0244745543659501,-0.0114132805087602,7.37678410025961e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.0159128346258899,0.00296173169994729,0.0101078404939933,0.0217178287577866,7.87897288416159e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,41693,-0.0513609252068163,0.00956072542938161,-0.0700999470484043,-0.0326219033652284,7.9167894905517e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.0224025476021608,0.00417950161325604,-0.0305943707641426,-0.0142107244401789,8.4535145240474e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,42145,0.040070011880318,0.00748296368680702,0.0254034030541762,0.0547366207064598,8.70343951331691e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0258232124179636,0.00482680813319698,-0.0352837563590297,-0.0163626684768975,8.94301921501536e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,42249,0.0170397415210018,0.0031885143833538,0.0107902533296284,0.0232892297123753,9.2328025108749e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,0.0253898513895856,0.00475798459763611,0.0160642015782188,0.0347155012009524,9.6399145257225e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.0707735682657169,0.0132685066214617,-0.0967798412437817,-0.044767295287652,9.76391798468003e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,41900,0.0130920325659045,0.00246168844206001,0.00826712321946686,0.0179169419123421,1.06429132292433e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLPS,Colipase,42115,0.0414936546009427,0.00780827388501119,0.0261894377863208,0.0567978714155647,1.08910872128777e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,41751,-0.0611436099519041,0.011510570977609,-0.0837043290680178,-0.0385828908357905,1.10224776967323e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,-0.044755614149409,0.00842976503421097,-0.0612779536164625,-0.0282332746823555,1.12220075772782e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0256102063612684,0.00483253987323318,-0.0350819845128055,-0.0161384282097314,1.18285052655671e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.0173512656349863,0.00327933522736604,0.0109237685893489,0.0237787626806237,1.23459821213408e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,-0.0310503401677504,0.00587725232818601,-0.042569754730995,-0.0195309256045058,1.29402660660571e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0311273903679566,0.00589679533650251,-0.0426851092275015,-0.0195696715084117,1.32128769589494e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.0508248423318662,0.00963854900279847,-0.0697163983773512,-0.0319332862863812,1.36683736133082e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.0283908432952934,0.00539077715013961,-0.0389567665095671,-0.0178249200810198,1.41171791285676e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,42070,-0.0529277048118897,0.0100517912446304,-0.0726292156513653,-0.0332261939724141,1.41958469633364e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0356269396221976,0.00676919364080356,-0.0488945591581726,-0.0223593200862227,1.44235276919169e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.0334953625589282,0.0063698133913497,-0.0459801968059737,-0.0210105283118828,1.4791687511152e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.0213383293539153,0.00406069827913458,-0.0292972979810191,-0.0133793607268116,1.50451386208056e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,41843,-0.0218425373159174,0.00416555187648583,-0.0300070189938296,-0.0136780556380052,1.5988687722365e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,39979,-0.0387649336686373,0.00740528681036148,-0.0532792958169458,-0.0242505715203288,1.68137968146667e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COCH,Cochlin,39958,-0.0255278527228433,0.0048770490586251,-0.0350868688777485,-0.0159688365679381,1.68581818993006e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,41997,-0.0347748521173966,0.00666464465480902,-0.0478375556408223,-0.0217121485939709,1.83752713708987e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,42296,-0.0187073307655368,0.00359296896486826,-0.0257495499366786,-0.011665111594395,1.9506392744591e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0183105575628997,0.00352398650064579,0.0114035440216339,0.0252175711041654,2.06577700571493e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,42016,0.0187384648352737,0.00360781607994189,0.0116671453185876,0.0258097843519598,2.09001606798615e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.0294537075460389,0.00568398450878818,-0.0405943171832637,-0.0183130979088141,2.22838230816777e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,41742,0.0502888030878011,0.00971370314148569,0.0312499449304891,0.0693276612451131,2.28688703867214e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0423499927535152,0.00817993835166936,-0.0583826719227871,-0.0263173135842432,2.28978538641737e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.0266437878859246,0.00516586743234451,-0.0367688880533199,-0.0165186877185294,2.54385830114182e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,-0.0363785599570133,0.00705694189177036,-0.0502101660648832,-0.0225469538491434,2.58039738587168e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.0289341394090728,0.00563390614270363,-0.0399765954487719,-0.0178916833693737,2.85920348558074e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,39638,-0.028088859219775,0.00547158619943443,-0.0388131681706664,-0.0173645502688835,2.89112103505751e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,42016,-0.0327736641741965,0.00641847040264838,-0.0453538661633873,-0.0201934621850057,3.33295684249291e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,39649,-0.0445052434171651,0.00872240079488423,-0.0616011489751381,-0.027409337859192,3.40929308571877e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.0268702150708704,0.00526699183712505,0.0165469110701053,0.0371935190716355,3.41312842444665e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,39930,-0.0312590714266974,0.00613212123253388,-0.0432780290424638,-0.019240113810931,3.49545607239434e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.0609740954648825,0.0119723298388106,-0.0844398619489512,-0.0375083289808138,3.57339717064644e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,39733,0.0207955636551928,0.00408587210560356,0.0127872543282098,0.0288038729821757,3.64624940918588e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,0.0276192058785456,0.00542970142750352,0.0169769910806387,0.0382614206764525,3.69285999709793e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,42296,-0.0227822470052054,0.00447937433647681,-0.0315618207046999,-0.0140026733057108,3.70461666131547e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0204805805658275,0.00402683430315112,-0.0283731758000037,-0.0125879853316513,3.70541125602229e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.0250379181386969,0.00492575271279174,-0.0346923934557688,-0.0153834428216251,3.76344727077561e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,39919,-0.0178548978528385,0.00351446929919117,-0.0247432576792532,-0.0109665380264238,3.82651150439143e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.019137137006377,0.00378125998751105,-0.0265484065818987,-0.0117258674308553,4.22550613533216e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.0123850758465593,0.00245076779437783,-0.0171885807235398,-0.00758157096957876,4.40557824827032e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0212533016338984,0.00420729874450695,-0.029499607173132,-0.0130069960946648,4.43922744186936e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.0167330161012897,0.00331227049103158,-0.0232250662637116,-0.0102409659388678,4.44392567097666e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.0387411863441809,0.00766992956894168,0.0237081243890552,0.0537742482993065,4.46232352804342e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.029595646088788,0.00586321311110342,-0.0410875437865507,-0.0181037483910253,4.54120691740234e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,0.0188171460203328,0.00373808242619777,0.0114905044649852,0.0261437875756804,4.86726253434075e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,39925,0.0256333135215418,0.00509258285054409,0.0156518511344754,0.0356147759086082,4.89106685211607e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F3,Tissue factor,42174,0.0139462082602594,0.00277115153928283,0.00851475124326504,0.0193776652772537,4.89962780933389e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.05757394682411,0.0114391252090434,-0.079994632233835,-0.0351532614143849,4.90073540470901e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0180284638488919,0.00358398032892124,-0.0250530652935775,-0.0110038624042063,4.97240468164722e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,-0.0568839136114833,0.0113093502904787,-0.0790502401808216,-0.034717587042145,4.98476243239556e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,-0.0633938507234794,0.0126040322500739,-0.0880977539336242,-0.0386899475133346,4.98902558440861e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.0238151853384375,0.00473681362258072,-0.0330993400386957,-0.0145310306381793,5.0404687322521e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.0311758053815682,0.00620443023060997,-0.0433364886335637,-0.0190151221295726,5.11736122220308e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.0115740646056257,0.00230448487811519,0.00705727424451998,0.0160908549667315,5.16818600053735e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,39929,-0.0383889880224448,0.007654009656447,-0.0533908469490809,-0.0233871290958087,5.36860324766076e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,42137,0.0167322857284451,0.00334362079624892,0.0101787889677972,0.023285782489093,5.6786588124293e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.013759245203833,0.00275215143082805,0.00836502839941005,0.019153462008256,5.82156647523593e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,42016,-0.0353345269611515,0.007071205538157,-0.0491940898159392,-0.0214749641063637,5.8975061658696e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,39929,-0.0727692945836661,0.014563533637839,-0.101313820513831,-0.0442247686535016,5.91969933744529e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,-0.0478718672325951,0.00959883787865638,-0.0666855894747616,-0.0290581449904286,6.20185234668808e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,-0.0250156478841437,0.00501671988797273,-0.0348484188645702,-0.0151828769037171,6.22633340810031e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.00815273535152086,0.00163505764355088,0.00494802237016114,0.0113574483328806,6.24840991764539e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.0195651942679211,0.00392549167702165,-0.0272591579548835,-0.0118712305809587,6.30073755472647e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.0180099755656806,0.00362076753393674,0.0109132711991646,0.0251066799321966,6.63629372294297e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.0148511180568894,0.0029895549123476,-0.0207106456850907,-0.0089915904286881,6.87838038545684e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,39990,-0.0114899671726174,0.00231340718440195,-0.0160242452540452,-0.00695568909118958,6.90946954576404e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.0308426527834273,0.00621314993197032,-0.0430204266500891,-0.0186648789167654,6.9857542915227e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,39958,-0.0284874821907355,0.00574171511936394,-0.0397412438246888,-0.0172337205567822,7.09667372546e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,42184,-0.0150538738986407,0.00303519599691965,-0.0210028580526032,-0.00910488974467817,7.14297406781728e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0326727070586627,0.00659090314154726,-0.0455908772160954,-0.0197545369012301,7.2365402452795e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.0275390670495267,0.00555751154006721,-0.0384317896680584,-0.016646344430995,7.32856739781736e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.0560115487564957,0.0113114517277316,-0.0781819941428495,-0.0338411033701418,7.44301052640829e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,41900,-0.0280334448221102,0.00566662834100539,-0.0391400363704808,-0.0169268532737397,7.62434271542688e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.0197071752785812,0.00398476359626502,-0.0275173119272606,-0.0118970386299017,7.68238460115288e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,41843,-0.0502907732611961,0.0101730033800711,-0.0702298598861354,-0.0303516866362568,7.76509801285709e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.0380569528832438,0.00769889848084676,-0.0531467939057035,-0.0229671118607842,7.77844269659731e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,39657,-0.022333222787844,0.00451982594282946,-0.0311920816357898,-0.0134743639398983,7.87933257378632e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00480124614576504,0.000974387223403636,0.00289144718789392,0.00671104510363617,8.42826162312016e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,41839,-0.0269924372355099,0.00547958647809872,-0.0377324267325834,-0.0162524477384364,8.49442582718253e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.0128622399345237,0.00262143341274005,0.00772423044555317,0.0180002494234942,9.37587634669911e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.0493757077246762,0.0100723576093789,-0.0691175286390589,-0.0296338868102935,9.5917617094381e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.01962939584704,0.00400892933022652,-0.027486897334284,-0.0117718943597961,9.87268665684643e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.0533713075529537,0.010918234909731,-0.0747710479760265,-0.031971567129881,1.03156535176555e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,42137,-0.03295040840603,0.0067458286125767,-0.0461722324866803,-0.0197285843253797,1.04844821725984e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.0397857790543966,0.00818777820211007,-0.0558338243305323,-0.0237377337782609,1.19231034984491e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,0.0142597873971817,0.00293725502513326,0.00850276754792056,0.0200168072464429,1.2184726282677e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.0132105307304245,0.00272120390148169,-0.0185440903773286,-0.00787697108352035,1.2193656255368e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,0.0211890541800312,0.00436861743751465,0.0126265640025025,0.0297515443575599,1.24674820066498e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,39736,-0.060593715519413,0.0125077922017619,-0.0851089882348664,-0.0360784428039597,1.28655849775749e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0347791504134447,0.00718338840489018,-0.0488585916870295,-0.02069970913986,1.30220151303451e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.0275115492985812,0.0056826185481182,-0.0386494816528929,-0.0163736169442695,1.30391134582024e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,42296,-0.0251757092966643,0.00520257966831098,-0.0353727654465538,-0.0149786531467748,1.31861716216185e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.0244821331600374,0.00507186518996096,-0.0344229889323609,-0.014541277387714,1.40381754340453e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.0483433876793624,0.0100439298947164,-0.0680294902730065,-0.0286572850857183,1.50155306199907e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.0243155469822493,0.00505408830658706,-0.0342215600631599,-0.0144095339013387,1.52057525310815e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.0214142734876756,0.00445182102807131,0.0126887042726558,0.0301398427026954,1.52699921442645e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,39638,0.0219210527127179,0.00455860067289262,0.0129861953938484,0.0308559100315874,1.53903257417493e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,-0.0342895043718185,0.00713738384346819,-0.0482787767050161,-0.0203002320386208,1.57418913594251e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0680586101497303,0.0141721575028537,-0.0958360388553236,-0.040281181444137,1.58560115514488e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0355728672331603,0.00741603596381794,0.0210374367440771,0.0501082977222435,1.63029289484209e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0299115376520426,0.00623636842768496,-0.0421348197703051,-0.0176882555337801,1.63341690917006e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,-0.0163572674573324,0.00341078204101712,-0.023042400257726,-0.00967213465693885,1.63780748512661e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,42077,-0.0117103538455471,0.00244194166992582,-0.0164965595186017,-0.00692414817249249,1.63997446844041e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0292721813270319,0.00610478355318686,-0.0412375570912782,-0.0173068055627857,1.64815711775147e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.0310591849668898,0.00647860666487703,-0.0437572540300487,-0.0183611159037308,1.65141001613878e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.0528491595073529,0.0110460870496288,-0.0744994901246254,-0.0311988288900805,1.73290649199618e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.021579954064767,0.00451064676262129,-0.0304208217195047,-0.0127390864100293,1.73437265471366e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,0.0137128444503703,0.00286655316008001,0.00809440025661351,0.0193312886441271,1.74226412034414e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,39958,-0.0329202004976445,0.00689090617670399,-0.0464263766039844,-0.0194140243913047,1.7985248322657e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,42144,0.0168288270705811,0.00352686870767266,0.00991616440354265,0.0237414897376195,1.84670696127629e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.0383372321314492,0.00803649332531444,-0.0540887590490655,-0.0225857052138329,1.86221631455944e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.0196950225930184,0.00413475116666013,-0.0277991348796723,-0.0115909103063646,1.92429726239922e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.0165002648729376,0.00346600914289181,0.00970688695286968,0.0232936427930056,1.95009499047758e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,-0.0324796587557429,0.00682917796871443,-0.0458648475744232,-0.0190944699370627,1.9953610744604e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,39930,-0.0352048505949162,0.00740658370239983,-0.0497217546516198,-0.0206879465382125,2.0270206480902e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,-0.0117334676155946,0.00247292896407603,-0.0165804083851836,-0.00688652684600556,2.10854324899769e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGRN,Agrin,42185,-0.0180032249520145,0.00379523401122581,-0.0254418836140171,-0.0105645662900119,2.12046933397253e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.039000028537779,0.00822496578713275,-0.0551209614805592,-0.0228790955949988,2.14122361014453e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.0161783837138272,0.00341880333811194,0.00947752917112784,0.0228792382565267,2.24369571692915e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,42122,0.0327094539453896,0.00692543097273158,0.0191356092388357,0.0462832986519435,2.34619373949314e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.019521961868826,0.00413574040813915,-0.0276280130687787,-0.0114159106688732,2.37903171304827e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,39649,-0.0229566784694259,0.00486460470218593,-0.0324913036857103,-0.0134220532531414,2.39767734225096e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0120301758664862,0.00254996308558948,0.00703224821873077,0.0170281035142415,2.40810483679021e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.031915682280648,0.00676589589757131,-0.0451768382398878,-0.0186545263214083,2.41577798351637e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0316681165983508,0.00671405788806475,-0.0448276700589577,-0.0185085631377439,2.42576476409828e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.0422297687130987,0.00895809460457888,-0.0597876341380733,-0.0246719032881241,2.45617802726642e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,0.0196336365909858,0.00416521975501011,0.011469805871166,0.0277974673108056,2.45669277337746e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0202907896815884,0.00430466635101431,-0.0287279357295765,-0.0118536436336004,2.45736776340361e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.0103793460258936,0.00220241446222632,-0.0146960783718572,-0.00606261367993005,2.4688661332623e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,39649,-0.0248733779026379,0.00528775838026733,-0.0352373843279619,-0.014509371477314,2.58262088677115e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.0137407898751669,0.00292796096126493,0.00800198639108767,0.0194795933592462,2.71915479539646e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.018009476091781,0.00383944355554069,-0.0255347854606408,-0.0104841667229213,2.75628933688895e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,42166,-0.0432306183856292,0.00924015143423732,-0.0613413151967344,-0.0251199215745241,2.91684728249625e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.0262168001294564,0.00560324949296777,-0.0371991691356732,-0.0152344311232396,2.9190768641653e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,42247,0.0151834110744433,0.00324686594480043,0.00881955382263447,0.0215472683262522,2.94855969091644e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0462966104321588,0.00991290850228259,-0.0657259110966326,-0.0268673097676849,3.03601630905089e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,39575,0.0345959770835632,0.0074187253514941,0.0200552753946347,0.0491366787724916,3.14802206342202e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,42119,0.030651533945143,0.00657497525568299,0.0177645824440044,0.0435384854462817,3.16378873141126e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,0.0312057515964513,0.00670634011694187,0.0180613249672452,0.0443501782256573,3.30693263456015e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,39736,-0.032776282904134,0.00704849869429841,-0.0465913403449589,-0.0189612254633092,3.35576765802797e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.0276749987751007,0.0059615917289337,-0.0393597185638107,-0.0159902789863906,3.48605545451561e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,42081,-0.051119984117335,0.011018385943807,-0.0727160205671967,-0.0295239476674733,3.52511852750486e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.0199913436772522,0.00431675141214532,-0.028452176445057,-0.0115305109094474,3.67760762316421e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0420005910812029,0.0090721352845062,-0.0597819762388351,-0.0242192059235708,3.69720398815283e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,0.0137583459925988,0.00297205903978883,0.00793311027461271,0.0195835817105849,3.71095032856311e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,0.0199702046771363,0.00431753579116787,0.0115078345264472,0.0284325748278253,3.77417006848725e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,41997,0.022460308316733,0.00486057205487679,0.0129335870891745,0.0319870295442915,3.85607166403224e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.0328236676813793,0.00713047903867285,-0.0467994065971781,-0.0188479287655805,4.20467837534296e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,42143,-0.0511650339983481,0.0111661428493184,-0.0730506739830121,-0.0292793940136841,4.64311063095718e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0705847623291612,0.0154038401290147,0.0403932356762925,0.10077628898203,4.64813136497875e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.0295050126525463,0.00644652615424052,-0.0421402039148578,-0.0168698213902349,4.76133646574421e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.0252587019740653,0.00551923900197435,0.0144409935301955,0.036076410417935,4.77063282400112e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,42129,-0.0150048831126909,0.003280010993085,-0.0214337046591375,-0.00857606156624432,4.81267680043655e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.0203953179138681,0.00446565400327788,0.0116426360674434,0.0291479997602927,4.98744463721456e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,39657,-0.0462032279265623,0.0101195670636557,-0.0660375793713275,-0.026368876481797,5.03129044023944e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0191063822059604,0.00418565178965712,-0.0273102597136883,-0.0109025046982324,5.04533158302171e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.03133582830414,0.00686526514091581,-0.044791747980335,-0.017879908627945,5.05293432138548e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,39948,-0.0213244667903755,0.00469297996962684,-0.0305227075308441,-0.0121262260499069,5.57911288321834e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,39657,-0.0277312895755536,0.00610302295979672,-0.0396932145767552,-0.015769364574352,5.58184195000947e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0275154241865988,0.0060558158180481,-0.0393848231899731,-0.0156460251832245,5.58726832082584e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.0464536286035787,0.0102287910056958,-0.0665020589747425,-0.0264051982324148,5.63530774800194e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,42262,0.0301010405825564,0.00663680061333384,0.0170929113804221,0.0431091697846908,5.79632330437145e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0236175255216041,0.00520760213270098,0.0134106253415102,0.033824425701698,5.8150908864333e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.032077895833113,0.00707539596604991,-0.0459456719265709,-0.0182101197396552,5.844386807157e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.0300403163809834,0.00662683690112172,-0.043028916707182,-0.0170517160547848,5.87112923382015e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.0325975430318897,0.00719386463656249,-0.0466975177195522,-0.0184975683442272,5.91257861770502e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,42137,0.0125398524726223,0.00276827076756645,0.00711404176819206,0.0179656631770525,5.95300454745894e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,0.0303370810087512,0.00670379433924881,0.0171976441038235,0.0434765179136788,6.07998147906416e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,39736,-0.0260731387332254,0.00576689621614916,-0.0373762553168777,-0.014770022149573,6.21325568521725e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.0405913142721114,0.00899103824875078,-0.058213749239663,-0.0229688793045599,6.39618633348604e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,-0.0278024013151413,0.00616143960092973,-0.0398788229329636,-0.0157259796973191,6.46643912943165e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,41984,0.0167599780113782,0.00371923805056135,0.00947027143227791,0.0240496845904784,6.65289494773373e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.0117830722935668,0.00262432424425311,-0.0169267478123029,-0.00663939677483069,7.19639220034121e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.0287746685124942,0.00641394256244261,-0.0413459959348817,-0.0162033410901066,7.32022421214443e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAT,Catalase,39827,-0.0249360669177792,0.00555991893698403,-0.0358335080342679,-0.0140386258012905,7.36482953193459e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,41839,-0.033907691087393,0.00756282981698502,-0.0487308375286836,-0.0190845446461024,7.40573831613607e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.0241884075849394,0.00539515899688591,-0.0347629192188358,-0.0136138959510431,7.42132930172967e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.0360587518009608,0.00804440839765568,-0.0518257922603659,-0.0202917113415557,7.45111758724157e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.0270540210035621,0.00604426130596608,-0.0389007731632556,-0.0152072688438686,7.66947841969371e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,-0.0399125334886956,0.00892337606323572,-0.0574023505726376,-0.0224227164047535,7.78422737923152e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFD,Complement factor D,39979,0.00960510605539123,0.00214790890537275,0.00539520460086064,0.0138150075099218,7.83002787236016e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.0214055509694641,0.00479128142654947,-0.0307964625655011,-0.0120146393734272,7.9755826321096e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,-0.0262544425757709,0.00588333214175357,-0.0377857735736078,-0.0147231115779339,8.1805209360401e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,41890,-0.0265217226776657,0.00597058058035618,-0.0382240606151638,-0.0148193847401676,8.98182732022947e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,39575,0.0146654475345056,0.00330525151982001,0.0081871545556584,0.0211437405133528,9.21042586900932e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,39914,-0.0459221356312926,0.010351243012876,-0.0662105719365295,-0.0256336993260556,9.23449179064044e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.0489867772757897,0.0110448595196614,-0.070634701934326,-0.0273388526172534,9.26916312886485e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.0214925994937896,0.00484809097601806,-0.030994857806785,-0.0119903411807942,9.35710658504148e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.0233267627803132,0.00526424092486081,-0.0336446749930404,-0.013008850567586,9.44567043249234e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,39657,0.0140987713807145,0.00318420974027782,0.00785772028976995,0.020339822471659,9.61507082595562e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,39492,-0.0330966337159542,0.00748315829139437,-0.0477636239670872,-0.0184296434648212,9.83676096144224e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0391274603644288,0.00884973653697427,-0.0564729439768983,-0.0217819767519592,9.90162419340564e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,39759,-0.0114695048378319,0.00259935601063208,-0.0165642426186708,-0.00637476705699307,1.03170651759746e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.0311924684001015,0.0070742681424765,-0.0450580339593554,-0.0173269028408476,1.04667534681332e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,39966,0.0223799072679861,0.00508400347132602,0.0124152604641871,0.0323445540717851,1.08224390133086e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,39657,-0.0212260904887368,0.0048224887038521,-0.0306781683482869,-0.0117740126291867,1.08523073695676e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,39929,-0.0352307851766425,0.00806203335176274,-0.0510323705460974,-0.0194291998071875,1.25374296906882e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0277585697223458,0.00635486501234254,0.0153030342981544,0.0402141051465371,1.26287424866582e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,39958,-0.0150440897051982,0.00344801272240564,-0.0218021946411132,-0.00828598476928313,1.29353178491842e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,42051,-0.0318771682057984,0.00732505506351792,-0.0462342761302935,-0.0175200602813033,1.36021060923563e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,0.015698854141321,0.00360963378407636,0.00862397192453131,0.0227737363581106,1.37680872518766e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.0230047320366371,0.00529229810140041,-0.0333776363153819,-0.0126318277578923,1.39341542423545e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.0184492556547797,0.00424481897284715,-0.0267691008415601,-0.0101294104679993,1.39681819384973e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.0208910619144923,0.00480666318609539,-0.0303121217592393,-0.0114700020697453,1.39708752615444e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,41997,-0.0318909688761208,0.00735081399151679,-0.0462985642994937,-0.0174833734527479,1.44556745052676e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.0195296334478073,0.00450189152875176,-0.0283533408441608,-0.0107059260514539,1.4500031857661e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.0396213190356972,0.00913827337839529,-0.057532334857352,-0.0217103032140425,1.46539946583358e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.0280620284761595,0.0064816114905167,-0.0407659869975723,-0.0153580699547468,1.50777877709647e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.0212546408965599,0.00491020547359018,-0.0308786436247967,-0.0116306381683232,1.51083634826982e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NBN,Nibrin,41913,-0.0248944834354791,0.00575358003354558,-0.0361715003012285,-0.0136174665697298,1.52407152219295e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,0.010748609553974,0.00248760401465711,0.00587290568524607,0.015624313422702,1.5651090865838e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,39859,0.0140158151814821,0.00324933576082569,0.0076471170902638,0.0203845132727005,1.62103869850776e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.0363043140088886,0.0084187134357425,-0.0528049923429439,-0.0198036356748333,1.62708871176813e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,-0.0196887453634671,0.00457061030982451,-0.0286471415707231,-0.010730349156211,1.66162096304134e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.016238941313071,0.00377284406245687,-0.0236337156754865,-0.00884416695065553,1.68786321986905e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0333711217963826,0.00775926164595392,-0.0485792746224523,-0.0181629689703129,1.71367712716378e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.0221514736662655,0.00515401272659536,-0.0322533386103924,-0.0120496087221386,1.73644105530906e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,-0.0160072788165531,0.00372615799782127,-0.0233105484922827,-0.00870400914082337,1.75169492658373e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,39347,-0.0564249164822646,0.013133724382997,-0.0821670162729387,-0.0306828166915904,1.75290597417165e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.0326392352240428,0.00761078819338295,-0.0475563800830733,-0.0177220903650122,1.81075195030335e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,39979,0.0150581602991866,0.003521259307465,0.00815649205655516,0.021959828541818,1.91527157022507e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.016951079516428,0.00396621948374337,-0.024724869704565,-0.00917728932829104,1.93724861635814e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,42070,-0.0402563657760947,0.00943301618862199,-0.0587450775057938,-0.0217676540463956,1.98935596048202e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00978999192611056,0.00229521683487088,0.00529136692976365,0.0142886169224575,2.01216990801105e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0354210817625693,0.0083104167499813,-0.0517094985925326,-0.0191326649326059,2.04015235169995e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,0.00976204526941456,0.00229094822573655,0.00527178674697093,0.0142523037918582,2.04759836534474e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,0.0119672204335045,0.00280905945615083,0.00646146389944885,0.0174729769675601,2.05863848547485e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,0.0508120223472035,0.0119343148330752,0.0274207652743761,0.0742032794200309,2.08001330498203e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,42137,-0.0401853529355248,0.00944873057821914,-0.0587048648688343,-0.0216658410022152,2.12351636688843e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0388820951105968,0.00916378045065607,-0.0568431047938826,-0.0209210854273109,2.2228859885029e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,41992,0.0148209269448105,0.00349325433219237,0.00797414845371349,0.0216677054359076,2.22304263121766e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.0262729208497329,0.00619519878608557,-0.0384155104704606,-0.0141303312290052,2.24484522460061e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,42099,-0.0215502569638769,0.00509724422909712,-0.0315408556529073,-0.0115596582748466,2.37514305239565e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0352635489176687,0.00834765527136228,-0.0516249532495387,-0.0189021445857986,2.4153524045878e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0320760150288942,0.00761058351361609,-0.0469927587155817,-0.0171592713422067,2.52097174990491e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.0207746873674907,0.00493369426399491,-0.0304447281249207,-0.0111046466100607,2.56455000318142e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,-0.0233075356066843,0.00553732684272702,-0.0341606962184292,-0.0124543749949393,2.58321600679682e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,0.0172118348513505,0.00409355735447238,0.00918846243658464,0.0252352072661164,2.63537587212682e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,39919,0.0467305464751888,0.0111283329877857,0.0249190138191288,0.0685420791312487,2.69861343384997e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0199012228765077,0.00474658793225247,-0.0292045352237225,-0.0105979105292928,2.77729029176067e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.0390379496680945,0.00933293847097604,-0.0573305090712076,-0.0207453902649815,2.90097436822629e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,0.025213087509879,0.0060302628510615,0.0133937723217985,0.0370324026979596,2.91939309905615e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,0.0214799302387567,0.00513771032657147,0.0114100179986766,0.0315498424788368,2.92267100774242e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,42145,0.0114418675914508,0.00274093283057979,0.0060696392435144,0.0168140959393872,3.00583015029067e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.0242110990891611,0.00580123495487746,-0.0355815196007209,-0.0128406785776013,3.01942416389131e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,41647,-0.0272102311261332,0.00652008843153831,-0.0399896044519483,-0.0144308578003181,3.02176203197689e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.0278954344102896,0.00668498594033514,-0.0409980068533465,-0.0147928619672327,3.03060275972608e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,42152,-0.0178570531596645,0.00428415212270066,-0.0262539913201578,-0.00946011499917121,3.08968643787283e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,42217,-0.0444991040820256,0.0106806708321956,-0.0654332189131291,-0.0235649892509222,3.11464775004239e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,39638,-0.0387468295738624,0.00930319409559609,-0.0569810900012307,-0.0205125691464941,3.13864822354807e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.0161880496745026,0.00389234734052003,-0.0238170504619219,-0.00855904888708336,3.22082575798117e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,39958,-0.0235955259028011,0.00568003480148005,-0.034728394113702,-0.0124626576919002,3.28936852139987e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0239725467823556,0.00577939649058723,0.0126449296608046,0.0353001639039066,3.37938799401717e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.0249064167701606,0.00601402302654869,-0.036693901902196,-0.0131189316381252,3.47302352577422e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,42185,-0.0406392167506198,0.00981519545716626,-0.0598769998466656,-0.0214014336545739,3.48735747948425e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0335281986745811,0.00811547261841358,-0.0494345250066717,-0.0176218723424905,3.63163009273633e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.022010686294835,0.00533054290477057,-0.0324585503881854,-0.0115628222014847,3.66241038733627e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00972241004625925,0.00235531942122555,0.00510598398065718,0.0143388361118613,3.68363383102079e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.0123798970594887,0.00299949023461934,0.00650089619963477,0.0182588979193426,3.69666698753545e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,42310,0.0086025344373365,0.00208539308970556,0.0045151639815136,0.0126899048931594,3.72698870372705e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,0.00862347233132853,0.00209267711909823,0.004521825177896,0.0127251194847611,3.80263782061166e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,0.0155382017395684,0.00377913912258825,0.00813108905929543,0.0229453144198414,3.95740247356891e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.030550804867327,0.00743853406109682,-0.0451303316270768,-0.0159712781075772,4.0300810698596e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.0460144443385885,0.0112042329440951,-0.0679747409090149,-0.0240541477681621,4.03899646080417e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.0474686168976466,0.0115722183429701,-0.0701501648498679,-0.0247870689454252,4.12077738491462e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,39979,0.0119269997501363,0.00291079010766033,0.00622185113912202,0.0176321483611505,4.2050860756276e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,41839,0.0324592257007572,0.00792955677095296,0.0169172944296894,0.048001156971825,4.27528391135912e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.0415178478102532,0.0101472875552083,-0.0614065314184614,-0.0216291642020449,4.31037897050889e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.0153756199803652,0.00376060335033631,-0.0227464025470244,-0.00800483741370604,4.3697597907784e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.0071702791588326,0.00175413801541915,-0.0106083896690541,-0.00373216864861106,4.38783604280981e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.0570441189442833,0.0139752175460717,-0.0844355453345839,-0.0296526925539828,4.50016900148099e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,41751,-0.0325404464235879,0.00797278641567253,-0.0481671077983061,-0.0169137850488697,4.50220465625094e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPARC,SPARC,42181,-0.0302344007768163,0.00740810477233573,-0.0447542861305943,-0.0157145154230383,4.50484454925188e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,41846,-0.0242955748687301,0.00595431662871796,-0.0359660354610173,-0.0126251142764428,4.52353972123484e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.0149940130776503,0.00367628605593301,-0.022199533747279,-0.0077884924080216,4.56300371392423e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.0344829660930965,0.00846560494106138,-0.0510755517775768,-0.0178903804086162,4.66197191538824e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.0205598088826542,0.00505355034481134,-0.0304647675584845,-0.010654850206824,4.76141592565419e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.0157451274590638,0.00387021082619388,-0.0233307406784038,-0.00815951423972376,4.7688958172466e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.0286597704167432,0.00705191642715036,-0.0424815266139579,-0.0148380142195285,4.85519181148254e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,0.0148660100405012,0.00366411658293452,0.00768434153794951,0.0220476785430528,4.99507457929397e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.0179449580833274,0.00442368879510124,-0.0266153881217258,-0.00927452804492898,5.01346442400364e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,0.013842642750831,0.00341393386790526,0.00715133236973674,0.0205339531319253,5.05299890413904e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.0345101712750098,0.00851352594199499,-0.0511966821213199,-0.0178236604286996,5.07265695421348e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,42137,0.0100680234649436,0.00248918583695424,0.00518921922451328,0.0149468277053739,5.26794863375531e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.0187713313047918,0.0046415166827248,-0.0278687040029324,-0.00967395860665117,5.28558953990893e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.02232971515609,0.00552930764061408,-0.0331671581316936,-0.0114922721804864,5.41064489994866e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.0266491320062992,0.00659990139664943,-0.0395849387437321,-0.0137133252688663,5.42502163958473e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0215210207372542,0.00533611525908772,0.0110622348294423,0.0319798066450661,5.54096515655693e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,42113,0.0125757151664229,0.00311890870205488,0.00646265411039532,0.0186887762224504,5.55869233932645e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFH,Complement factor H,39418,-0.0100549991968856,0.00249715225764195,-0.0149494176218639,-0.00516058077190739,5.69787378606206e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0330683886224557,0.0082283149600557,-0.0491958859441649,-0.0169408913007465,5.88704840928587e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.02314938290356,0.00577639442504175,-0.0344711159766418,-0.0118276498304782,6.17439927202372e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,42145,0.0161664869192975,0.0040488672254633,0.00823070715738942,0.0241022666812056,6.56306314724316e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NADK,NAD kinase,42145,-0.0230963346788929,0.00579854874814589,-0.0344614902252588,-0.0117311791325269,6.83710903985375e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.0307610999651037,0.0077278740902007,-0.0459077331818971,-0.0156144667483104,6.91246145406841e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,42166,-0.0246313197155411,0.00619015436696974,-0.0367640222748017,-0.0124986171562804,6.95328112473927e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,-0.0216936172353445,0.00545908663037305,-0.0323934270308757,-0.0109938074398134,7.11556587870398e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.0204100104681568,0.00513894823585243,-0.0304823490104276,-0.0103376719258861,7.18224039027378e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.0165551847383952,0.00417002569204755,-0.0247284350948084,-0.00838193438198198,7.2302428594969e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.0183978851474269,0.00463543414183727,-0.027483336065428,-0.00931243422942587,7.26415776991816e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,0.0119654163753536,0.00301567501963648,0.00605469333686613,0.0178761394138411,7.29282487756714e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.0208136907463489,0.00524675450032937,-0.0310973295669945,-0.0105300519257033,7.32419674667651e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.0117315218915709,0.00295853530598252,0.00593279269184514,0.0175302510912966,7.36817411193209e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.00893672199979386,0.00225485492264314,0.0045172063514133,0.0133562376481744,7.43746506570484e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.0490619292644933,0.0123821116297047,-0.0733308680587146,-0.024792990470272,7.46065494678114e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0384697773292866,0.00971058562659833,-0.0575025251574193,-0.0194370295011539,7.48937910521967e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.024401507335816,0.0061595451880077,-0.0364742159043111,-0.0123287987673209,7.49132017441044e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0177008613504179,0.00447158550295588,-0.0264651689362114,-0.00893655376462434,7.58009955675488e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,39934,-0.0231633030067181,0.00585573789128323,-0.0346405492736332,-0.011686056739803,7.67886905981696e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,0.0161866995183012,0.00409489489602296,0.00816070552209617,0.0242126935145062,7.76784665393409e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.0130588329233126,0.00330470243143128,0.0065816161577073,0.0195360496889179,7.80810639976808e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.0200803398761054,0.00508436981992732,-0.030045704723163,-0.0101149750290479,7.88108399073291e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0217023810126003,0.00549656537994414,-0.0324756491572908,-0.0109291128679098,7.90977911029232e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,39649,-0.0286442702072056,0.00727939588708782,-0.0429118861458977,-0.0143766542685135,8.37134939263103e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,-0.0379893949306197,0.00968794987912252,-0.0569777766936998,-0.0190010131675396,8.85020323224583e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,39575,-0.0203166529482367,0.00518740371914391,-0.0304839642377587,-0.0101493416587146,9.03745058657094e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.0150463545877245,0.00384258484164535,-0.0225778208773494,-0.0075148882980996,9.069003639866e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.00995481180623412,0.0025442686462497,-0.0149415783528835,-0.00496804525958472,9.17389116734319e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.0105821513244559,0.00270516081484832,-0.0158842665215586,-0.00528003612735319,9.21298706445038e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,0.0130547582882445,0.00334616681594433,0.00649627132899366,0.0196132452474954,9.62022120540525e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,41839,-0.0281526810851052,0.00722153257279651,-0.0423068849277864,-0.013998477242424,9.72935434405834e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,-0.0498932991753064,0.0128033739573394,-0.0749879121316915,-0.0247986862189212,9.80161350388681e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,39875,0.0301603325027035,0.00774709109961408,0.0149760339474599,0.0453446310579471,9.95346810425938e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.0137012500518317,0.00352474082637734,-0.0206097420715313,-0.00679275803213216,0.000101900765708128
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.0122189388629294,0.00314869185114991,0.00604750283467556,0.0183903748911832,0.000104678625695263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.0315591617072992,0.00813640867692961,-0.0475065227140813,-0.0156118007005172,0.000105584591337234
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.0270703581333733,0.00698542592452129,-0.040761792945435,-0.0133789233213115,0.00010710995050094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,42166,0.013428849508385,0.00346567731421895,0.00663612197251583,0.0202215770442541,0.000107208748888014
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.025526005094307,0.00660167477254378,-0.0384652876484929,-0.0125867225401212,0.000110877125882187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.0149083420742316,0.00385645228034475,-0.0224669885437073,-0.00734969560475587,0.000111356728124065
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.018297010374121,0.00473503744779088,0.00901633697645087,0.0275776837717911,0.000112086797833737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.0165241612031502,0.00428274920698402,-0.0249183496488388,-0.0081299727574615,0.000114808700664404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.0109640636439681,0.00284851860005166,-0.0165471601000693,-0.00538096718786682,0.00011924989663654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.0117405373751159,0.0030505319471417,-0.0177195799915136,-0.00576149475871814,0.000119303352910473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTG,Protogenin,42262,-0.00998206541248889,0.00260540245301768,-0.0150886542204035,-0.00487547660457423,0.000128041015930914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,39638,-0.0480063741265672,0.0125465639876497,-0.0725976395423606,-0.0234151087107737,0.000130823999080819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.0179754161242703,0.00470482947171872,-0.027196881888839,-0.00875395035970156,0.00013382190027436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPSE,Heparanase,39866,-0.0386816035613634,0.0101393925494559,-0.058554812958297,-0.0188083941644298,0.000136920217025895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,41913,0.0117700289295996,0.00308598323832024,0.00572150178249192,0.0178185560767073,0.000137336832997566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,42079,0.0115958946072971,0.00304275923387938,0.00563208650889354,0.0175597027057007,0.000139032363668654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,39701,-0.0262947850164305,0.00690729327415135,-0.0398330798337672,-0.0127564901990939,0.000141525219669076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,39946,-0.0192467474158959,0.00506414348276667,-0.0291724686421186,-0.00932102618967323,0.000145105163545728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.0179230597413371,0.004729353362741,-0.0271925923323094,-0.00865352715036473,0.00015160043113067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,39979,0.00848393223128671,0.00223920152903711,0.00409509723437397,0.0128727672281994,0.000152144375626986
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.0285317721919867,0.00753198790313858,-0.0432944684821383,-0.0137690759018351,0.000152470854505344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.026924624101438,0.00712217210236995,-0.0408840814220831,-0.0129651667807929,0.000157403823039095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.0178567845634209,0.00473875803690624,-0.0271447503157571,-0.00856881881108463,0.000165114633311812
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.0195845491371678,0.00520114598205176,-0.0297787952619892,-0.00939030301234633,0.00016712589539216
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LXN,Latexin,41960,0.0273138012568127,0.00725796774713265,0.0130881844724327,0.0415394180411926,0.000168413238805753
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.0242801046338853,0.00645544565889297,0.0116274311424551,0.0369327781253155,0.000169959415581471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.0153919050897594,0.00410748946509111,-0.0234425844413379,-0.0073412257381808,0.000179523066677868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,39906,-0.0129609524142522,0.00345912631092786,-0.0197408399836708,-0.00618106484483356,0.00017993379938772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.0246569290456313,0.00658385534959943,0.0117525725604164,0.0375612855308462,0.000181272609283591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.0219655470330957,0.00587077045556614,-0.0334722571260053,-0.010458836940186,0.000183670884775164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0120523965165633,0.00322396653546047,-0.0183713709260658,-0.00573342210706081,0.000186124785985533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,0.0164377633317741,0.00440143485650692,0.00781095101302052,0.0250645756505277,0.000188749854107562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,0.0112315636800675,0.00300788912958677,0.00533610098607744,0.0171270263740576,0.000189202434017543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,39929,0.0356442329087909,0.00955790307429231,0.0169107428831779,0.0543777229344038,0.000192953160160837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,42249,-0.00898405378015718,0.00241115281351077,-0.0137099132946383,-0.00425819426567608,0.000195295401126669
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,-0.0311352695297323,0.00836908511089346,-0.0475386763470835,-0.0147318627123811,0.000199995673371904
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.0354881386792812,0.00954583667492448,-0.0541979785621332,-0.0167782987964293,0.000201894502126626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGRN,Neugrin,39929,-0.00884455545510029,0.00237988182188082,-0.0135091238259867,-0.00417998708421389,0.000203066811604423
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,39908,-0.0337537541215115,0.0090994650376479,-0.0515887055953014,-0.0159188026477216,0.000208727746040364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,39929,-0.0149934204061465,0.00404656652281088,-0.0229246907908558,-0.00706215002143719,0.000212212202766177
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0305085211795384,0.00825407774288401,-0.0466865135555911,-0.0143305288034858,0.000219903539772173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.0243394910424118,0.00659642627895526,-0.0372684865491641,-0.0114104955356595,0.000225330312400199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0194217945936398,0.00526634639447951,-0.0297438335268196,-0.00909975566045992,0.00022721452456817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.0328248272689961,0.00891552913843215,-0.0502992643803231,-0.0153503901576691,0.000232532274087604
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.0135042228515333,0.00366972388808261,0.00631156403089141,0.0206968816721752,0.000234221965573132
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.0305874400752398,0.00831523896516865,-0.0468853084469704,-0.0142895717035093,0.000235714200540577
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.0570150792625751,0.0155058770355203,-0.0874065982521949,-0.0266235602729553,0.000237086022759521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,0.0111159057924249,0.00302357490837345,0.00518969897201296,0.0170421126128369,0.000237451836076812
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0115557650504354,0.00314331780911987,0.0053948621445605,0.0177166679563104,0.000237548744432675
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.0134125240520427,0.00364922212359437,-0.0205649994142877,-0.00626004868979778,0.000238546025964387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0103370299449723,0.00281398963089407,0.00482161026841992,0.0158524496215247,0.000240218293211798
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,-0.0274322312543839,0.00747021716545576,-0.0420738568986772,-0.0127906056100906,0.000241601008387134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.0169998202465061,0.00463298061876184,0.00791917823373293,0.0260804622592794,0.000244326212330696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,-0.0483950648324484,0.013193604009643,-0.0742545286913486,-0.0225356009735481,0.000245544119626031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.015342343763951,0.00418299327527984,-0.0235410105834995,-0.00714367694440253,0.000245776030529944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0147094150390631,0.00401275545745731,0.00684441434244679,0.0225744157356794,0.000247824805683527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.0236702045681467,0.00646357719568797,-0.0363388158716952,-0.0110015932645983,0.000251119929146431
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.0407010978065491,0.0111174040732164,-0.0624912097900533,-0.0189109858230448,0.000252370520130657
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,42231,-0.0145247647538122,0.00397129790129022,-0.0223085086403411,-0.00674102086728341,0.000255711010466674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.0255201805364884,0.00697974540046637,-0.0392004815214025,-0.0118398795515743,0.000256827957937083
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,39900,-0.0176654389682544,0.00483234227767638,-0.0271368298325001,-0.0081940481040087,0.000257676640189037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.0376295252501424,0.0102956213181545,-0.0578089430337251,-0.0174501074665596,0.000258470245660497
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.0128709932522942,0.00353192853794357,0.0059484133179248,0.0197935731866636,0.00026925326558408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.0284819600937326,0.00782115547672271,-0.0438114248281091,-0.0131524953593561,0.000272116219171622
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.0234274248928625,0.00643672588307396,-0.0360434076236874,-0.0108114421620375,0.000274048715792075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0111150963324903,0.00305479564563275,-0.0171024957979305,-0.00512769686705013,0.000275368681979478
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,41638,0.00912544030770338,0.00250858620994201,0.00420861133621703,0.0140422692791897,0.000276163596984232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.0177462551683519,0.00488234102710558,0.008176866755225,0.0273156435814789,0.000279444944498367
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.0333973774396234,0.00918828367674118,-0.0514064134460361,-0.0153883414332107,0.000279450751328244
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0119540542598825,0.00328970449089236,0.00550623345773348,0.0184018750620316,0.000280533970286369
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,0.0122059918708803,0.00336046764372349,0.00561947528918224,0.0187925084525783,0.000282019962336923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.0341749576473217,0.00941031533905488,-0.0526191757118692,-0.0157307395827741,0.000282890063129981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,0.0104663314479038,0.00288647107974374,0.00480884813160607,0.0161238147642015,0.000288900803698713
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0294635839173608,0.00812969524204122,0.01352938124296,0.0453977865917616,0.00029116820761641
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0237487547115817,0.00655871178528279,-0.036603829810736,-0.0108936796124275,0.000294598863110486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,41913,0.0178852732714798,0.00494050899302361,0.00820187564515352,0.0275686708978061,0.000295550280608378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,-0.00764259327031347,0.0021124719835888,-0.0117830383581475,-0.00350214818247942,0.000298154627525532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0227932274815856,0.00630237095563874,-0.0351458745546375,-0.0104405804085337,0.000299781646217877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.0093481802725336,0.00258803866407714,-0.0144207360541248,-0.0042756244909424,0.000304863199689458
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.0120240245335564,0.00333615487364508,0.00548516098121202,0.0185628880859007,0.000314312252679259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.0192009480843978,0.00532918001787359,-0.02964614091943,-0.00875575524936553,0.000315933064331196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,39657,-0.0187533694633392,0.00521018032765543,-0.0289653229055438,-0.00854141602113453,0.000320383463011719
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,42296,-0.0233097131681119,0.00647793386406822,-0.0360064635416856,-0.0106129627945382,0.000321402140498647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,39736,-0.0206040979139333,0.00572570517844092,-0.0318264800636775,-0.00938171576418908,0.000321414504010511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.0191223173360751,0.0053175568306676,-0.0295447287241836,-0.00869990594796665,0.000324478871211512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0253743599683473,0.00705779071158806,-0.0392076297630598,-0.0115410901736347,0.000325254416909999
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0185179087936989,0.00515094648422852,-0.0286137639027868,-0.00842205368461102,0.00032550323055466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.0208592302232327,0.00580737502480886,-0.0322416852718581,-0.00947677517460735,0.000329486493511389
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0246891477664796,0.00687892856411564,-0.0381718477521463,-0.011206447780813,0.000333261038069643
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,-0.0226463287257345,0.00631220825412783,-0.0350182569038251,-0.010274400547644,0.000335009980417789
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,-0.0411086998728083,0.0114727089610746,-0.0635952094365145,-0.018622190309102,0.000340871559156843
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.0142254098937794,0.00397049798612795,-0.0220075859465901,-0.00644323384096858,0.000341421719527425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.0185640644053465,0.00519988397061695,-0.0287558369877557,-0.00837229182293731,0.000358332392869337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.0202936206941437,0.00568739677980831,-0.031440918382568,-0.00914632300571942,0.000360963006963552
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.0129710609631292,0.00363585007288508,-0.020097327105984,-0.00584479482027449,0.000361588289370463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.0272959261774805,0.00765844614075059,-0.0423064806133517,-0.0122853717416094,0.000366551206577902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.0140656651779423,0.00394643291758269,0.00633065665948024,0.0218006736964044,0.000366592231238672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,42119,-0.0260329882732637,0.0073223782387117,-0.0403848496211386,-0.0116811269253887,0.000378889014469979
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,0.0180704240489557,0.00508270538311838,0.00810832149804364,0.0280325265998677,0.000378890798453561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,-0.0322102794325112,0.00906058233579955,-0.0499690208106783,-0.014451538054344,0.000379571531315095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.0118626823339345,0.00333822554752507,-0.0184056044070837,-0.00531976026078542,0.000381599126336436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.0075287505527897,0.00212428154394593,-0.0116923423789237,-0.00336515872665567,0.000395229268975116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.0484087470128425,0.0136935072481356,-0.0752480212191883,-0.0215694728064966,0.000408887166784425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,42286,0.0113103527092561,0.00320685842077713,0.00502491020453295,0.0175957952139793,0.000421790288291326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,0.00996843213329593,0.00282994815608619,0.00442173374736699,0.0155151305192249,0.000428945519721803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,39934,0.0129558788875541,0.00368513465516497,0.00573301496343081,0.0201787428116775,0.000440286881184339
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.0117702476106717,0.00334882581605152,-0.0183339462101327,-0.00520654901121071,0.000441656984177783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,42016,0.00453152449473355,0.00129006578656577,0.00200299555306464,0.00706005343640246,0.000445153341886149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.0197819205367476,0.00563168394032495,0.00874382001371067,0.0308200210597845,0.000445158101103227
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.0128654807966975,0.00367504089792726,0.00566240063676005,0.0200685609566349,0.000465430703997293
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,-0.0210048047175229,0.0060102670283113,-0.032784928093013,-0.00922468134203274,0.000476238594592232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.0153097551180046,0.00439106196379461,-0.0239162365670421,-0.00670327366896719,0.000490839122245823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,42112,-0.0244223886474641,0.00700542199063187,-0.0381530157491025,-0.0106917615458256,0.000491467415146894
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.00683605503996793,0.00196444226483194,0.00298574820089732,0.0106863618790385,0.000503490255356962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.0205081813015915,0.00590694064516724,-0.0320857849661192,-0.00893057763706367,0.000518442753674734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.0254312215848796,0.00733222178608337,-0.039802376285603,-0.0110600668841562,0.00052547457506424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,41843,0.0199446842391987,0.00575555496102591,0.00866379651558796,0.0312255719628095,0.000531331862425067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.00969394619036773,0.00279952213765626,-0.015181009580174,-0.00420688280056147,0.000536407764153226
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.0173814025495944,0.00502640160496856,-0.0272331496953327,-0.00752965540385598,0.000546158384651471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,41997,-0.0293196569270233,0.00849135610982686,-0.0459627149022839,-0.0126765989517626,0.000556343618017206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,42137,0.00728786426191301,0.00211122409638503,0.00314986503299835,0.0114258634908277,0.000558227106982961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.0116199359003896,0.00336904135893579,0.00501661483687543,0.0182232569639037,0.000564348402071394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.0158398967700512,0.0046059719851617,-0.0248676018609681,-0.00681219167913427,0.000585684129979802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.027525929270581,0.00801949230362912,-0.0432441341856941,-0.0118077243554679,0.00060045108626095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,42070,-0.0201945114384175,0.00588559115995423,-0.0317302701119278,-0.00865875276490722,0.000602769702294304
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,-0.0160800347120361,0.00468873682444621,-0.0252699588879506,-0.0068901105361215,0.000606912817841001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,42232,0.0151824484393261,0.00443176372105974,0.00649619154604904,0.0238687053326032,0.0006147416795453
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,0.00703841759038003,0.00205526668869672,0.00301009488053447,0.0110667403002256,0.000617931451290004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BGN,Biglycan,41820,0.0428193158820069,0.0125068052722492,0.0183059775483985,0.0673326542156153,0.000619664218630301
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.0157012099599573,0.00458798940128231,-0.0246936691864706,-0.00670875073344397,0.000623323440087889
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.0187222285565028,0.00547720783305507,-0.0294575559092907,-0.00798690120371485,0.000632629110289767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.0168958819745075,0.00494464089513505,0.00720438582004285,0.0265873781289722,0.00063542924155257
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.0282268542505272,0.00826436542042041,-0.0444250104745512,-0.0120286980265032,0.000638546392018347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLU,Clusterin,39979,0.010889315018943,0.00319450714771626,0.00462808100941917,0.0171505490284669,0.000654846661555163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.0188646777060916,0.00554063494537277,-0.0297243221990222,-0.00800503321316101,0.000664457119355104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,41881,-0.0187039789728788,0.00549656734434164,-0.0294772509677884,-0.00793070697796917,0.000668843991377584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,42016,-0.0118140210381291,0.00347676953888492,-0.0186284893343436,-0.00499955274191467,0.000680807097892943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,41913,-0.0292194463179148,0.00860010374340904,-0.0460756496549965,-0.0123632429808331,0.000681864713137119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,0.0397977709621482,0.0117354544924872,0.0167962801568733,0.0627992617674232,0.000697753538044476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,42070,-0.0115371913800626,0.0034025563664822,-0.0182062018583677,-0.00486818090175751,0.000699038252205669
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.0283147511075204,0.0083622104394734,-0.0447046835688883,-0.0119248186461525,0.000711133266245646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.0143575808726015,0.0042441888893819,-0.0226761910957901,-0.00603897064941301,0.000719370838053285
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,39736,0.0163271385551883,0.00483017325791563,0.00685999896967372,0.025794278140703,0.000726716518137806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,39929,-0.0303125853565473,0.00897526095306155,-0.0479040968245479,-0.0127210738885467,0.000734345268288833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.0229901447956873,0.00681627776404828,-0.0363500492132219,-0.00963024037815267,0.000746490443265585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.0180537968283934,0.00537522086986954,-0.0285892297333377,-0.00751836392344912,0.000785723197722979
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.0166904597636579,0.00497263451529516,-0.0264368234136364,-0.00694409611367939,0.000792061442166026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPART,Spartin,39736,-0.0277078852950988,0.00825547432358799,-0.0438886149693312,-0.0115271556208663,0.000792557972235088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,0.00652556988270104,0.0019483029112804,0.00270689617659145,0.0103442435888106,0.000812613008167221
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0281155222862229,0.00840295613999904,-0.044585316320621,-0.0116457282518248,0.000822385353874839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.0254521810761589,0.00760715122072472,-0.0403621974687794,-0.0105421646835385,0.000823095172965684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0213050086885682,0.0063682576665152,0.00882322366219839,0.033786793714938,0.000823554822275827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,0.0128912436009525,0.00385378280756495,0.00533782929812521,0.0204446579037798,0.000824836776461563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,0.0118550269415455,0.00354475962528378,0.00490729807598934,0.0188027558071017,0.000826905974634698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.0239765147266809,0.00717096859470374,-0.0380316131723002,-0.00992141628106159,0.000829370909328517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.0245395986287842,0.00734277736451296,-0.0389314422632296,-0.0101477549943389,0.000834534459193424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.0147708110129942,0.00442049641828846,-0.0234349839928396,-0.0061066380331488,0.000836236230780144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,42145,0.0143472122431949,0.00429504729621691,0.00592891954260973,0.02276550494378,0.000838812705886214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.016921623265328,0.00506626153593868,-0.0268514958757678,-0.0069917506548882,0.000839892730985816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,-0.0222509876063272,0.00667595966931867,-0.0353358685581918,-0.00916610665446264,0.00086146062661062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.023725390236316,0.0071242985956718,-0.0376890154838327,-0.00976176498879925,0.000870132029500575
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.022350706007439,0.0067278516980079,-0.0355372953355345,-0.00916411667934356,0.000895713256457846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,39979,0.00797065997926233,0.00239999264571214,0.00326667439366654,0.0126746455648581,0.000899397117522944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0251730008036826,0.00758095267954037,0.0103143335517835,0.0400316680555817,0.000901287421243677
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,42262,-0.0390135063102178,0.0117542618651215,-0.0620518595658561,-0.0159751530545796,0.000905460741514647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.0188243447330513,0.00568639942943425,-0.0299696876147424,-0.00767900185136017,0.000933988979475159
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0298902927146912,0.0090337770280411,-0.0475964956896517,-0.0121840897397306,0.000940214718633891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,0.0143442300133441,0.00433617752961101,0.00584532205530654,0.0228431379713817,0.000942446463518116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,39560,-0.0195732507121711,0.0059173580728771,-0.0311712725350102,-0.00797522888933194,0.000943453379158543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.020353867302606,0.00615721178967857,-0.032422002410376,-0.00828573219483602,0.00095035406151639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.0349554979499692,0.0105769512516365,-0.0556863224031768,-0.0142246734967617,0.000953131746985033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.0281779419801186,0.00854527331699922,-0.0449266776814371,-0.0114292062788002,0.000978048318483442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.0108060490055192,0.00327813363659437,-0.0172311909332441,-0.0043809070777942,0.000982326885080875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,39934,-0.0102474394725991,0.00310952443394266,-0.0163421073631268,-0.00415277158207152,0.000985482459167759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,-0.0134979516191823,0.00410435729611433,-0.0215424919195664,-0.00545341131879821,0.00100962353324522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,39586,-0.022398748832188,0.00682782421200779,-0.0357812842877232,-0.00901621337665269,0.00103942246257573
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,39649,-0.0150408334757966,0.00458760847710847,-0.0240325460909292,-0.00604912086066403,0.00104653913413563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.0232297091183811,0.00709236233023964,-0.0371307392856508,-0.00932867895111139,0.00105810710351978
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,0.00989243336572716,0.00302083973158664,0.00397158749181734,0.015813279239637,0.00106078886040619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.0223521281373224,0.00683934233133246,-0.035757239106734,-0.00894701716791076,0.0010856808580896
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.0231449409618622,0.00708984447730675,-0.0370410361373835,-0.009248845786341,0.0010997996669674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.023620536732155,0.00723596958500506,-0.037803037118765,-0.00943803634554513,0.00110051758288617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,42070,0.00523199904905246,0.00160454623930495,0.00208708842001474,0.00837690967809017,0.0011140016535936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,42262,-0.0129018781484586,0.00396004107024233,-0.0206635586461336,-0.00514019765078367,0.00112467945745928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.0245421647070777,0.00753252612684061,-0.0393059159156853,-0.00977841349847015,0.00112473133213446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,0.0153726393336341,0.00472571420552115,0.00611023949081261,0.0246350391764555,0.00114482976978877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.0209808077570063,0.00645760687805103,-0.0336377172379863,-0.00832389827602626,0.00116096300626746
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.0148411047041803,0.00457142130860928,0.00588111893930616,0.0238010904690545,0.00117182739487458
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.0198172725941518,0.0061130335793439,-0.0317988184096659,-0.00783572677863776,0.00119064555661516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0249835705283135,0.00771161973669101,-0.0400983452122279,-0.00986879584439908,0.00119931840890015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,41843,-0.015245479843654,0.00471168110773881,-0.024480374814822,-0.00601058487248592,0.00121652510603486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0357206229300487,0.0110435029036049,0.0140753572389831,0.0573658886211142,0.00122189313356157
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.0311973300409969,0.00964770565519194,-0.0501068331251732,-0.0122878269568207,0.00122577294324665
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,41839,0.0155817117563661,0.00482241522913432,0.00612977790726284,0.0250336456054694,0.00123615624266479
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.0263675404765062,0.00816084702488846,-0.0423628006452875,-0.0103722803077248,0.00123662480233171
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0188538980709871,0.00585704042566577,-0.0303336973052921,-0.00737409883668224,0.00128931667194223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.0249396396341005,0.00775478650655179,-0.040139021186942,-0.00974025808125897,0.00130289251944826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.00857789897484237,0.00267487213298753,0.0033351495941868,0.0138206483554979,0.00134509193865259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.0275181848153623,0.00858312334276061,-0.0443411065671731,-0.0106952630635515,0.0013493896229407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0310901149180255,0.00970206655754376,-0.0501061653708112,-0.0120740644652397,0.00135689643728883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,0.0155710141207085,0.00486101813464469,0.0060434185768049,0.0250986096646121,0.00136204441217995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,39575,0.0117707507390594,0.00367807126002068,0.00456173106941886,0.0189797704086999,0.00137698776227102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.0124037850530118,0.00387661596287125,0.00480561776578415,0.0200019523402394,0.00137915365901486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,42070,0.0118471205443755,0.00370404882835174,0.00458718484080608,0.0191070562479449,0.00138500388161929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,42181,0.0113935737511463,0.00356438083892307,0.00440738730685706,0.0183797601954355,0.00139420189173203
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0114563343422376,0.00359221222241043,-0.0184970702981621,-0.00441559838631317,0.00143057986166213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,39919,-0.0163002403338748,0.0051134104062421,-0.0263225247301093,-0.00627795593764024,0.00143777691355907
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,42310,-0.0192720384132165,0.00604611378298855,-0.031122421427874,-0.0074216553985589,0.00143826390108204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_DRA,,42060,0.0122566989417696,0.00385287064268468,0.00470507248210766,0.0198083254014316,0.00147006205268294
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0130170376565617,0.00409278046994829,-0.0210388873776603,-0.00499518793546302,0.00147358934845703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNLY,Granulysin,42137,0.0181306022061948,0.00571547509542656,0.00692827101915877,0.0293329333932309,0.0015162918843246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.0106511236870128,0.00336038432284109,-0.0172374769597813,-0.00406477041424424,0.0015305804408522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,0.00828787054883919,0.00261519727733668,0.0031620838852593,0.0134136572124191,0.00153238239660681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCT,Secretin,39649,-0.0161851535376118,0.00511551121031435,-0.0262115555098279,-0.00615875156539568,0.00156072524309862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,0.0120421209906176,0.00380900683812219,0.00457646758789812,0.0195077743933371,0.00157380169082353
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.025690560070332,0.00813574792169038,-0.0416366259968452,-0.0097444941438189,0.00159347565251
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0210390815525896,0.00666638281675135,-0.0341051918734222,-0.00797297123175693,0.00160371746549144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.0297332057873328,0.009425089647716,-0.0482063814968562,-0.0112600300778095,0.0016108956684394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,42119,-0.0228413598405614,0.00724195545507989,-0.037035592532518,-0.0086471271486048,0.00161383948028914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.0137541128353731,0.00436735593907643,-0.0223141304759629,-0.0051940951947833,0.0016401859858169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00945391869872748,0.00300521436298398,0.00356369854727889,0.0153441388501761,0.00165969941957591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.00790319094093406,0.00251270969550484,-0.0128281019441236,-0.00297827993774457,0.00166280624399338
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.00969889552956956,0.00308560616342657,-0.0157466836098856,-0.00365110744925348,0.00167502717514895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,39736,-0.0195282868650321,0.00621668010695006,-0.0317129798746542,-0.00734359385540996,0.00168655928798044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,39966,-0.028380866078391,0.0090472240653552,-0.0461134252464872,-0.0106483069102948,0.00171139682084585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.0310840481057806,0.0099118269589316,-0.0505112289452865,-0.0116568672662747,0.00171606213504937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0214036676915303,0.00682900531035846,-0.0347885180998329,-0.00801881728322772,0.0017274471079463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.0115686801564649,0.00369382414453353,0.00432878483317915,0.0188085754797506,0.00174129287898695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,42310,0.0245421971409175,0.00784738452692656,0.00916132346814148,0.0399230708136936,0.00176706904132722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,42116,-0.0134216123956511,0.00429444466956985,-0.021838723948008,-0.00500450084329422,0.00177973941461411
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,0.0126119415528954,0.00403659180274034,0.00470022161952429,0.0205236614862664,0.00178615411985866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.01766291457415,0.00566161704224023,-0.0287596839769409,-0.00656614517135916,0.00181377445306312
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0277666102502025,0.00891219921587447,-0.0452345207133165,-0.0102986997870886,0.00184046645171982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FN1,Fibronectin,39979,-0.00899082812924474,0.0028928935187769,-0.0146608994260475,-0.00332075683244202,0.00188885177100794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.0139995982041268,0.00451561995182813,0.00514898309854366,0.0228502133097099,0.00193836453139563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0103582722009332,0.0033452678707869,-0.0169149972276756,-0.00380154717419091,0.00196288967273081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.0288983161772953,0.00933620969858469,-0.0471972871865213,-0.0105993451680693,0.00197097149375318
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.00942830087456499,0.00304826334860603,-0.0154028970378328,-0.00345370471129717,0.00198542223519011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,39897,-0.030410526385496,0.00983312325053302,-0.0496834479565407,-0.0111376048144513,0.00198853534046574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.0110223097322906,0.00356856428846039,-0.0180166957376729,-0.00402792372690821,0.0020151688725092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,42137,-0.00883318301801686,0.00286114466621698,-0.0144410265638021,-0.00322533947223159,0.0020239878108106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,0.012793172954747,0.00415590848796567,0.00464759231833424,0.0209387535911597,0.00208607187822575
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,39929,0.013078268025797,0.0042513578131616,0.00474560671200026,0.0214109293395937,0.00210117002572456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,-0.0203824143520137,0.00663129031483475,-0.0333797433690898,-0.00738508533493755,0.00211956702457562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0168813912553503,0.00549349037085017,0.00611415012848393,0.0276486323822166,0.00212362506225346
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.0109131898020906,0.00355520793813796,-0.017881397360841,-0.00394498224334016,0.00214827615551706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.0331696036836497,0.0108069189098247,-0.054351164746906,-0.0119880426203933,0.00215089729717622
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,39575,-0.0205537191959558,0.00669965208624047,-0.0336850372849871,-0.00742240110692443,0.00216109440649904
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.0223017871973738,0.00727240892466856,-0.0365557086897242,-0.00804786570502347,0.00217004735095617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.0149820105663211,0.00488681141674188,-0.0245601609431351,-0.00540386018950698,0.00217517216213443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0188873064480291,0.00616432628199086,-0.0309693859607311,-0.00680522693532699,0.00218854585527193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0324214638782875,0.0105830391081982,-0.0531642205303559,-0.0116787072262191,0.00219255458286634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,42119,-0.011143886346274,0.00364846746170915,-0.018294882571224,-0.00399289012132408,0.00225948523654209
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEXN,Nexilin,39990,-0.0226390547860616,0.00741747640410002,-0.0371773085380976,-0.00810080103402556,0.00227751985627646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,0.0110586943156331,0.00362366369847768,0.00395631346661681,0.0181610751646493,0.00227913296309157
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.037937269441235,0.0124449137043632,-0.0623293003017869,-0.0135452385806831,0.0023050118066843
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,42119,-0.0191634972742235,0.00628911107875899,-0.0314901549885911,-0.00683683955985584,0.00231513055761074
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,0.0111105989920692,0.00365122377324322,0.00395420039651247,0.0182669975876259,0.0023469736138566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,-0.0295261933010891,0.00970624885739483,-0.048550441061583,-0.0105019455405952,0.00235479850991192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,-0.0185697035042782,0.00610645560076567,-0.0305383564817789,-0.00660105052677747,0.00236350618692809
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.0144774722400174,0.00476942312845968,-0.0238255415717984,-0.00512940290823641,0.00240701558412019
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0216189283465306,0.00713285396196991,-0.0355993221119916,-0.00763853458106958,0.00244399415881498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.0273308528624878,0.00902615454742888,-0.0450221157754484,-0.00963958994952716,0.00246682863253725
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIT,Vitrin,39958,-0.0123616825024317,0.00408548314194939,-0.0203692294606525,-0.00435413554421094,0.00248565927314882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0299086979604648,0.00989439838032991,-0.0493017187859114,-0.0105156771350181,0.00251015132907118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.0136207909137492,0.00451333418076479,-0.0224669259080482,-0.00477465591945021,0.00255014294594084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.026590034915029,0.00882247966115145,-0.0438820950508858,-0.00929797477917217,0.00258496662703709
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,0.0123832526049507,0.00411150800198756,0.00432469692105509,0.0204418082888463,0.00260247360787193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,0.00970185424343632,0.00322192538330268,0.00338688049216308,0.0160168279947096,0.00260705791478971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.011730868574855,0.0039017621096177,0.00408341484000434,0.0193783223097057,0.00264814131788166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,39930,-0.0278866491778322,0.00929162281276856,-0.0460982298908586,-0.0096750684648058,0.00269443467256668
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,42137,-0.0160696857603005,0.00536226438478932,-0.0265797239544876,-0.00555964756611341,0.00273315554170282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,0.0140760801027959,0.0047038670075462,0.00485650076800534,0.0232956594375864,0.00277248982858778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,0.0193095373689235,0.00649112345554739,0.0065869353960506,0.0320321393417964,0.00293743536508461
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,41881,0.0178721642603427,0.00602103566982409,0.00607093434748747,0.0296733941731979,0.00299998551773017
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,39930,-0.0325541256939026,0.0109749962053725,-0.0540651182564327,-0.0110431331313725,0.00302125204326701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,42084,-0.0252731851013737,0.00852579959359561,-0.041983752304821,-0.00856261789792627,0.00303884729375105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,42016,0.0133539214945241,0.00450501065179083,0.0045241006170141,0.0221837423720342,0.00303967335494899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.0233653208060288,0.00788445476897514,-0.0388188521532201,-0.00791178945883754,0.00304837142416508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,39929,0.00950544671077116,0.0032114493539734,0.00321100597698328,0.015799887444559,0.00308414170241815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.0126552531593943,0.00427586901807045,-0.0210359564348124,-0.00427454988397624,0.00308585719849018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOC,Myocilin,42137,0.0140166451429944,0.00473800037798153,0.00473016440215056,0.0233031258838382,0.00309829478391639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.023112813393552,0.00781267251344314,-0.0384256515199006,-0.00779997526720347,0.00309921860045953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSPN,Persephin,42119,-0.0270950312717613,0.00916223855354757,-0.0450530188367146,-0.0091370437068081,0.00310932970851736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,0.00903628294753076,0.00305745556588269,0.00304367003840069,0.0150288958566608,0.00312714439419041
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.0214138050543331,0.00724635119200553,-0.0356166533906639,-0.00721095671800223,0.00313102459783736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,0.0125393450143717,0.00426397970730913,0.00418194478804582,0.0208967452406976,0.00328067485520283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,39657,-0.0383393031028862,0.0130506567245483,-0.0639185902830009,-0.0127600159227715,0.00331307521011472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.014403284242771,0.00490306278353474,-0.0240132872984991,-0.00479328118704288,0.00331440993657069
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,41843,-0.0120235212245414,0.00409558107608751,-0.0200508601336729,-0.0039961823154099,0.00333335597706149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.0147305790486208,0.00501958418819547,-0.024568964057484,-0.00489219403975771,0.00334526871431602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,41843,-0.0177049784939578,0.00604581207426024,-0.0295547701595079,-0.00585518682840777,0.0034121516257748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,42310,-0.0272858569156856,0.0093282731610849,-0.045569272311412,-0.00900244151995923,0.00344942473693361
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.0368032841900588,0.0125847073871101,0.0121372577113231,0.0614693106687945,0.00345643320555211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,-0.00888299243546682,0.00304537967619612,-0.0148519366008112,-0.00291404827012242,0.00354147483561321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.0173808932766787,0.00595929748251025,-0.0290611163423988,-0.00570067021095861,0.00354584922330733
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,-0.0184853633915734,0.00633956452580459,-0.0309109098621504,-0.00605981692099639,0.00355277605958137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOST,Sclerostin,42129,-0.0119787047491189,0.00410838593211528,-0.0200311411760648,-0.00392626832217292,0.00355506231879539
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.00738730135360522,0.00253629331762261,-0.0123584362561455,-0.0024161664510649,0.00358982061826866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.0259112263230086,0.00891860869490575,-0.0433916993650239,-0.00843075328099335,0.00367609846326824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,39757,0.0511047939103636,0.017632145707409,0.016545788323842,0.0856637994968853,0.00375817234737814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.0211277866146452,0.00729246715630876,-0.0354210222410104,-0.00683455098828007,0.00377102811975899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,0.00757100573780403,0.00261476786692966,0.0024460607186219,0.0126959507569862,0.0037919315318207
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,39990,-0.0230438917445967,0.00796986507131008,-0.0386648272843645,-0.00742295620482897,0.00384282007133128
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0114527371648052,0.00396962174315356,-0.0192331957813862,-0.0036722785482242,0.00391913701211198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0101056589353509,0.00351296426907307,-0.0169910689027341,-0.00322024896796767,0.00402645851860592
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.0145655836947709,0.0050653100955097,-0.02449359148197,-0.00463757590757193,0.00404067817069703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.0272661245810817,0.00948638258400476,-0.045859434445731,-0.00867281471643235,0.00405635938873909
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.0221152455798556,0.00770539785218845,-0.037217825370145,-0.00701266578956628,0.00411128965302504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.0200203940980455,0.00698272986906104,-0.0337065446414051,-0.00633424355468584,0.00414862885496951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.0302479634189045,0.010594326021261,-0.0510128424205762,-0.00948308441723291,0.00430879439001245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,39358,-0.00735767886815308,0.00257903494660449,-0.0124125873634979,-0.00230277037280827,0.00434075304530635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0249555401860744,0.00875180202294803,-0.0421090721510525,-0.00780200822109623,0.00435827807732541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.0359141954733082,0.0126548209756325,-0.060717644585548,-0.0111107463610685,0.00454666542918985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,42232,0.012625086067686,0.00445182637595406,0.00389950637081603,0.0213506657645559,0.00457591836895944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.0210888874017568,0.00744198964229344,-0.035675187100652,-0.00650258770286169,0.00460714295772342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.0227251397587209,0.00803948023011169,-0.0384825210097398,-0.00696775850770202,0.00471164061548032
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,0.0089930539050696,0.00318265668812736,0.00275504679633997,0.0152310610137992,0.00472539217300176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0229720171631811,0.0081458552827351,-0.0389378935173419,-0.00700614080902028,0.00480817270316281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.0160338048162172,0.00570099516206542,-0.0272077553338654,-0.00485985429856899,0.00492490997306176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.00788801799877995,0.00280631060400039,0.00238764921493918,0.0133883867826207,0.00495006650965528
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,39575,0.0100762007700439,0.00358561956501745,0.00304838642260973,0.0171040151174781,0.00496029907697053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,39990,-0.0275977317156382,0.00982591905878738,-0.0468565330708614,-0.00833893036041489,0.00498318180649224
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.0132235490024035,0.00471414481671352,-0.022463272843162,-0.00398382516164501,0.00503920581074565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0155962946299311,0.00556583299994322,-0.0265053273098198,-0.00468726195004241,0.00508496318737325
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.0197985758557853,0.00711692313726945,-0.0337477452048334,-0.00584940650673714,0.00541179604444591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,41800,0.0141818510787902,0.00510217813242464,0.00418158193923786,0.0241821202183424,0.00545082687046768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,42181,-0.0157818801609365,0.00570193983256691,-0.0269576822327676,-0.00460607808910534,0.0056510955750701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,-0.0169294919300122,0.00611656989604569,-0.0289179689262617,-0.00494101493376263,0.00565130497786187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,42103,0.0183585946016598,0.00663327192339174,0.00535738163181195,0.0313598075715076,0.00565384379753844
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,39925,-0.00752800714395018,0.00272008599255959,-0.012859375689367,-0.00219663859853338,0.00565689701893302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0270294356746546,0.0097799636387318,0.00786070694274023,0.0461981644065689,0.00572349256270782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0148466803847125,0.00538740522542218,-0.02540599462654,-0.00428736614288502,0.00586241615285374
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.0325910984506151,0.011836500204288,-0.0557906388510196,-0.00939155805021056,0.0059052907765029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.00845492546437881,0.00307095790381556,-0.0144740029558573,-0.0024358479729003,0.00591135778397455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.028884765451201,0.0105076876062338,-0.0494798331594193,-0.00828969774298266,0.00598871654497943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,42310,0.0121468135299154,0.00442715520085959,0.0034695893362306,0.0208240377236002,0.00608288409994673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.0166152453180303,0.00608750634758177,-0.0285467577592906,-0.00468373287677002,0.00635500667461753
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0257018885291239,0.0094266016923973,-0.0441780278462226,-0.00722574921202522,0.00641030656292216
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.00716348961318392,0.00263521951611404,-0.0123285198647674,-0.0019984593616004,0.0065688586782448
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.0139429854979756,0.0051318000423883,0.00388465741489451,0.0240013135810566,0.00659845151429852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.013713767238066,0.00505232159308914,-0.0236163175605207,-0.0038112169156113,0.00665063524559806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.0206687356025279,0.00761875699155046,-0.0356014993059668,-0.00573597189908897,0.00667863098743824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,39575,0.0146590619860321,0.00540838447391026,0.00405862841716801,0.0252594955548962,0.00672999388884858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,42185,0.0119318282686961,0.00440537512750786,0.00329729301878072,0.0205663635186115,0.00676787923051034
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00803762161016299,0.00297147530900268,-0.0138617132158083,-0.00221353000451774,0.00684241953139323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.0212776549462777,0.00787077160189275,-0.0367043672859874,-0.00585094260656787,0.00687432274615609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0107887750837476,0.00399447478884463,-0.0186179456698831,-0.00295960449761214,0.00692531564304117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.0190334813992929,0.0070555005880477,-0.0328622625518664,-0.00520470024671942,0.00699279014709805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,42070,0.00820427067070002,0.00304909539728494,0.00222804369202152,0.0141804976493785,0.00713853573723354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0113703142318622,0.00422570533473423,-0.0196526966879412,-0.00308793177578308,0.00713962555427693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,41830,-0.0244385229216218,0.00908345226248306,-0.0422420893560886,-0.00663495648715497,0.00714465301333297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DMD,Dystrophin,39638,-0.014698524499893,0.00546654206914463,-0.0254129469554165,-0.00398410204436956,0.00718136695226668
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.00753555963530109,0.00280406084158275,0.00203960038579889,0.0130315188848033,0.00721209192116746
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.0247594980588797,0.00922958671595138,-0.0428494880221444,-0.00666950809561504,0.00731365188854388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,39575,0.0165365833731901,0.00616869074869705,0.00444594950574386,0.0286272172406363,0.00735719199851553
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0151104288039361,0.0056373706116308,0.00406118240513974,0.0261596752027325,0.00736224635039694
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIM,Vimentin,41900,-0.032593158817773,0.0121690922441686,-0.0564445796163434,-0.00874173801920256,0.00740755096955354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0185039603228607,0.00691028020058745,-0.0320481095160121,-0.00495981112970929,0.00742112899018711
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.0242108146800076,0.00905383650038586,-0.0419563342207639,-0.00646529513925135,0.00750387839586072
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,39930,-0.0223333354581838,0.00835536608840898,-0.0387098529914654,-0.00595681792490223,0.00752989213218938
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.00767499748261993,0.00287275869026947,-0.0133056045155481,-0.00204439044969178,0.00755873368427743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.0195206268540201,0.00730822587225296,-0.0338447495636359,-0.00519650414440433,0.00757246036506255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.0117493420984089,0.00441082221199612,-0.0203945536339213,-0.00310413056289649,0.00773677778804177
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,39990,0.0068350656544391,0.00256686774100969,0.00180400488206011,0.0118661264268181,0.0077601462334331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0168203005081015,0.00631956956434777,-0.0292066568542231,-0.00443394416197983,0.00778586966996263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.025549490916812,0.00960788759787946,-0.0443809506086558,-0.00671803122496828,0.00784318426306041
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0115346784851269,0.00433911510440018,0.00303001288050251,0.0200393440897512,0.00786458870963026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,42035,-0.0191362681520774,0.00720058082297275,-0.033249406565104,-0.00502312973905085,0.0078792213495922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.0103932245703147,0.00391178700019247,-0.0180603270906919,-0.00272612204993745,0.00789571455144538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,42103,0.019661532598845,0.00740175615657386,0.00515409053196022,0.0341689746657297,0.0079088300750161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0316814314291761,0.0119488188741445,-0.0551011164224993,-0.00826174643585291,0.00802458272070039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.0184633386504324,0.00696892545283873,-0.0321224325379963,-0.00480424476286844,0.00807548933440792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.0234825754040591,0.00886990540637808,-0.0408675900005601,-0.00609756080755804,0.00811962886259844
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.0182166379931268,0.00688431676765834,-0.0317098988577372,-0.00472337712851647,0.00815179028212985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.0155701319398421,0.00589129787134724,-0.0271170757676827,-0.00402318811200152,0.00823116376995284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.0217941348193142,0.00824749600522481,-0.0379592269895548,-0.00562904264907358,0.00823877946822275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,42145,0.0132405678105837,0.00502389612954633,0.0033937313966729,0.0230874042244945,0.00841047154765113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,42070,-0.0164653973226207,0.00625415097189827,-0.0287235332275413,-0.00420726141770005,0.00848020481359473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,42310,0.00707419008153947,0.00269115141810865,0.00179953330204652,0.0123488468610324,0.00858112330151906
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.00827274881716443,0.00314794692567531,0.00210277284284082,0.014442724791488,0.0085989581012582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,0.00749496052587316,0.0028604836807991,0.00188841251150693,0.0131015085402394,0.00879830784402394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,39575,0.0116180950974741,0.00443466743164659,0.0029261469314468,0.0203100432635014,0.00880935146133362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,42145,-0.0119069141103369,0.00454590666634084,-0.020816891176365,-0.00299693704430889,0.00882188018586645
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.0211077259893288,0.00806432564578234,-0.0369138042550622,-0.0053016477235954,0.00886980187198527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,42217,0.00822633865642457,0.00314297038737414,0.00206611669717126,0.0143865606156779,0.00887063602935517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.00759974845275338,0.00290537267244365,-0.0132942788907429,-0.00190521801476382,0.00891476867469602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0251058811228345,0.00960275807355916,-0.0439272869470104,-0.00628447529865851,0.00894938032092306
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.0142429920540193,0.00545066928010452,-0.0249263038430242,-0.00355968026501445,0.00898333371661322
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,38503,-0.0295634309187907,0.0113179043653918,-0.0517465234749586,-0.00738033836262286,0.00901253230555311
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,42249,0.00775674143449899,0.00297355111130696,0.00192858125633735,0.0135849016126606,0.00910182487985037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.0113493188248439,0.00435472985436762,-0.0198845893394044,-0.00281404831028332,0.00916735461657963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.0205470784786569,0.00788460556895771,-0.0360009053938141,-0.00509325156349982,0.009173508682077
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,42187,0.00752916801206616,0.00289058382841072,0.00186362370838115,0.0131947123157512,0.00920489030530934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.0315729436935933,0.0121433755728148,-0.0553739598163103,-0.00777192757087635,0.00933409473825836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,41843,0.0104176157094374,0.00401250352456437,0.00255310880129122,0.0182821226175836,0.00943410618974354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.0244680268343605,0.00942475853844481,-0.0429405535697124,-0.0059955000990087,0.0094380311556112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.02037885553099,0.00786486922152822,-0.0357939992051853,-0.00496371185679467,0.00957677858855053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.0109606223147619,0.00423680992356897,-0.0192647697649571,-0.00265647486456673,0.0096939453616146
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.0155923503661226,0.00602718437069352,0.0037790689995633,0.0274056317326819,0.00969411320871977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.00571589913547116,0.00221129110190433,0.00138176857573867,0.0100500296952037,0.00975436543755226
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.009311035501039,0.00360790972785719,-0.0163825385676391,-0.00223953243443891,0.00986960232669256
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALLD,Palladin,39657,0.0104464863659765,0.00404824225649944,0.00251193154323758,0.0183810411887154,0.0098785270857641
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,42119,-0.0180954601320289,0.00701994662077126,-0.0318545555087406,-0.00433636475531725,0.00995593088052632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.0110093920585114,0.00427186969171009,-0.0193822566542632,-0.00263652746275968,0.00997340170999886
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,42145,0.010644620401925,0.00413080065042135,0.00254825112709912,0.0187409896767508,0.00997983907232917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.0128422167433491,0.00498427642842842,-0.0226113985430688,-0.00307303494362935,0.00998989694477219
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0167574136797553,0.00650455251389221,-0.029506336606984,-0.00400849075252658,0.0100004361234763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,42119,-0.0130601168524108,0.00507091502498127,-0.0229991103013741,-0.00312112340344754,0.0100201937767179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.00972939984105849,0.00377931767770829,-0.0171368624893667,-0.00232193719275024,0.0100527077562542
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,39806,0.00975429767692647,0.00379258835172311,0.00232082450754917,0.0171877708463038,0.0101259004454383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,41839,-0.0222829708974648,0.00868136207379967,-0.0392984405621121,-0.00526750123281741,0.0102762602711537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.00930590486007066,0.00363532571221451,0.00218066646413022,0.0164311432560111,0.0104844162445816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.00671898081657685,0.00262831041406053,-0.0118704692281355,-0.00156749240501822,0.0105893714680154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,42262,0.00761229653338318,0.00298076090906845,0.00177000515160902,0.0134545879151573,0.0106659016162787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.0082623657424809,0.00323616223412639,-0.0146052437213686,-0.00191948776359318,0.0106865270296384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00719018494004165,0.00282051389749995,0.00166197770094176,0.0127183921791415,0.0108091248548271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,-0.0106375762060576,0.00417420565061552,-0.018819019281264,-0.0024561331308512,0.0108350140116255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.00740383887158844,0.0029129727470176,0.00169441228743394,0.0131132654557429,0.0110430885461418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,42224,-0.0193007277473813,0.00759391724583518,-0.0341848055492183,-0.00441664994554439,0.0110455069246122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,39959,0.0103971358680401,0.00409382003801101,0.00237324859353851,0.0184210231425417,0.0111074972514922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,41992,-0.00869325141056323,0.00342329733389115,-0.0154029141849899,-0.00198358863613659,0.0111142818205788
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,0.0109492660825717,0.00431176267925586,0.00249821123123023,0.0194003209339132,0.0111177085870381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,0.00741929202768635,0.00292925578480225,0.00167795068947395,0.0131606333658988,0.0113281259271844
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,-0.00979265945712641,0.00387020964765306,-0.0173782703665264,-0.00220704854772641,0.0114114944627436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0168478182785395,0.00666000254798272,-0.0299014232725857,-0.00379421328449342,0.0114297568389831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,-0.0124132672183753,0.00490768348732536,-0.022032326853533,-0.00279420758321763,0.0114386372301424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.0213826407453112,0.00846163338492245,-0.0379674421797592,-0.0047978393108632,0.0115153327821124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,42145,0.00937559064586773,0.00371432377503102,0.00209551604680692,0.0166556652449285,0.011608462001023
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,42181,-0.016380086754677,0.00649903979903572,-0.0291182047607871,-0.00364196874856703,0.011733995425247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLG,Plasminogen,39742,-0.00583591057359338,0.00232088764739438,-0.0103848503624864,-0.00128697078470038,0.0119335374017237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.00620827273096797,0.00246963730113316,-0.011048761841189,-0.00136778362074697,0.0119565786475298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.0264551261222098,0.0105280053170383,-0.0470900165436048,-0.0058202357008148,0.0119881193130204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,42069,-0.0117615205569765,0.00469535165227552,-0.0209644097954365,-0.00255863131851645,0.0122593261197816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,42007,0.0130955831824742,0.00523006984471936,0.00284464628682428,0.0233465200781242,0.0122949849298337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.00965252961381248,0.00385818778544157,-0.017214577673278,-0.00209048155434699,0.0123670486095437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.0120279966231456,0.0048102682780397,0.00259987079818778,0.0214561224481034,0.0124167496978412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.00999187995831806,0.00399642556673077,-0.0178248740691104,-0.00215888584752575,0.0124241048862295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.0201571821741463,0.00807057923831501,-0.0359755174812438,-0.00433884686704892,0.0125178128637703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,39560,0.00906199002348061,0.00363115859774071,0.00194491917190882,0.0161790608750524,0.0125883277819568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.0125088690225417,0.0050129136293713,-0.0223341797361094,-0.00268355830897394,0.0125983720661346
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0274903518954966,0.0110169039959827,-0.0490834837276227,-0.00589722006337039,0.012599874366607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.0190556775251729,0.00765056092329826,-0.0340507769348375,-0.00406057811550835,0.0127593343991857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,42119,0.0207394893239357,0.00834822522965015,0.00437696787382145,0.03710201077405,0.0129926822881142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,0.0112999247067581,0.00454996532188541,0.00238199267586275,0.0202178567376535,0.0130211707317867
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0255125702495274,0.0102962590766934,-0.0456932380398464,-0.00533190245920838,0.0132299565376748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,0.00930525924647555,0.00375862291462151,0.00193835833381739,0.0166721601591337,0.0133093051254577
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,41900,0.013633245486956,0.0055118937266196,0.0028299337827816,0.0244365571911304,0.0133949546614068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,-0.0105552970981128,0.00427251738965221,-0.0189294311818312,-0.00218116301439448,0.0135070498261301
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0110027519934513,0.00445585612912387,-0.0197362300065341,-0.00226927398036855,0.0135510279799574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,41714,0.00690801719710525,0.00280050558468759,0.00141902625111758,0.0123970081430929,0.0136490062629678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.0221022141714854,0.00897606717589186,0.00450912250673734,0.0396953058362334,0.0138182466166314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.011191361277466,0.00455304697657017,-0.0201153333515435,-0.00226738920338849,0.0139866782784512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0241953384791699,0.00984484520242268,0.00489944188242141,0.0434912350759183,0.0139991901476764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0178513693205452,0.00726664020667319,-0.0320939841256246,-0.0036087545154657,0.0140374999192459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCN,Decorin,41900,0.00598094708310948,0.00243769867187447,0.00120305768623552,0.0107588364799834,0.0141592285043118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.0138578445030325,0.00565099416515745,-0.0249337930667411,-0.00278189593932393,0.014208056355883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.00843094045954341,0.00344239187463829,-0.0151780285338344,-0.00168385238525236,0.014334308146229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.0103860629651453,0.0042409531397048,0.00207379481132393,0.0186983311189667,0.0143410783560245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,0.00935583051747293,0.00382154326360355,0.00186560572080996,0.0168460553141359,0.0143705444367767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,42018,0.0124369622075229,0.00508408076404592,0.00247216390999285,0.0224017605050528,0.0144476011375415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.0153085865590127,0.00625908415018619,-0.0275763914933776,-0.00304078162464773,0.0144679508452001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,0.00451278002952694,0.00184600487972775,0.000894610465260555,0.00813094959379332,0.0145131904385619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.00770253926128033,0.00315849532753976,-0.0138931901032583,-0.00151188841930241,0.0147564881548528
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0118011666794278,0.00484379379738797,-0.0212950025223082,-0.00230733083654736,0.014851741760341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,42145,0.00761479573850993,0.00313667564361114,0.00146691147703209,0.0137626799999878,0.0152093413764354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,42261,0.00889553239889101,0.00367172574273252,0.00169894994313526,0.0160921148546468,0.0154180692103186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.00975777042496286,0.00402919007500921,0.00186055787794481,0.0176549829719809,0.0154584758941942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.0217563718820617,0.00898395403704638,-0.0393649217946726,-0.00414782196945081,0.0154640219413784
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.0254776026314168,0.0105208100039109,-0.0460983902390821,-0.00485681502375149,0.0154667799714549
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.0250699517273762,0.0103741662019376,-0.045403317483174,-0.00473658597157841,0.0156835006596996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.00759015647456598,0.00314163426413087,-0.0137477596322625,-0.00143255331686948,0.0157087403005302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,39726,0.00538496658425656,0.00222980149820675,0.00101455564777133,0.00975537752074179,0.0157513072736387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,0.0151954262743005,0.00630597019544033,0.00283572469123749,0.0275551278573636,0.0159792315873149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRNN,Cornulin,41749,0.0171948318694265,0.00713803042542505,0.00320429223559336,0.0311853715032596,0.0160141563146142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.0213580779899655,0.00887035078445615,-0.0387439655274996,-0.00397219045243147,0.0160619809984158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,0.0116498677882097,0.00483920589027397,0.00216502424327274,0.0211347113331467,0.0160800343889313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.0157094184395698,0.00652727503395578,-0.0285028775061231,-0.00291595937301644,0.0161091627268857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.0189575985925502,0.00788889961887672,-0.0344198418455486,-0.00349535533955185,0.016274180611888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.0260158435461862,0.0108285192590843,-0.0472397412939914,-0.00479194579838109,0.0162985021032949
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00859420381419959,0.00358273830949543,-0.0156163709008106,-0.00157203672758855,0.0164662457881964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,39586,0.0118964464322588,0.00496826198154042,0.00215865294843955,0.021634239916078,0.0166602180024454
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0116073014402293,0.00484902931422079,0.00210320398435653,0.021111398896102,0.016691182451022
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,39586,-0.0138559563138884,0.00579415810590801,-0.025212506201468,-0.00249940642630866,0.0168025023204772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.00690774265578514,0.00289525118459592,-0.0125824349775931,-0.00123305033397713,0.0170542967697583
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00869595895495157,0.00364658271406202,0.00154865683539002,0.0158432610745131,0.0171104041845953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,0.00565180119560137,0.00237176904083952,0.00100313387555591,0.0103004685156468,0.0171882616383946
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.0141033514103807,0.00593246098173401,-0.0257309749345793,-0.002475727886182,0.0174529401749718
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0102011163006699,0.00430207176931281,-0.018633176968523,-0.00176905563281681,0.0177437337757514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.0143142649841625,0.00604762573681632,-0.0261676114283224,-0.00246091854000247,0.0179538327404147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.0200253608517704,0.00846602493273884,0.00343195198360226,0.0366187697199385,0.0180289198053414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,39575,-0.0141226320793088,0.00597284309902655,-0.0258294045534008,-0.00241585960521676,0.0180730018849804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.00858004503570624,0.00363285839198943,-0.0157004474840055,-0.00145964258740695,0.0182010204239843
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSPN,Claspin,41820,0.0089072483701831,0.00377221869383303,0.00151369973027036,0.0163007970100958,0.018226607995145
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.0272035372432215,0.0115324061960668,-0.0498070533875125,-0.00460002109893063,0.018344741627974
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-0.0112177659345459,0.00475992133582997,-0.0205472117527727,-0.00188832011631919,0.0184544565699546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,41913,0.0120249548329253,0.00511391193221261,0.00200168744578857,0.022048222220062,0.0187164048069792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,39850,-0.0246125492744904,0.0104702321285618,-0.0451342042464716,-0.00409089430250929,0.0187544622286112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.0166044182522504,0.00708070234597617,-0.0304825948503637,-0.00272624165413707,0.0190405543935468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.0146809386209457,0.00626676347202629,-0.0269637950261172,-0.00239808221577417,0.0191641236111728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0107810353943944,0.004605011520652,-0.0198068579748723,-0.00175521281391651,0.0192414877962531
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,0.00633735098046139,0.00271554053409826,0.0010148915336288,0.011659810427294,0.0196269660190536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0222100933656815,0.00952349663732921,-0.0408761467748468,-0.00354403995651628,0.019710900314086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",42262,0.0179753174398726,0.00770971814622596,0.00286426987326977,0.0330863650064755,0.0197407246700328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.00989038005661884,0.0042449742284198,-0.0182105295443216,-0.00157023056891604,0.0198291732203676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.0194880413052347,0.00839237094710331,0.00303899424891222,0.0359370883615572,0.020244709957322
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.00766782822404939,0.00330412159309487,-0.0141439065465153,-0.00119174990158344,0.0203214757049977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.0107848829342716,0.00464856016799682,-0.0198960608635453,-0.00167370500499781,0.0203559543556289
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.0234165765062394,0.0100961442673175,-0.0432050192701817,-0.00362813374229708,0.0203939014511919
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.0261125540197862,0.0112861592482427,-0.0482334261463419,-0.00399168189323061,0.020703561804429
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,39586,-0.0102753826393544,0.00444985962313719,-0.0189971075007033,-0.00155365777800555,0.0209538528111121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,39736,-0.0075945380135941,0.00329134165140728,-0.0140455676503524,-0.00114350837683583,0.0210491493903965
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,42158,0.00755322502338961,0.00327511364956748,0.00113400227023735,0.0139724477765419,0.0211117742740247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,0.00848182831287528,0.00368420008327957,0.00126079614964732,0.0157028604761032,0.0213409694595104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.0212342051105207,0.00923218367578406,-0.0393292851150575,-0.00313912510598396,0.0214655012750087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,42249,-0.0275285710600769,0.0119760261760166,-0.0510015823650694,-0.00405555975508429,0.0215404355897091
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.00953979896651703,0.00416255188772521,-0.0176984006664584,-0.00138119726657562,0.0219345678408081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0105172244129064,0.00459289275138463,-0.0195192942056203,-0.00151515462019253,0.0220431972502127
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,0.0133552011339834,0.00586381761489126,0.00186211860879652,0.0248482836591703,0.0227719050659399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,39575,0.015618358550351,0.00686212028779581,0.00216860278627125,0.0290681143144308,0.0228636818337085
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,42296,-0.00856007556758764,0.00376359781833086,-0.0159367272915161,-0.00118342384365916,0.022954969564062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.0135081679605614,0.00595155366922269,-0.0251732131522379,-0.00184312276888493,0.0232420690222196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,41913,-0.0170324645811495,0.00750880678408571,-0.0317497258779575,-0.00231520328434148,0.0233249404807791
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.00636016474925954,0.0028055178889516,0.000861349686914411,0.0118589798116047,0.0234083819411852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0404401461981132,0.0178860878184146,0.00538341407402061,0.0754968783222057,0.0237763340807751
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.00785195601148534,0.00349564353856865,-0.0147034173470799,-0.00100049467589079,0.0247069361341308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.0153166175791853,0.00683374802397041,-0.0287107637061673,-0.00192247145220325,0.0250251012244616
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.00878655354655076,0.00392145426775757,0.00110050318174592,0.0164726039113556,0.025068867914763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.00676408434025858,0.00302046965797635,-0.0126842048698922,-0.000843963810624933,0.0251482036139995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.0234516585300259,0.010474489433298,-0.04398165781929,-0.00292165924076172,0.0251796948224995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.0107758211511312,0.00481303417203084,-0.0202093681283116,-0.00134227417395073,0.0251828550904105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.0163099881610777,0.00729509298774812,-0.030608370417064,-0.0020116059050914,0.0253843967889355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.0065006954682362,0.002909259076063,-0.0122028432573197,-0.000798547679152713,0.0254706097064833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLGN,Calmegin,39649,-0.0108332248257909,0.00485403565451935,-0.0203471347086488,-0.00131931494293295,0.0256483196269162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.00847661784787412,0.00379850881716121,-0.0159216951295101,-0.00103154056623814,0.0256598524034224
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,39757,0.00981668754981463,0.00440283937450708,0.00118712237578075,0.0184462527238485,0.0257920696616344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.0090140832830025,0.00404729661366857,-0.0169467846457929,-0.00108138192021211,0.0259518611618045
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.0170074635296492,0.00763803593912438,-0.031978013970333,-0.00203691308896545,0.0259852125703021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,39575,0.0108216567487504,0.00486712897576657,0.00128208395624796,0.0203612295412529,0.0262079838608364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.0168267611213213,0.00757949372147365,-0.0316825688154096,-0.00197095342723291,0.0264330809035565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,0.00802065898685618,0.00361816172890602,0.000929061998200382,0.015112255975512,0.0266548925625621
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,39560,0.00939517657358993,0.00423888835376087,0.00108695540021862,0.0177033977469612,0.0266828889298919
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,39757,-0.00679128706146465,0.00306837297541174,-0.0128052980932717,-0.000777276029657645,0.0268958432785135
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.0195778543368488,0.0088468207844172,0.00223808559939107,0.0369176230743065,0.0269193707377204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.0109710354697939,0.00498151438504876,-0.0207348036644895,-0.00120726727509832,0.0276606952770348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0169682627936933,0.00772226601462657,-0.0321039041823613,-0.00183262140502518,0.0280179670390433
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.0132746025673871,0.00604330186412811,-0.0251194742210783,-0.00142973091369605,0.0280705638830651
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,39934,-0.017895544090423,0.00817239227080551,-0.0339134329412018,-0.00187765523964417,0.0285622578401116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.00529316481269904,0.00242086083571817,-0.0100380520507067,-0.000548277574691434,0.0288008620615869
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.00888435484368733,0.00406568740078953,0.00091560753813986,0.0168531021492348,0.0288910551075768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,42137,-0.0168770850686688,0.00772427763570865,-0.0320166692346577,-0.00173750090267981,0.0289103146038293
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERVV_1,,39575,0.0101076249472918,0.00462898613214054,0.00103481212829633,0.0191804377662872,0.029016398674103
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,42015,-0.0116992730197884,0.00535951625961666,-0.022203924888637,-0.00119462115093972,0.0290606574788703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.0128160308182641,0.00588179587264666,-0.0243443507286516,-0.0012877109078767,0.0293577916407548
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00798071245995168,0.00366502527791279,0.000797262915242612,0.0151641620046608,0.0294620505482826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,39657,0.012636665934299,0.00580692174211115,0.00125509931976113,0.0240182325488368,0.0295660036279586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0204095564188751,0.00938776026001556,0.00200954630924455,0.0388095665285055,0.0297212405597183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.012364046968941,0.00569233540154686,0.00120706958190921,0.0235210243559729,0.0298727774078517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.0110402514006113,0.00509075849569901,-0.0210181380521814,-0.00106236474904127,0.0301273379954544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.00988621888523439,0.00455921381704814,0.000950159803820036,0.0188222779666488,0.0301455895828598
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.00975825697931854,0.00450270816212525,-0.018583564977084,-0.000932948981553057,0.0302369728764102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,41839,0.0106483393020712,0.00492653023267189,0.000992340046034252,0.0203043385581081,0.0306801771935873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,39518,0.0101019907333264,0.00467394916863027,0.000941050362811098,0.0192629311038418,0.030690794952917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,39649,-0.0149969407299573,0.00695359239866587,-0.0286259818313424,-0.00136789962857218,0.0310491147870905
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,39649,0.00867299516902608,0.0040295571398601,0.000775063174900285,0.0165709271631519,0.031391821300449
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.00535702158732103,0.00249302850934,0.000470685709014622,0.0102433574656274,0.0316678939250456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,42119,0.013580648722677,0.00632757668459757,0.00117859842086573,0.0259826990244882,0.0318696829451061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.00660184401608657,0.00307740784131882,-0.0126335633850715,-0.00057012464710168,0.0319531718041607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BSG,Basigin,42284,-0.00474991392632415,0.00221420539820085,-0.00908975650679782,-0.000410071345850478,0.0319543886569531
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,41814,-0.00831599964963039,0.00387854035892132,-0.0159179387531162,-0.000714060546144607,0.032042625475131
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,39649,-0.0112393346397272,0.00524199494722588,-0.02151364473629,-0.000965024543164498,0.0320470378125417
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.016448698549452,0.0076806083048014,0.00139470627204123,0.0315026908268627,0.0322482433915243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.0119399724993131,0.00557738682305782,-0.0228716506725064,-0.00100829432611973,0.0323134177943484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.010845034296235,0.00507488509969461,-0.0207918090916365,-0.000898259500833599,0.0326192674878585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0058165830576263,0.00272703318875505,0.000471598007666401,0.0111615681075862,0.032948232993722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.00691022397412318,0.00324045460029018,-0.0132615149906919,-0.000558932957554418,0.0329883567251582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.0119781100256946,0.00561784808448809,0.000967127780097899,0.0229890922712912,0.0330161088394192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,0.00739631141312779,0.00347066524746768,0.000593807528091128,0.0141988152981644,0.0330996105256149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0148950840766446,0.00699311484716965,-0.0286015891770972,-0.00118857897619212,0.0331925440550198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,0.00909608992495614,0.00427685050905321,0.000713462927211854,0.0174787169227004,0.0334532629195183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.00549396149133399,0.00258355738142885,0.000430189023733448,0.0105577339589345,0.0334789173149968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,39575,0.00908097307534367,0.00427534513737027,0.000701296606097935,0.0174606495445894,0.0336897039661662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,42048,0.0130937812096236,0.00616530358066899,0.00100978619151238,0.0251777762277348,0.0337063011950676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.0111120391699924,0.00525072632566428,0.000820615571690409,0.0214034627682944,0.0343422210257544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.0155992465233106,0.0073732192118595,-0.0300507561785552,-0.00114773686806598,0.0343959486153248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.00814385466411013,0.00385000477120109,0.000597845312556002,0.0156898640156643,0.0344274816828883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.0109754940631073,0.00519206022338405,0.000799056025274579,0.02115193210094,0.0345463174446079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,0.0082807124497188,0.00392055384428023,0.00059642691492954,0.0159649979845081,0.0346936601981954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.0109707003985968,0.00519485305409911,-0.0211526123846311,-0.000788788412562531,0.0347220672828272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,39638,-0.00668246193290448,0.00316533178804348,-0.0128865122374697,-0.000478411628339265,0.034782610543767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,41913,0.0135114433952582,0.00642431652159781,0.000919783012926528,0.0261031037775899,0.0354694443108055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,42096,0.00976457636327864,0.00465180503672257,0.000647038491302392,0.0188821142352549,0.0358271371888863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,39736,0.0068032937498876,0.00324553828150718,0.000442038718133535,0.0131645487816417,0.0360870609634439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.0166530132515951,0.00794498681631061,0.00108083909162629,0.0322251874115639,0.036101428478662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0109905987538139,0.00525267418275071,-0.0212858401520053,-0.000695357355622542,0.0364271541734009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0125728036533832,0.00602873761828072,0.000756477921553004,0.0243891293852134,0.0370449713621976
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,39930,-0.0266392902965801,0.012810249455828,-0.0517473792300029,-0.00153120136315731,0.0375911512816487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,39930,-0.00965916716217127,0.00464520835163413,-0.0187637755313742,-0.000554558792968368,0.037604599082786
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.00608184703679234,0.00292642403324705,-0.0118176381419566,-0.000346055931628115,0.0377048692806755
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,0.00706441777218014,0.00340350039038893,0.000393557007017823,0.0137352785373424,0.0379467402499696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.0131178229195304,0.00633359813171471,0.000703970581369527,0.0255316752576912,0.0383680708407259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,41839,-0.0134876338787558,0.00651486073884118,-0.0262567609268845,-0.000718506830627045,0.0384447838860755
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.00927533350614156,0.00448271527647631,0.000489211564247995,0.0180614554480351,0.0385562643494617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,-0.00768505329200133,0.00372588878235168,-0.0149877953054106,-0.000382311278592037,0.0391691237729918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00614667053108546,0.00298002194646497,-0.0119875135461568,-0.000305827516014125,0.0391709240714071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.0183949069566939,0.00892042806064306,-0.0358789459555543,-0.000910867957833482,0.0392203772337326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.0227675227439455,0.0110485305082866,-0.0444226425401872,-0.00111240294770371,0.0393560347109654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,39575,-0.00857723501741547,0.00416694517109308,-0.0167444475527579,-0.000410022482073029,0.0395754187327339
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,0.00454627640787584,0.00221384101913555,0.000207148010370155,0.00888540480538152,0.0400366394722777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,41900,-0.00969600143296353,0.00473025926591544,-0.0189673095941578,-0.000424693271769274,0.0404052525476915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.0201439724851587,0.00983576491484737,-0.0394220717182595,-0.000865873252057829,0.0405763268588795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,42137,0.00822603493614571,0.00402213420658473,0.000342651891239653,0.0161094179810518,0.0408552687426573
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.0189614122254898,0.00927800637224115,0.000776519735897114,0.0371463047150824,0.0410073665964341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.0205734302051494,0.0100709588272158,-0.0403125095064923,-0.000834350903806427,0.0410906795048926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRELP,Prolargin,42123,0.00506541805243206,0.00248174903386178,0.000201189946062983,0.00992964615880114,0.041263461444576
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.0111388432892424,0.00546549331223683,-0.0218512101812266,-0.00042647639725818,0.0415661021142324
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C5,Complement C5,39979,0.00325033744962664,0.00159530736772936,0.000123535008877098,0.00637713989037619,0.041629407341426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.0055765335061733,0.00275222677331232,0.000182169030481146,0.0109708979818654,0.0427650178790594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.01596029923901,0.00790396980597845,-0.0314520800587278,-0.000468518419292284,0.043478380979116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,42016,0.0224034637697645,0.0110952707407908,0.000656733117814542,0.0441501944217144,0.0434872861329915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00891805977680897,0.00442065477930618,0.000253576409368848,0.0175825431442491,0.0436820493693772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.0123749043214412,0.00614645865024976,-0.0244219632759307,-0.000327845366951648,0.0440991816208276
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.0159814250191959,0.00795044116311417,-0.0315642896988997,-0.00039856033949217,0.0444414383609947
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00560448449877337,0.00279239198191793,0.000131396214214229,0.0110775727833325,0.0447682752874829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.00794354591206558,0.00396418891866464,-0.0157133561926483,-0.000173735631482879,0.0451124284489786
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0182236004261221,0.00910346105741604,-0.0360663840986575,-0.000380816753586661,0.0453271961636135
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00800479132596336,0.0040066308520601,-0.0158577877960011,-0.000151794855925569,0.0457536989097155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.0101504459343402,0.00508506196882952,-0.020117167393246,-0.000183724475434341,0.0459400819750677
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.0120101440697494,0.00602199665845989,-0.0238132575203308,-0.000207030619167993,0.0461307649325485
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,39657,0.00362265255914127,0.00181986416771446,5.57187904209346e-05,0.00718958632786161,0.0465475844073264
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,0.014370014889201,0.00721933809603175,0.000220112220978771,0.0285199175574232,0.0465618276713161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.00732979469222855,0.00368368936929342,0.000109763528413444,0.0145498258560437,0.0466333566801972
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,0.0122038647981651,0.00613479333847723,0.000179669854749754,0.0242280597415805,0.0466895597496819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0146731953613905,0.00737809292791851,0.000212133222670238,0.0291342575001108,0.0467488884638949
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.0260903258042423,0.0131223300707684,-0.0518100927429483,-0.000370558865536233,0.046806017459104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0114005951659749,0.00573718639073371,0.000155709840136858,0.022645480491813,0.0469274015985294
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,39966,0.00912203542198027,0.00459165633164949,0.000122389011947258,0.0181216818320133,0.0469846518821458
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,41839,-0.0152212010630725,0.00766566628817392,-0.0302459069878934,-0.000196495138251608,0.0470946677874868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.0106536794875465,0.00536607669510421,0.000136169165142202,0.0211711898099507,0.0471275097190565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,39475,-0.00835709954897943,0.00420951127616642,-0.0166077416502656,-0.000106457447693243,0.047137322167356
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,39934,-0.00537867539814089,0.00270944659787458,-0.0106891907299751,-6.81600663067199e-05,0.0471511314423392
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,39699,-0.00935606581690258,0.00471734141888481,-0.0186020549979168,-0.00011007663588835,0.0473546858590996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,39736,-0.0228933509963648,0.0115572673196725,-0.0455455949429229,-0.000241107049806618,0.0476313207970631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.0105384785179577,0.00535882462298867,-0.0210417747790155,-3.51822568999544e-05,0.0492583390554681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,41843,0.0112166715825091,0.00570823036277257,2.85400714748561e-05,0.0224048030935433,0.0494351312835491
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,42296,-0.0165002247575986,0.00839964419352371,-0.0329635273769051,-3.69221382921225e-05,0.0495044129364974
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.00614041275241296,0.00312619772878232,1.3065203999618e-05,0.0122677603008263,0.0495344800301758
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.0111213518663367,0.00566827334007449,-0.0222311676128827,-1.15361197907532e-05,0.0497828279786094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.0080757101759278,0.00411860037201583,-0.0161481669050788,-3.25344677677523e-06,0.0499286415249639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,42119,-0.00662245890871223,0.00337799458661828,-0.0132433282984841,-1.58951894039736e-06,0.0499613221963075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,42146,0.0113500385063688,0.00579889833828168,-1.5802236663252e-05,0.0227158792494009,0.050335656315088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,0.00631804724876826,0.00323082343072675,-1.43666754561667e-05,0.0126504611729927,0.0505383931161805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.0131430860792908,0.00672498448106358,-0.0263240556621754,3.78835035938115e-05,0.0506788803146728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,-0.0127777003092589,0.00653889472349355,-0.0255939339673062,3.85333487885036e-05,0.0507139538465145
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,39966,0.0236766335785284,0.0121621641101334,-0.000161208077333087,0.0475144752343898,0.0515899015948062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.0101248509841827,0.00520700661758243,-0.0203305839546443,8.0881986278843e-05,0.0518639117725094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0083273695758938,0.00428588983263725,-7.29744960752034e-05,0.0167277136478628,0.0520404352380117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.0106620117120496,0.00549027779664964,-9.8932769383683e-05,0.0214229561934829,0.052165029801914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.0181138936660641,0.00934974341398861,-0.0364393907574817,0.000211603425353594,0.0527258108611385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.00950575273282479,0.0049178356293355,-0.00013320510067279,0.0191447105663224,0.0532725020406398
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,39908,0.0125302216778235,0.0064888435025174,-0.000187911587110583,0.0252483549427576,0.0535029698052095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.00784689936011649,0.00406515445555938,-0.000120803372779902,0.0158146020930129,0.0535923968523043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00611972857126069,0.00317205964665097,-9.75083361752097e-05,0.0123369654786966,0.0537241214641072
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,-0.0226592048423299,0.0117525546716613,-0.045694211998786,0.000375802314126174,0.0538786470257995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,41797,0.00969496451511748,0.00503014524480196,-0.000164120164694352,0.0195540491949293,0.0539546402517862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,39966,-0.0172309345573525,0.00894558122073688,-0.0347642737499968,0.000302404635291773,0.0541049288832351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00793442603768985,0.00412874847874877,-0.000157920980657736,0.0160267730560374,0.0546629751885647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.0120749016764219,0.00629808011857342,-0.000269335355981965,0.0244191387088258,0.0552331636310557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.00762247856695427,0.00397738748273744,-0.0154181580331196,0.000173200899211105,0.055332538463711
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.0134042287840879,0.00700783291238031,-0.000331123724177509,0.0271395812923533,0.0558061292758891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.00899349207104018,0.00470605311487333,-0.0182173561761919,0.000230372034111543,0.0560242791822142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,41843,-0.0124820634176445,0.00653264784863638,-0.0252860532009718,0.000321926365682852,0.0560620940932754
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESPL1,Separin,39560,0.0108067367934598,0.00566204352959701,-0.000290868524550321,0.02190434211147,0.0563361467666013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.00745925085085683,0.00392136436432124,-0.0151451250049265,0.000226623303212803,0.0571655206085937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.00912887038975055,0.00480763924215466,-0.0185518433043737,0.000294102524872589,0.0576087053545915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00592348067521896,0.0031208928326272,-0.000193469276730348,0.0120404306271683,0.0577166116199614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,39930,-0.00702850506696566,0.00370627653585345,-0.0142928070772384,0.000235796943307106,0.0579353579559052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,41774,0.0127656186423544,0.00674511142496208,-0.000454799750571314,0.0259860370352801,0.0584365220841587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,39919,-0.0171868129381479,0.00908228563817668,-0.0349880927889742,0.000614466912678347,0.0584705946545369
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.011949676819181,0.00632108009348561,-0.0243389938024128,0.000439640164050749,0.0587239323965772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,42137,-0.00497257474328561,0.00263437850365461,-0.0101359566104487,0.000190807123877434,0.059105025624391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,41900,-0.0145620465675681,0.00771896821282148,-0.0296912242646982,0.000567131129562051,0.0592456571483555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,39757,0.00669375153148848,0.00354816657160667,-0.000260654948860599,0.0136481580118376,0.0592484196787168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,39854,-0.00862680018012101,0.00457430127994708,-0.0175924306888173,0.000338830328575259,0.0593304660971073
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,39649,0.0134588393417541,0.00713851761909991,-0.000532655191681714,0.0274503338751899,0.0594043696712796
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.0136182067303759,0.00724046369443447,-0.000573102110715687,0.0278095155714674,0.0600191810065568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,41900,-0.0167904642864924,0.00895723069258964,-0.0343466364439681,0.000765707870983262,0.0608813617613238
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.00662395106905863,0.00353373857519768,-0.000302176538328812,0.0135500786764461,0.0608847236316459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,42073,-0.00766207632210237,0.0040924278318255,-0.0156832348724803,0.0003590822282756,0.0611927120105009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,42070,0.0147979135981521,0.00791967174458895,-0.000724643021242238,0.0303204702175465,0.0617139780002134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,41839,0.00640179339643816,0.00342684362107213,-0.000314820100863218,0.0131184068937395,0.0617658617905855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.0152928874949749,0.00821167159726934,-0.0313877638256228,0.000801988835673039,0.0625823652601737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.00762888132593447,0.00409664965941539,-0.0156583146583886,0.000400552006519697,0.0625981576931505
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,41959,-0.00856775526483186,0.00460122944098558,-0.0175861649691636,0.000450654439499877,0.0626168807774148
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.013992865602416,0.00755197530568635,-0.0287947372015612,0.000809005996729293,0.0639262099381954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.0129562434359843,0.0069936518877983,-0.026663801136069,0.000751314264100368,0.0639697127584137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,39876,-0.00930292464942139,0.005024597000461,-0.0191511347703249,0.000545285471482165,0.0641271194426927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,42299,-0.00666841543472362,0.0036021745140717,-0.0137286774823041,0.000391846612856904,0.0641595001777513
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00711909124978629,0.00384696655541549,-0.000420963198828074,0.0146591456984007,0.0642577262121357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,42262,-0.00622702507097524,0.00336696213461276,-0.0128262708548162,0.00037222071286576,0.0644145762084412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,-0.0376120695078161,0.0203872668634382,-0.0775711125601549,0.00234697354452276,0.0650768495476486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.0103750042421825,0.00562721275611214,-0.0214043412441623,0.000654332759797292,0.0652500654093168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.00770128237649124,0.00418182931509469,-0.0158976678340768,0.000495103081094343,0.0655595431595211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,39657,0.00578234232548471,0.00314539080348407,-0.000382623649344057,0.0119473083003135,0.0660370394959691
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.00611147353543839,0.00332769766176395,-0.000410813881618943,0.0126337609524957,0.0663036292204326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,42070,0.00634670647943205,0.00347117299896877,-0.000456792598546734,0.0131502055574108,0.0675110493980304
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.00636884148296671,0.00348531119530589,-0.0132000514257663,0.000462368459832836,0.0676759551005146
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.00913646488980221,0.00500061221054901,-0.0189376648224783,0.000664735042873859,0.0677111061533052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,39958,-0.0139849829624469,0.00765646473492828,-0.0289916538429063,0.00102168791801256,0.0677923683585605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,42296,0.00937370473959713,0.00513566390483421,-0.00069219651387791,0.0194396059930722,0.067989949903597
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.0231538851247847,0.0127142355683715,-0.0480737868387928,0.00176601658922348,0.0686185883871816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,42145,-0.0221197798816691,0.0121659287707191,-0.0459650002722786,0.00172544050894045,0.0690595636726225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,42087,-0.0127514125279899,0.00701784376007732,-0.0265063862977414,0.00100356124176165,0.0692395061205343
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.00677892925446859,0.00373301421277343,-0.0140956371115045,0.000537778602567342,0.0694016986635481
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,0.0152619848545308,0.00842655701834746,-0.00125406690143024,0.0317780366104918,0.0701355668119166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,-0.0167598437795565,0.00927328329241232,-0.0349354790326847,0.00141579147357162,0.0707388723745821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.0118001141407639,0.00653953809682922,-0.00101738052902138,0.0246176088105492,0.0711918878595072
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,41913,-0.0217230923494743,0.0120970165204496,-0.0454332447295555,0.00198706003060681,0.0725585990048522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,39919,0.00505819360154227,0.00282257798041214,-0.000474059240065527,0.0105904464431501,0.0731520688887827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,39990,0.0101785039940555,0.00567986245679131,-0.000954026421255423,0.0213110344093665,0.0731541274807851
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGN,Cingulin,39649,-0.00712714848890466,0.00397759032782326,-0.0149232255314383,0.000668928553628926,0.073188248202489
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00568054416696213,0.00317135996260166,-0.000535321359737129,0.0118964096936614,0.0732844610993598
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.0203690515951938,0.0113752085595984,-0.0426644603720066,0.001926357181619,0.0733756825863057
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,42210,0.00802218660799851,0.00448083551297232,-0.000760250997427235,0.0168046242134242,0.0734226523565773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,39958,-0.0051767935211701,0.00289161890185237,-0.0108443665688007,0.000490779526460538,0.073436311555251
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.00889293859409658,0.00496800698211853,-0.000844355090855731,0.0186302322790489,0.07347483755688
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0132866996034882,0.00743747711395315,-0.00129075553985997,0.0278641547468364,0.0740527417126925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0211856048073606,0.011861093777649,-0.0444333486115527,0.0020621389968314,0.0740989464331245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,39979,0.00575517704264309,0.00323148569434978,-0.000578534918282472,0.0120888890035687,0.0749441235425326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,39657,0.0104948388901934,0.00590377255323037,-0.00107655531413813,0.0220662330945249,0.0754889015125968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,41900,0.0114710713357762,0.00645347701696601,-0.00117774361747722,0.0241198862890296,0.0755084504945594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.00647644837945972,0.00364763050598512,-0.000672907412271118,0.0136258041711906,0.0758341043354528
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.0225682619516363,0.0127275320782494,-0.0475142248250052,0.00237770092173258,0.0762206582917908
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00427914451190689,0.00242220516591575,-0.000468377613287971,0.00902666663710176,0.0773121701570123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,39979,0.00352456457448341,0.00199646509953148,-0.000388507020598279,0.00743763616956511,0.0775229513933927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.00703440980480984,0.0039855388485647,-0.0148460659479966,0.000777246338376969,0.0775942635666459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.00975732318470594,0.00553756853940155,-0.020610957521933,0.00109631115252109,0.0780884778069629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00669286094197418,0.00379858134663575,-0.0007523584974319,0.0141380803813803,0.0781077816444711
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.00808476285356476,0.00459188534510335,-0.0170848581299673,0.000915332422837794,0.0783224254127768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,42224,-0.0129735104359335,0.00737060807775495,-0.0274199022683332,0.0014728813964662,0.0784017176354408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,39934,-0.0113415921124145,0.00644458935355964,-0.0239729872453914,0.00128980302056242,0.0784580698107268
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,39586,0.0090043718333154,0.00514864910610291,-0.0010869804146463,0.0190957240812771,0.0803396106002055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,39721,-0.0107622767730641,0.00615667748395121,-0.0228293646416084,0.0013048110954803,0.0804802447972762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.0113127381548726,0.00649950643654699,-0.00142629446075948,0.0240517707705047,0.0817894575825375
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.00931794217771718,0.00535960618627909,-0.0198227703028242,0.00118688594738985,0.0821411503451257
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.0085817047629003,0.00493829265263852,-0.0182607583620718,0.0010973488362712,0.0822760511932663
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.00828318487223498,0.0047686603166034,-0.0176297590927776,0.00106338934830769,0.0824092194223718
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,42138,0.00752567614126,0.00433578523133211,-0.000972462912150945,0.0160238151946709,0.082637454957916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.00788473777012703,0.00454606686282517,-0.0010255532810103,0.0167950288212644,0.0828685670752261
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.0154070330203774,0.00888399364192757,-0.0328196605585554,0.00200559451780067,0.0829025098784387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.0160811577086747,0.00928429109916752,-0.034278368263043,0.00211605284569365,0.0832865729555904
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.0073890145961284,0.00426800086992006,-0.0157542963011717,0.000976267108914923,0.0834328164815478
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0105805077935931,0.00612491348885158,-0.0225853382317421,0.00142432264455604,0.084108938562064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.0149252415653751,0.00865792585807359,-0.00204429311644914,0.0318947762471993,0.0847573678380506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-0.00435415843228445,0.00252856545942636,-0.00931014673276012,0.000601829868191222,0.0850946441736934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,39575,0.00721796270174455,0.00419311277324841,-0.00100053833382234,0.0154364637373114,0.0852091101211617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,0.010777433920592,0.00626597639821717,-0.00150387981991369,0.0230587476610976,0.0854566169466515
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.00621143601064256,0.00361403965770366,-0.000872081718456604,0.0132949537397417,0.0856979163526664
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,-0.0199449950845586,0.0116276255455323,-0.042735141153802,0.00284515098468483,0.0863111409684828
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,41839,-0.0132997164004202,0.00778987365003127,-0.0285678687544815,0.00196843595364109,0.0877882005580506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.0158979472434667,0.00934631475219201,-0.034216724157763,0.00242082967082965,0.0889685679395543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,-0.00946329583383294,0.00556821426597366,-0.0203769957951413,0.00145040412747545,0.0892445879606676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,41913,-0.0138338029537576,0.00814706103555183,-0.0298020425834392,0.00213443667592396,0.0895289695889007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.00813509789296219,0.00479524183516036,-0.0175337718898765,0.00126357610395212,0.0898203045989985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,0.00663336003910897,0.00391273331952445,-0.00103559726715896,0.0143023173453769,0.0900365191205683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.0103984256560363,0.00615201774820775,-0.0224563804425235,0.00165952913045085,0.0910044583682956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,42165,0.00958281946647996,0.00567987640423653,-0.00154973828582364,0.0207153772187836,0.0915969632976004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.0165690792195122,0.00983606379173743,-0.0358477642513176,0.00270960581229312,0.0921040320044738
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0101126628176764,0.00600391481064062,-0.0218803358465321,0.00165501021117917,0.0921386129203327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,39915,0.00438558626589532,0.00260919430948579,-0.000728434580696834,0.00949960711248748,0.0928254619403429
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,39757,0.00688132410000615,0.00409827931968355,-0.0011513033665736,0.0149139515665859,0.0931651558622369
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,42070,-0.00991007218511885,0.00590247848984979,-0.0214789300252244,0.00165878565498673,0.093181484798748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0104713485947512,0.00624723572328518,-0.00177323342288774,0.0227159306123902,0.0937305398455121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,42200,0.006658297708817,0.00397553749266638,-0.0011337557768091,0.0144503511944431,0.0939931369423555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.0103354938552721,0.0061759577530805,-0.00176938334076565,0.0224403710513099,0.0942564661181817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,39560,0.013785404002463,0.00824567032644221,-0.00237610983736371,0.0299469178422897,0.0945853190848456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0108940267772176,0.00651785855405333,-0.0236690295431621,0.00188097598872695,0.0946636560651347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.00702309411366739,0.00420501500119371,-0.0152649235160071,0.00121873528867228,0.0949086786638446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,41843,0.0157113420442596,0.00942053149457473,-0.00275289968510683,0.0341755837736261,0.095383724391995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.0121314143641403,0.00727610509886511,-0.0263925803579159,0.00212975162963529,0.0954789031684164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.00777728397735018,0.00466525622238212,-0.0169211861732191,0.00136661821851878,0.0955292051588424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0060747445652736,0.00364423835056703,-0.00106796260183777,0.013217451732385,0.0955529308346086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,39638,-0.00520231658058759,0.0031218718949145,-0.01132118549462,0.000916552333444835,0.0956602786384712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.00554099552736181,0.00332924641752295,-0.0120663185057068,0.000984327450983174,0.0960681837650046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,42145,-0.00623363769436915,0.00375041810968139,-0.0135844571893447,0.00111718180060637,0.0965122434507362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.012491928055192,0.007518859997063,-0.00224503753905144,0.0272288936494355,0.0966591600887037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.00662233475458302,0.00398810555576428,-0.00119435213471498,0.014439021643881,0.0968328745670887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,0.016970000500092,0.0102422387806229,-0.003104787509929,0.0370447885101129,0.0975754547115719
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,39757,0.00933178076599242,0.00565394798153557,-0.00174995727781731,0.0204135188098021,0.0988710425997722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.00470573620032572,0.00285149094767071,-0.0102946584577603,0.000883186057108873,0.0989149281173527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.00780031719958921,0.00472888794112022,-0.0170689375641848,0.00146830316500642,0.0990731166589195
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,41839,-0.00784799229239327,0.00475900505786034,-0.0171756422057995,0.001479657621013,0.0991544456481943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,42216,-0.0102373552733416,0.00621046972774593,-0.0224098759397236,0.00193516539304041,0.0992931268037192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.0223819467247312,0.0135840936721125,-0.0490067703220716,0.00424287687260926,0.0994504984379758
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,42145,-0.0118764023950311,0.00721204232179886,-0.0260120053457568,0.0022592005556947,0.0996334473058834
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,42262,0.00800982933635987,0.00489434990196813,-0.00158309647149767,0.0176027551442174,0.10174837498831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.0130113842869521,0.00795683916032748,-0.028606789041194,0.00258402046728975,0.102025333884098
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.00596760130213113,0.00365807755685869,-0.0012022307093119,0.0131374333135742,0.102840238684067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.00963520305236375,0.00590880189403091,-0.0212164547646643,0.00194604865993683,0.102991445622666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,42137,-0.00776850791163236,0.00476621162639258,-0.0171102826993618,0.0015732668760971,0.103143257179075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,0.00641484903943424,0.00394815018563742,-0.00132352532441509,0.0141532234032836,0.104239116875068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00930865621126643,0.00574295814367605,-0.00194754175033862,0.0205648541728715,0.105066810284138
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,41300,0.0085917507008051,0.00530722500321441,-0.00181041030549514,0.0189939117071053,0.10549830972327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.00866251715339819,0.00535981177103615,-0.00184271391783267,0.0191677482246291,0.10607983639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0202467629389229,0.0125288632065021,-0.044803334823667,0.00430980894582127,0.106120074496761
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00517773597081049,0.0032041015348632,-0.00110230303752138,0.0114577749791424,0.106124348860144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.00583828998501881,0.00364108753217312,-0.0129748215480781,0.0012982415780405,0.108863861079975
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,42144,-0.00503789207843699,0.00314256653874727,-0.0111973224943816,0.00112153833750766,0.108932829471896
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,0.0104305050722584,0.00651554542361496,-0.00233996395802694,0.0232009741025437,0.109434831050989
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,0.00473740306307508,0.00296212866258838,-0.00106836911559815,0.0105431752417483,0.109777230814123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,-0.011451284419489,0.00716700858302902,-0.0254986212422259,0.00259605240324783,0.110120598098966
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.0108243589395192,0.00678705433832508,-0.00247826756359794,0.0241269854426364,0.110768685613656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,41756,-0.0124637118339278,0.00781628345482481,-0.0277836274053844,0.00285620373752882,0.110829563143664
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.00687758254142739,0.00431544875180178,-0.0153358620949589,0.0015806970121041,0.111023683888609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.0191336623298491,0.0120516683071758,-0.0427549322119136,0.00448760755221543,0.112391918697946
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RETN,Resistin,42105,0.00720742689335274,0.00454957122299762,-0.00170973270372259,0.0161245864904281,0.113171819858071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.0093881188719372,0.00593248732138444,-0.00223955627797631,0.0210157940218507,0.113565885059875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,39652,0.0119039541518001,0.00753848094182042,-0.00287146849416792,0.0266793767977681,0.114343598775208
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,0.0107873461353213,0.00684048439880135,-0.0026200032863293,0.024194695556972,0.114827674397468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,-0.0193449424787179,0.0122693378184633,-0.043392844602906,0.00470295964547017,0.114890628250476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,39586,0.00879952632561602,0.00558487495588559,-0.00214682858791972,0.0197458812391518,0.115146919776996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.0140113014725058,0.00890031758785448,-0.00343332099968902,0.0314559239447005,0.115459098265342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,0.00523420019105769,0.00332728907507784,-0.00128728639609488,0.0117556867782103,0.11572158550104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.00878481100262415,0.00558473571447653,-0.00216127099774985,0.0197308930029981,0.115745770920295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,39575,-0.0100274284533645,0.00637543888389442,-0.0225232886657976,0.00246843175906854,0.115788941268645
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,0.014887405607759,0.00948097440418495,-0.00369530422444349,0.0334701154399615,0.116387229812301
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,39870,-0.00542979987953153,0.00346012114397332,-0.0122116373217192,0.00135203756265618,0.116617450336152
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,42107,-0.0152111265921216,0.00970204279452733,-0.0342271304693951,0.003804877285152,0.116944890377678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.0102376387005791,0.006538181311663,-0.00257719667028039,0.0230524740714386,0.117418746748626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,39657,-0.0105848998342938,0.00678230137997267,-0.0238782105390402,0.00270841087045263,0.11863145182452
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,41900,0.00536254869304162,0.00344371238377932,-0.00138712757916584,0.0121122249652491,0.119446817768773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.00602814977763622,0.00387137097070658,-0.00155973732494868,0.0136160368802211,0.119473246507056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.00949390597978247,0.00610674251915046,-0.00247530935775243,0.0214631213173174,0.120055962640768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0140298177161879,0.0090297703410052,-0.00366853215218234,0.031728167584558,0.120272931646556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,0.00715892233928865,0.00460999516323247,-0.00187666818064699,0.0161945128592243,0.120472290207439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.00594024411028381,0.00382557976803212,-0.0134383804556268,0.00155789223505914,0.120501949236037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00643576975243934,0.00414837582014786,-0.00169504685505046,0.0145665863599291,0.120835715739586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.0209820280200356,0.0135331335717225,-0.0475069698206117,0.00554291378054049,0.121064264765112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.00573965214308846,0.00370429761496886,-0.0130000754684274,0.00152077118225051,0.121300586930942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00500007328316806,0.00323086602878806,-0.00133242413325654,0.0113325706995927,0.121748621365328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.00916402635952487,0.00594156677032544,-0.0208094972293627,0.002481444510313,0.123015103399871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00935664422493834,0.00607381487470139,-0.00254803292947639,0.0212613213793531,0.123470034322971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,42115,-0.0143581128281723,0.00933465034295265,-0.0326540275003595,0.00393780184401485,0.12403481914838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00565135897352792,0.00368363672163484,-0.00156856900087637,0.0128712869479322,0.125008639004283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00795643322244211,0.00518796868848611,-0.00221198540699067,0.0181248518518749,0.125149110348611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,0.00793381279664012,0.00518338183017474,-0.00222561559050237,0.0180932411837826,0.125886358777897
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,0.0100682269962477,0.00658929016008319,-0.00284678171751533,0.0229832357100108,0.126548806317429
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,0.0122981269286545,0.00804926793039957,-0.0034784382149286,0.0280746920722377,0.126576941237037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.00815661783122365,0.00534131364042318,-0.0186255925664531,0.00231235690400579,0.126764794679467
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.0122506577115701,0.00803638822822457,-0.00350066321575008,0.0280019786388902,0.127437146345826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,41900,0.00628582616400656,0.00413102012898545,-0.00181097328880492,0.014382625616818,0.128129109074852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,-0.00734597760917051,0.00483029350947025,-0.0168133528877322,0.00212139766939118,0.128334539503537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.00929095691411966,0.00612719587823695,-0.0213002608354641,0.00271834700722477,0.129454893847607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00439796753012644,0.00290611482497879,-0.00129801752683199,0.0100939525870849,0.130219220717619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.00592918102930496,0.00391840364389891,-0.0136092521713468,0.00175089011273691,0.13026228509147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,39638,0.00659247209822097,0.00435837410293929,-0.00194994114354004,0.015134885339982,0.130410189854115
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,0.00915320202670498,0.00605550708792104,-0.00271559186562025,0.0210219959190302,0.130676321011708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,39638,-0.0117785239566243,0.00780372783741348,-0.0270738305179548,0.00351678260470609,0.131239054733191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.0102092864986605,0.0067693973438049,-0.00305873229519711,0.0234773052925181,0.131539118066441
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,39757,0.00898422666546675,0.0059669039059209,-0.00271090499013821,0.0206793583210717,0.132178562627862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.00636842284239621,0.00423569500625941,-0.0146703850546646,0.00193353936987222,0.132734685799614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0090047990205659,0.00600021903185767,-0.00275563028187514,0.0207652283230069,0.133444954190151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.00765649302130288,0.00510854512806968,-0.0023562554297137,0.0176692414723194,0.133964162335284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.00763353391017929,0.0051156036111155,-0.0176601169879657,0.00239304916760708,0.135673017722233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.0167548188938778,0.0112554304614046,-0.00530582481047527,0.0388154625982309,0.136621812417584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.0158332815021565,0.0106394855493793,-0.0366866731789399,0.00502011017462698,0.136735912325015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.008518286582627,0.00572608548402682,-0.0197414141313196,0.00270484096606557,0.136872272617461
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,39575,0.00675335684696499,0.00454968111722693,-0.00216401814279979,0.0156707318367298,0.137742614531645
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.006025693825237,0.00406488529159675,-0.0139928689967666,0.00194148134629263,0.138263723135855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.00839576596620156,0.00567547212570006,-0.00272815940017056,0.0195196913325737,0.139081988960686
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.0102518131232117,0.0069336532111182,-0.0238417734170034,0.00333814717057994,0.139286129820134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,0.00513266417573115,0.00347610099614717,-0.00168049377671731,0.0119458221281796,0.139817577013562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.0108297876104561,0.0073442208498979,-0.00356488525534382,0.0252244604762559,0.140348602509998
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0042187749121664,0.00286202277137323,-0.00139078971972513,0.00982833954405793,0.140490362387778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.00494501155956773,0.00335653834568017,-0.0115238267171009,0.00163380359796539,0.140707668670819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,0.00782428283812413,0.00531288865699464,-0.00258897892958536,0.0182375446058336,0.140861014993457
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.00839141989478646,0.00570556212287556,-0.00279148186604963,0.0195743216556225,0.141389189725393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0061295815946086,0.00417077054585825,-0.0143042918644908,0.00204512867527358,0.14167945720395
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,0.00960985071808309,0.00655550039376157,-0.00323893005368959,0.0224586314898558,0.142692828163555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,42119,-0.0100211044283327,0.00684615939439705,-0.023439576841351,0.00339736798468547,0.143283977083137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,39690,-0.0132421582110368,0.00906213142751544,-0.031003935808967,0.00451961938689349,0.143971585583158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,39958,0.00467175171192329,0.00319762584737078,-0.00159559494892345,0.01093909837277,0.144041357196339
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.0148475993926534,0.0101702904025063,-0.0347813685815658,0.00508616979625907,0.144345972461383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0063322386314089,0.0043400709963375,-0.0021743005214126,0.0148387777842304,0.144587924271985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.0100153186278833,0.0068649369559313,-0.0234705950615087,0.00343995780574205,0.144617910868409
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,39937,-0.00500532369864683,0.00343169944943205,-0.0117314546195336,0.00172080722223998,0.144715224515699
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,42113,-0.00370655207011723,0.00254224992933593,-0.00868936193161564,0.00127625779138119,0.144869022454092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.0120814757419696,0.00832243438602784,-0.00423049565464499,0.0283934471385841,0.146619478243054
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,42070,-0.0126639336879167,0.00875342592901012,-0.0298206485087766,0.00449278113294312,0.1479929538334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,42123,0.0197284100749358,0.0136455564249291,-0.00701688051792518,0.0464737006677968,0.148263376388931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,39649,0.00888745018733667,0.00614816226028395,-0.00316294784281988,0.0209378482174932,0.148332997278307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.0033937091150885,0.00234775314784315,-0.00799530528486108,0.00120788705468408,0.148336748433495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,41538,-0.00434273760011464,0.00300915860317287,-0.0102406884623335,0.00155521326210418,0.148995845844532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.00899788633958326,0.00625277121030066,-0.0212533179117726,0.00325754523260603,0.150172280309592
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.011654010590818,0.00810373324112591,-0.00422930656178874,0.0275373277434248,0.150432616570607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,41843,0.0134813150333165,0.0093769557486963,-0.00489751823412822,0.0318601483007613,0.150540830641081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWC2,Brorin,41973,0.00621598933431903,0.00433354494062735,-0.00227775874931059,0.0147097374179486,0.151484658633827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,41913,0.00776902401620758,0.00541850190090982,-0.00285123970957567,0.0183892877419908,0.151654095333783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.00497754860686794,0.0034748291951202,-0.00183311661556764,0.0117882138293035,0.152035751863643
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,42119,0.00754091053401417,0.00527097400184237,-0.00279019850959688,0.0178720195776252,0.152554120726516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.00868425293849634,0.00607371594924868,-0.0205887361990238,0.00322023032203108,0.15279491123761
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,39757,-0.013100428182551,0.00918136715839828,-0.0310959078130116,0.00489505144790963,0.153651293025648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.00869001791396743,0.00609188131617872,-0.0206301052936777,0.00325006946574285,0.153754955606656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,39919,-0.010671046443942,0.00748467244100301,-0.0253410044283079,0.00399891154042385,0.153976786095599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.00654779115742045,0.00460586616226618,-0.0155752888354622,0.00247970652062127,0.155160162825638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,41825,0.00849028487283676,0.00597682163850605,-0.00322428553863511,0.0202048552843086,0.15547553492832
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,0.00734710861136262,0.00517528129652498,-0.00279644272982633,0.0174906599525516,0.155731403931727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAX,Protein max,41839,-0.015909556604848,0.0112678664116949,-0.03799457477177,0.00617546156207406,0.157990993078009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.00520665940690587,0.0036900556080148,-0.00202584958480314,0.0124391683986149,0.158268306242121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.00498562689628126,0.00353433171661049,-0.0019416632682753,0.0119129170608378,0.158382677109676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,42166,0.00458657421409318,0.00325871648518478,-0.001800510096869,0.0109736585250554,0.159308384939081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.00262190251845424,0.00186285928111819,-0.0062731067094459,0.00102930167253741,0.159313564644122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MB,Myoglobin,42310,0.00836958740752178,0.00594687113836146,-0.00328628002366669,0.0200254548387103,0.159333426909891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00648851923218919,0.00462927197669501,-0.0155618923065114,0.00258485384213303,0.16105454892782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.00614709626068088,0.00439176414003774,-0.0147549539751549,0.0024607614537931,0.1616350491842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0114668293110605,0.00819417024064717,-0.0275274029827289,0.00459374436060798,0.161723760356164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,39657,0.00440424405947267,0.00314920813048501,-0.00176820387627796,0.0105766919952233,0.1619837306329
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.00757997557244883,0.00542949814233113,-0.0182217919314178,0.00306184078652018,0.162715351573111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,0.0121392576938516,0.00870104500705834,-0.00491479051998271,0.029193305907686,0.162998563017105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0110095927529656,0.00790353005135933,-0.0044813261476987,0.0265005116536299,0.163648052740924
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,39560,-0.010480778096642,0.00755294594686178,-0.025284552152491,0.00432299595920713,0.165274575608075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.00691052604678428,0.00498334189944084,-0.0166778761696883,0.00285682407611977,0.165548899327718
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,39575,-0.0111300714367799,0.00805670259935778,-0.0269212085315211,0.00466106565796136,0.167163438359058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00744554618192692,0.00539482454952561,-0.00312830993514327,0.0180194022989971,0.167575476421701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00664145075179677,0.00481616864613897,-0.0160811412982292,0.00279823979463561,0.167925760471164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,-0.00392260140938707,0.00284632522809269,-0.00950139885644874,0.00165619603767461,0.168186489156986
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.00702980568593196,0.00511473538352196,-0.017054687037635,0.00299507566577108,0.169338760275017
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,42239,-0.00881215220079098,0.00642856526440648,-0.0214121401190277,0.00378783571744571,0.170465934019232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,39930,-0.00533580439737136,0.00389417176204768,-0.0129683810509848,0.0022967722562421,0.170650805722244
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBN1,Drebrin,39657,-0.00742336119888891,0.00542112074043314,-0.0180487578501379,0.00320203545236004,0.170920616899364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,0.00532653990479808,0.00389650344282928,-0.00231060684314731,0.0129636866527435,0.171646533614025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,-0.0098008918897379,0.00717490084739168,-0.0238636975506256,0.00426191377114981,0.171962464600028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,0.00494174252000029,0.00363075725830336,-0.0021745417062743,0.0120580267462749,0.173511924140021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,39649,-0.0112364145620409,0.00825799278159024,-0.0274220804139578,0.00494925128987596,0.173645312373094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.00858624110435479,0.00631287695632937,-0.0209594799387604,0.00378699773005077,0.173821386163191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.00515918579803756,0.00379476728093748,-0.0022785580725999,0.012596929668675,0.173999067602011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.00428924837771503,0.00315558742358965,-0.0104741997279507,0.00189570297252069,0.17408890416523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.0106118170724901,0.00781368799443888,-0.0259266455415903,0.00470301139661014,0.174453173922303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.00971629217350138,0.00715739611782507,-0.00431220421743576,0.0237447885644385,0.17464448719726
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,41976,0.00802928230972856,0.00591972137613893,-0.00357337158750373,0.0196319362069609,0.175007062075902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,42070,-0.00446833504630356,0.00330229884967211,-0.0109408407916609,0.00200417069905378,0.176046928616546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,0.00414749291933412,0.00306878745471647,-0.00186733049191017,0.0101623163305784,0.176555041226912
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.00533246413005558,0.00394557406710987,-0.00240086104147978,0.0130657893015909,0.176561035062038
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.012386658635181,0.00916668914608816,-0.0303533693615138,0.00558005209115181,0.176637371440627
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.00410903836757282,0.00304238573458798,-0.00185403767221962,0.0100721144073653,0.17685224184443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.00522220859793404,0.00387280442091352,-0.0128129052629245,0.00236848806705645,0.177546833130502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.0052010153129072,0.00385757141471636,-0.0127618552857513,0.00235982465993687,0.177601883704143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.0214215764955777,0.015904556089083,-0.0525945064301804,0.00975135343902494,0.178040489092229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.00431900476320738,0.00321381180024059,-0.00198006636526419,0.0106180758916789,0.179012015785811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGN,Mimecan,42137,0.00615647629900216,0.00458274920241073,-0.00282571213772288,0.0151386647357272,0.179164227921004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.00444110551870615,0.00330912550576106,-0.00204478047258553,0.0109269915099978,0.179598411281397
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,0.00449920825559057,0.00336238903311113,-0.00209107424930724,0.0110894907604884,0.180886865610767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00542134802301055,0.0040714155822474,-0.00255862651819436,0.0134013225642155,0.183030568453259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.0171617041375273,0.0128907104749273,-0.0424274966683849,0.00810408839333027,0.183105079877166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.00930863094769143,0.00702900346951907,-0.00446821585256595,0.0230854777479488,0.185424812617623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.0131619175985387,0.00994411305491768,-0.0326523791861773,0.00632854398909995,0.185662078800216
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,41668,-0.00514174034273323,0.00388651691515592,-0.0127593134964388,0.00247583281097238,0.185868925849946
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00618827601561305,0.00468524017814897,-0.00299479473355893,0.015371346764785,0.18659399405404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C7,Complement component C7,39722,0.00467440875739305,0.00354004401644239,-0.00226407751483404,0.0116128950296201,0.186715983740556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.0114961903316225,0.00871310742682967,-0.0285738808882087,0.0055815002249636,0.187058454654284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,41839,0.00740370426384191,0.00561160247605938,-0.00359503658923448,0.0184024451169183,0.18707277019064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,0.00344215590003623,0.00260931333552008,-0.00167209823758312,0.00855641003765558,0.187135818664237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.0138581024885748,0.010509121012285,-0.0344559796726535,0.00673977469550379,0.187304844723026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.00609646767655771,0.00462430917246121,-0.0151601136545817,0.00296717830146626,0.187413165150591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.00802337696839099,0.00609040897975937,-0.00391382463193737,0.0199605785687193,0.187739113611635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.0114864314758347,0.00872764020830623,-0.0285926062841149,0.00561974333244548,0.188168391604079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.00807268291502465,0.00614287658970951,-0.0201127210308553,0.003967355200806,0.188817013379656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,42145,-0.00522419743610273,0.00397641205655755,-0.0130179650669555,0.00256957019475007,0.18893684560422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,0.00657544701962906,0.00501636856050998,-0.00325663535897052,0.0164075293982286,0.189947995369287
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,39575,0.00811463629927419,0.00619280242473297,-0.00402325645320242,0.0202525290517508,0.190110470820167
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00672218694904329,0.00513897871847815,-0.00335021133917388,0.0167945852372605,0.190873289536335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00566705708551438,0.00433554442574834,-0.00283060998895237,0.0141647241599811,0.191200707575808
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.004533342219028,0.00347069355859517,-0.0113359015938745,0.00226921715581853,0.191514078104895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.00506500651641591,0.00387867164047566,-0.0126672029317482,0.00253718989891638,0.191622178791952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,42249,0.00313306965008931,0.00240097702220483,-0.00157284531343217,0.00783898461361078,0.191943973894364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00570512502366697,0.00437219249841584,-0.00286437227322807,0.014274622320562,0.191965953436632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.00500911446413197,0.00386087087345556,-0.0125764213761049,0.00255819244784092,0.1945181647221
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,41913,0.0100737900009687,0.00777488224978158,-0.00516497920860314,0.0253125592105406,0.19510686356067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.00768630890129938,0.00593706543012185,-0.0193229571443382,0.00395033934173945,0.195470009727351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.00531325228271274,0.00410789201111289,-0.013364720624494,0.00273821605906852,0.195885992100007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0050301574745962,0.00388932197100922,-0.00259291358858187,0.0126532285377743,0.195920764012085
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.00469297459099682,0.00365376177179571,-0.00246839848172276,0.0118543476637164,0.199021202199673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00573549525144536,0.00446544235550115,-0.00301677176533689,0.0144877622682276,0.199022611391624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,42185,-0.00519815430465728,0.00405613651749484,-0.0131481818789472,0.00275187326963261,0.200021336296546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.0101681864945707,0.00796799449214378,-0.0257854556991725,0.00544908271003115,0.201932028872516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,39657,0.00416663828055878,0.00326987800292241,-0.00224232260516915,0.0105755991662867,0.202602018676871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.0404390370100254,0.0317476400677188,-0.102664411542754,0.0217863375227034,0.202768556937406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,0.00577443850446668,0.00453485519582026,-0.00311387767934102,0.0146627546882744,0.202922354473194
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,42119,-0.00522224093865823,0.00410178456508718,-0.0132617386862291,0.00281725680891265,0.202982047464745
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,41864,0.00671015320135965,0.00527347804441478,-0.00362586376569332,0.0170461701684126,0.20324123556248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,39560,0.00711102002250983,0.00559980704341587,-0.00386460178258527,0.0180866418276049,0.204158343048682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,0.0063817886002265,0.00503122400056987,-0.00347941044089046,0.0162429876413435,0.204668833567181
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,39649,-0.00301220305398698,0.00237595475743886,-0.00766907437856714,0.00164466827059318,0.204900966941147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,39919,-0.0104449576059852,0.00825116735707285,-0.026617245625848,0.00572733041387756,0.20558340887903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.0104119026040437,0.0082296656622519,-0.0265420473020574,0.00571824209397007,0.205838098476455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,39929,-0.00939151387436921,0.0074248716922684,-0.0239442623912153,0.00516123464247685,0.205943157985164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,0.00930742360245398,0.00738202141832969,-0.00516133837747221,0.0237761855823802,0.207399368297118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,41900,0.0142924046759264,0.0113974632845884,-0.0080466233618668,0.0366314327137196,0.20986450072119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.0123617347338247,0.00986383391803378,-0.0316948492131709,0.00697137974552155,0.210140662292591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.00414148910933026,0.00330698219469118,-0.010623174210925,0.00234019599226445,0.210464922462826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.00459347360282982,0.00366916276207659,-0.00259808541084029,0.0117850326164999,0.210628116760794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.00723146753715085,0.00578074705316761,-0.0185617317613594,0.00409879668705767,0.210975835703036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRTN,Neurturin,41913,-0.00655731677516701,0.00524967177706209,-0.0168466734582087,0.0037320399078747,0.211653823175056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.00738664964685312,0.00592290146613756,-0.0189955365204827,0.0042222372267765,0.212375104117925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,39757,-0.00930482782259564,0.00746707121544842,-0.0239402874048745,0.00533063175968326,0.212748422965484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00654922363927341,0.00525729512134887,-0.00375507479857038,0.0168535220771172,0.212886399528405
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.00397768606706411,0.00319760442143774,-0.0102449907330821,0.00228961859895386,0.213536701242631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,39575,0.00465475163878859,0.00374849150626265,-0.00269229171348621,0.0120017949910634,0.214349217077121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,39638,-0.00410778985458302,0.00330965584830807,-0.0105947153172668,0.0023791356081008,0.214575546114304
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTN,Titin,39575,-0.00910194727167516,0.00735694786192751,-0.0235215650810531,0.00531767053770276,0.216042773829852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.00453276996536017,0.00366982638636559,-0.0026600897519164,0.0117256296826367,0.216797858863723
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,0.00374656936101488,0.0030336216460842,-0.00219932906531015,0.00969246778733992,0.216850330794487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,41843,-0.00858344078957076,0.00695132995396641,-0.0222080474993449,0.00504116592020341,0.216930145579608
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,42119,0.0117085736861434,0.00951966030166312,-0.00694996050511633,0.0303671078774031,0.218742444252187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,41913,0.00630424711182912,0.00514836784162911,-0.00378655385776394,0.0163950480814222,0.220780157052862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.00296350628719227,0.00242432297178659,-0.00178816673750944,0.00771517931189398,0.221575482607398
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.00796851302982573,0.00652283741628182,-0.00481624830608663,0.0207532743657381,0.221867546121394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.00356399145291371,0.00291765667425658,-0.00928259853445662,0.00215461562862919,0.221908216468091
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,42262,0.00382985684864217,0.00313548371094023,-0.00231569122480067,0.00997540492208502,0.221934316145736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,39586,0.0060347665230227,0.00494473138769169,-0.003656906996853,0.0157264400428984,0.222322895530484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00869590284058519,0.00712965455753158,-0.0226700257733471,0.00527822009217671,0.222612109019272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,-0.0146211484453666,0.0119895886074766,-0.0381207421160208,0.00887844522528755,0.222685203195866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,-0.00864022815303319,0.00709968217768064,-0.0225556052212872,0.00527514891522087,0.223630467735331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,39930,0.0149566753190333,0.0122910671076691,-0.00913381621199828,0.0390471668500648,0.223677651101229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,-0.0081128880250135,0.00666810293189717,-0.0211823697715319,0.00495659372150495,0.223755399346995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,39649,-0.00405982169176772,0.00334347284607015,-0.0106130284700652,0.00249338508652978,0.224677106442682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.0154773337898971,0.0127579454556092,-0.0404829068828911,0.00952823930309686,0.225092603261337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00472018045385644,0.00390129387249255,-0.0123667164439418,0.00292635553622896,0.226342660108701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,42119,-0.00652428166250906,0.00539887092610283,-0.0171060686776706,0.00405750535265248,0.226894208304314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0134214634684058,0.0111374610875615,-0.0352508872000264,0.00840796026321473,0.228196037215697
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.00384941803503339,0.00319751841969199,-0.0101165541376297,0.00241771806756291,0.228658275589069
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-0.00782300148371481,0.00649849884830849,-0.0205600592263995,0.00491405625896984,0.228686245996241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.00504746409583164,0.00420229566867262,-0.01328396360643,0.0031890354147667,0.229729902390196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,0.00430915014723963,0.00359585271851536,-0.00273872118105047,0.0113570214755297,0.230799975893561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.009132852091838,0.00762453278905494,-0.0240769363583857,0.00581123217470969,0.231010433041763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.00541051697012565,0.0045211735442608,-0.0142720171168768,0.00345098317662552,0.231446891246385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,39657,-0.00502270519417511,0.0042242697458466,-0.0133022738960344,0.00325686350768422,0.234460686101973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.00826800252194762,0.0069730444738362,-0.0219351696906666,0.00539916464677134,0.235757960091104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,39575,0.00563008740869701,0.00475021424333365,-0.00368033250823694,0.014940507325631,0.23595293448859
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,39649,-0.0114891643604431,0.00969836248581272,-0.030497954832636,0.00751962611174981,0.236181371213224
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,39929,0.00613728806982153,0.00518981214899495,-0.00403474374220858,0.0163093198818516,0.237006571428843
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,41843,0.0202583344946682,0.0171798276131666,-0.0134141276271384,0.0539307966164747,0.238342470097244
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,39575,-0.0140251800703151,0.0119003292594307,-0.0373498254187992,0.00929946527816908,0.238601388511232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,39934,-0.00656536347838037,0.00557412954125562,-0.0174906573792414,0.00435993042248064,0.238890083396975
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,41913,0.00514393515075981,0.00437579511545816,-0.00343262327553817,0.0137204935770578,0.239798582095205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.00873299024185136,0.00743554294675075,-0.0233066544174828,0.00584067393378011,0.240222884741081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.00313943111957792,0.00267610531470679,-0.0021057352972474,0.00838459753640323,0.240762555208399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.00494416959910728,0.00421740725125701,-0.00332194861335647,0.013210287811571,0.241087474069439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00633070791209779,0.00540893845395076,-0.0042708114576457,0.0169322272818413,0.241854682299582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,0.00522034375006578,0.0044608435113585,-0.00352290953219688,0.0139635970323285,0.241921618654805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00942586772609805,0.00806861891838144,-0.00638862535392958,0.0252403608061257,0.242746097827945
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,41913,0.00388943441870154,0.00334206300290325,-0.00266100906698883,0.0104398779043919,0.244533024624887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.00424329981186772,0.00365118206129411,-0.0113996166520042,0.00291301702826873,0.245186390813332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,39636,0.00552354047844209,0.00475349785986935,-0.00379331532690184,0.014840396283786,0.245262647676288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.00583655043752353,0.00502729133257701,-0.0156900414493745,0.0040169405743274,0.245673730337079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,42296,-0.00719184359834491,0.00619646609309971,-0.0193369171408203,0.00495322994413052,0.24581005854421
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,41839,-0.00849050798089446,0.00731743359053631,-0.0228326778183456,0.0058516618565567,0.245942613818929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.00627358916426455,0.00540907718239138,-0.0168753804417516,0.00432820211322255,0.246139882855883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,0.00738703799035349,0.00637108459832429,-0.00510028782236212,0.0198743638030691,0.246287701205518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,42262,-0.0027222086230808,0.00234826555738493,-0.00732480911555526,0.00188039186939367,0.246377718933296
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00315474859954023,0.00272150525008261,-0.00848889888970215,0.00217940169062169,0.246402784995896
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,-0.00567100708282526,0.00490137541586082,-0.0152777028979125,0.00393568873226195,0.247283583172984
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDK,Midkine,42129,-0.00627571777266337,0.00542529650492443,-0.0169092989223152,0.00435786337698851,0.247394484351818
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.00263747908217641,0.00228408674838151,-0.00183933094465134,0.00711428910900417,0.248229741410924
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.0046817244065835,0.00405965419562024,-0.0126386466299992,0.00327519781683217,0.248840158047675
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.00632917240571437,0.00549362547745395,-0.0170966783415241,0.00443833353009537,0.24930319727052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0112462363072616,0.00977059933612855,-0.00790413839155036,0.0303966110060736,0.249745645551424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,39657,0.00346609985324306,0.00301479476942191,-0.00244289789482388,0.00937509760130999,0.250293645584852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,0.00840670332296211,0.00731307775547797,-0.00592692907777472,0.0227403357236989,0.250356691300072
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,0.00511204824067346,0.00445066236713114,-0.00361124999890358,0.0138353464802505,0.250739470187149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,42249,-0.00790600797098736,0.00690602583291525,-0.0214418186035012,0.00562980266152652,0.252312713399334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.00549089908624399,0.00479748972800291,-0.0148939789531297,0.0039121807806417,0.252421733372439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.00369991336094962,0.00323331056467283,-0.0100372020677084,0.00263737534580913,0.252519165802211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.00747923038008935,0.00654450928423596,-0.0203064685771918,0.00534800781701313,0.253135246578628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0100716965218753,0.00883451272625229,-0.0273873414653297,0.00724394842157924,0.254294783561877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.00853250781306779,0.0074881825304926,-0.0232093455728333,0.0061443299466977,0.254534505779596
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0149429768309722,0.0131179332819855,-0.0107681724017194,0.0406541260636639,0.254671273735779
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.00754003576241597,0.00662115542090597,-0.0205175003873917,0.00543742886255974,0.254820042935692
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.00398732600388183,0.00350366290833218,-0.0108545053042129,0.00287985329644924,0.255126181853342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,41839,-0.00602158409767913,0.00531720516450233,-0.0164433062201037,0.00440013802474544,0.257456707249693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,39649,0.00585436037620766,0.00517031132498785,-0.00427944982076851,0.0159881705731838,0.257531531325792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0176240071287861,0.0155676665935061,-0.0481366336520581,0.0128886193944859,0.257621164865622
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00375866845804251,0.00332292472426561,-0.0102716009176031,0.00275426400151809,0.258019771360447
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00617870043325373,0.00547897101805048,-0.00456008276212522,0.0169174836286327,0.25946589062964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENG,Endoglin,42310,0.00206545654478262,0.00183188176856694,-0.00152503172160859,0.00565594481117383,0.259548600136536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,39649,0.00704857437902501,0.00626007345709749,-0.00522116959688608,0.0193183183549361,0.260208118603613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,0.0067247680469656,0.00597620535832314,-0.00498859445534774,0.0184381305492789,0.260500041790887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.00626102043681076,0.00558023129919325,-0.0171982737832295,0.00467623290960802,0.261886515913141
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,41991,-0.00616496371315709,0.00549868300225554,-0.016942382397578,0.00461245497126377,0.262235202520777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,39649,-0.0087714822773254,0.00783583270686212,-0.0241297143827752,0.00658674982812436,0.2629910813863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.00475631563942215,0.00425546293232216,-0.0130970229867736,0.00358439170792928,0.263716952529684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00506267824120161,0.00453379571573842,-0.0038235613616457,0.0139489178440489,0.264166829516642
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.00470973815391705,0.00421937480506868,-0.0129797127718517,0.00356023646401756,0.264352927261493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,0.00885799113943765,0.00793848213264697,-0.00670143384055041,0.0244174161194257,0.264519630101706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.00675354755582441,0.00605614545499468,-0.018623592647614,0.00511649753596515,0.264803663483591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.00977101020054735,0.00877380054337171,-0.0269676592655559,0.0074256388644612,0.265445878659368
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.004662145438783,0.00419521877273863,-0.00356048335578471,0.0128847742333507,0.266463705078649
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,39757,0.00683029060235207,0.00614642564050555,-0.0052167036530388,0.018877284857743,0.266479442760366
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00715199132483692,0.00643952265973834,-0.00546947308825023,0.0197734557379241,0.26674765350295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,39929,-0.0115608928913419,0.0104093724329471,-0.0319632628599181,0.00884147707723431,0.266754045403064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00355148048954192,0.00319998939636373,-0.00982345970641483,0.00272049872733099,0.267090902259868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,42196,-0.00347094413671553,0.00314233793294349,-0.00962992648528477,0.00268803821185371,0.269363858308512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.0059424882558486,0.00538696249460535,-0.0165009347452751,0.00461595823357789,0.26999745548664
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,39560,0.00764667434665499,0.00693444077005318,-0.00594482956264924,0.0212381782559592,0.270177512797154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARTN,Artemin,41913,0.00528072931884722,0.00478892466364454,-0.00410556302189607,0.0146670216595905,0.270179024177587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,41814,-0.00711875616982012,0.0064632181043683,-0.019786663654382,0.00554915131474175,0.270731376389922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,0.00501721522088399,0.00455671041903303,-0.00391393720042075,0.0139483676421887,0.2708900211603
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,42016,0.0042537555452152,0.00387278902161368,-0.00333691093714762,0.011844422027578,0.272062637866629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.00365230806886239,0.00333812512978997,-0.0101950333232507,0.00289041718552596,0.273925787230746
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.00557528686216742,0.00511330194814569,-0.015597358680533,0.00444678495619814,0.2755790016232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,0.00458521828944997,0.00421087552304979,-0.00366809773572762,0.0128385343146276,0.276217935286752
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.00588547901699043,0.00540912453237524,-0.00471640506646505,0.0164873631004459,0.276586226233246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.00788786452427543,0.00725272383551481,-0.00632747419333359,0.0221032032418845,0.276807276979938
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,0.00658698331927802,0.00606401322863802,-0.0052984826088525,0.0184724492474085,0.277395805214218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.00853718588940689,0.00786535458534392,-0.023953280876681,0.00687890909786719,0.27775697174747
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.00437932328117376,0.00403559614234862,-0.00353044515782952,0.0122890917201771,0.277864001899783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.00899425757583072,0.00829068060716232,-0.0252439915658689,0.00725547641420742,0.278005148442308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,39929,0.00435178673937214,0.00405522600297991,-0.00359645622646849,0.0123000297052128,0.283235421995676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,41913,0.0107202989833055,0.00999924491940434,-0.00887822105872695,0.030318819025338,0.283689679515857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,0.0036107185433442,0.00336973622798753,-0.00299396446351136,0.0102154015501998,0.283962074598922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,42262,0.00499673247460877,0.00466983646170119,-0.00415614699032557,0.0141496119395431,0.284637492870951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.00342237563284137,0.00320163765101158,-0.00969758542882407,0.00285283416314133,0.285117654397609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,42016,0.0144910055323267,0.0135565000743377,-0.0120797346133752,0.0410617456780285,0.285118586403865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,42119,0.00390879818037914,0.003659115043405,-0.00326306730469466,0.0110806636654529,0.285433172893003
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,39919,0.00649591901248307,0.00608311652358405,-0.00542698937374167,0.0184188273987078,0.285606278811863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,39560,0.00344475228269831,0.00323013258670572,-0.0028863075872449,0.00977581215264153,0.286246923861076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.0085288314293432,0.00801389703396864,-0.0242360696159217,0.00717840675723533,0.287236506741166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,0.00626725419199027,0.00589325501567985,-0.00528352563874224,0.0178180340227228,0.28759562063794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,39638,-0.00887735087476587,0.00834917382142788,-0.0252417315647645,0.00748702981523278,0.287686868173829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.00578444408388343,0.00544233374293324,-0.0164514182200326,0.00488253005226572,0.287868237222903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0041802935853267,0.00394405372006625,-0.00355005170600315,0.0119106388766566,0.289210458711109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,0.00460605972519659,0.00435102883644048,-0.00392195679422675,0.0131340762446199,0.289794592020749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,42224,0.0068628563716132,0.00648364974615733,-0.00584509713085516,0.0195708098740816,0.289852423261013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCIN,Adseverin,39586,0.00829405895754383,0.00784324390505178,-0.00707869909635765,0.0236668170114453,0.290316678809962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,0.00623531908612767,0.00590074585605491,-0.00533014279173995,0.0178007809639953,0.290667733750116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,39934,-0.00525245667178883,0.00498047591789913,-0.0150141894708711,0.00450927612729347,0.291626487604694
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.029868639117846,0.028323294728489,-0.0256450185499925,0.0853822967856846,0.291649277291639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.00537151508227958,0.00510360869339719,-0.00463155795677891,0.0153745881213381,0.292592385079532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.00324060117673017,0.00308805049116922,-0.00281197778596151,0.00929318013942185,0.294016846566066
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.00747120080434453,0.00711987939989495,-0.00648376281944957,0.0214261644281386,0.294043084201762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,39757,0.00257984421510082,0.00245973750464625,-0.00224124129400584,0.00740092972420748,0.294279511308386
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,39657,0.00291813929580142,0.00278260327918321,-0.00253576313139767,0.0083720417230005,0.294335291346606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-0.00932478847804305,0.00889916921738938,-0.0267671601441262,0.00811758318804014,0.294737428899098
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,39398,0.00782512294788341,0.00747839366403806,-0.00683252863363118,0.022482774529398,0.29541636467201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,0.00324193366829757,0.00310061454180583,-0.00283527083364185,0.00931913817023699,0.295775155865208
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.00352192231558265,0.00337227932876929,-0.0101315897999704,0.00308774516880515,0.296335166448236
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.00692614042152581,0.00663316563505741,-0.0199271450662383,0.00607486422318671,0.296429868091829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.00430414619942964,0.00412263205284129,-0.00377621262413929,0.0123845050229986,0.296491172279945
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.00588519065833678,0.00563700989295117,-0.00516334873184751,0.0169337300485211,0.296495044370188
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,39757,0.0057290913138837,0.00548824991474315,-0.00502787851901287,0.0164860611467803,0.296562096724441
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,0.00335642872314391,0.0032214828648628,-0.00295767769198716,0.00967053513827499,0.297485904337599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.0040411736572837,0.00388668277826108,-0.0116590719026754,0.00357672458810802,0.298479538502593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.00398036358053174,0.00382917725017478,-0.0114855509908743,0.00352482382981082,0.298599268493419
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0036955126663932,0.00355522886357418,-0.0106637612389986,0.00327273590621219,0.298609969919431
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,39560,-0.00440339893532413,0.00424883211698249,-0.0127311098846098,0.00392431201396155,0.300048387045276
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.00684452482216676,0.00660939517675,-0.0197989393685968,0.00610988972426324,0.300423094888518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,0.00390474436331597,0.00378216668466549,-0.00350830233862839,0.0113177910652603,0.301902437476351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,0.00458811029111867,0.00444996564856268,-0.00413382238006418,0.0133100429623015,0.302539631716891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.0070604765398191,0.00684908874587777,-0.0204846904817395,0.00636373740210133,0.302627318547833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.0110948874274622,0.010820654888396,-0.0323033710087184,0.010113596153794,0.305219670943794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.0161462167304718,0.0157976903200066,-0.0471096897576848,0.0148172562967411,0.306770299272952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,39657,-0.00357910939902385,0.00350491499519603,-0.0104487427896081,0.00329052399156037,0.307196872718055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.0100115695472423,0.00980886461314821,-0.0292369441890128,0.00921380509452815,0.307435450564722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,42148,-0.0101939278075238,0.0100108337716725,-0.029815162000002,0.00942730638495427,0.308558538047123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.00411445320972797,0.00404229799891568,-0.0120373572876027,0.00380845086814676,0.308771494205372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00449470460320937,0.00442706694613631,-0.0041823466112178,0.0131717558176366,0.309991782266567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,42189,-0.00387475124947897,0.00381795458498948,-0.0113579422360583,0.00360843973710041,0.310182912404899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.0048980192001055,0.00482848119022843,-0.0143618423329532,0.00456580393274223,0.310413358188475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,39586,0.010492747337277,0.0103698495903325,-0.00983215785977474,0.0308176525343286,0.311631370276092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00698710570952447,0.0069091545221898,-0.00655483715396753,0.0205290485730165,0.311903604755358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,0.00785835508155664,0.00778171170362926,-0.0073937998575567,0.02311051002067,0.312589459821631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.00379548475382563,0.00375851169109913,-0.00357119816072867,0.0111621676683799,0.312595578511913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PI3,Elafin,41966,-0.00602784752759197,0.00596922817860145,-0.0177275347576508,0.00567183970246687,0.312599693594884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.0034972419521548,0.00346733573895092,-0.00329873609618901,0.0102932200004986,0.31317668804357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPHS2,Podocin,39657,0.0109142408671947,0.0108212390593915,-0.0102953876892127,0.032123869423602,0.313191275856336
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,42144,-0.00348534665359153,0.00345916770657208,-0.0102653153584728,0.00329462205128975,0.313679902257375
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.00523478269844836,0.0051984981269024,-0.0154238390271771,0.00495427363028036,0.31396654633409
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,39900,0.00562352962182558,0.00559011750951682,-0.0053331006968274,0.0165801599404785,0.314448176247672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,0.00330755903634294,0.00328822667802523,-0.00313736525258651,0.0097524833252724,0.314495663077181
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,42137,-0.0129726560391752,0.0129103322739932,-0.0382769072962019,0.0123315952178516,0.314997912304402
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.00631507658480445,0.0062877145284116,-0.0186389970604912,0.00600884389088228,0.315231279419439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,39560,0.00496053995180919,0.0049629805521362,-0.00476690193037775,0.0146879818339961,0.317570616172075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,41877,0.00454484243822243,0.00454763838663489,-0.00436852879958195,0.0134582136760268,0.317626346202941
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,-0.00291390634274556,0.00291738804907613,-0.00863198691893478,0.00280417423344366,0.317906031870285
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0121578256058799,0.0121793199395236,-0.0117136414755864,0.0360292926873463,0.318186650539827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.00294883395947021,0.00295499061101589,-0.00874061555706136,0.00284294763812093,0.318337612678013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.00742319194192744,0.00744286442897665,-0.0071648223388668,0.0220112062227217,0.318609001189599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,41900,0.00288518154677268,0.00289313976818231,-0.00278537239886466,0.00855573549241002,0.318661669647803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.00673775763785852,0.00675933758840622,-0.0199860593111347,0.00651054403541767,0.318875716886279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.00578317462408031,0.00580682961230854,-0.0171645606642051,0.00559821141604443,0.319307740979418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,0.00420874263684659,0.00423146269711302,-0.00408492424949492,0.0125024095231881,0.319937876555861
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,0.00553189142520799,0.00556725142007207,-0.00537992135813325,0.0164437042085492,0.320415577940123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,0.00753564454265229,0.00759139867740323,-0.00734349686505804,0.0224147859503626,0.320899532833069
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,39560,0.00631180453688489,0.00636765146547771,-0.00616879233545142,0.0187924014092212,0.3215953687258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,39586,0.00976166082620488,0.00984841797496696,-0.00954123840473036,0.0290645600571401,0.321614275109039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.00412089243341245,0.00416051310388358,-0.00403371325019937,0.0122754981170243,0.321962873917425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.00602499144606556,0.00608876020935973,-0.0179589614564106,0.00590897856427951,0.322426920006672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.00942131383737796,0.00952448149839485,-0.00924666989947595,0.0280892975742319,0.322598515845151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,42123,0.0037626273919116,0.00380811491898212,-0.00370127784929335,0.0112265326331166,0.323143338557919
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.00543517728229229,0.00550562405289528,-0.016226200425967,0.00535584586138246,0.323559811609006
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0105146917524259,0.0106599529910287,-0.0314081996148421,0.0103788161099903,0.323971103748281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,39966,0.0088800415338998,0.00903240090075057,-0.0088234642315713,0.0265835472993709,0.325563448351874
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-0.0027948485544633,0.00284324170489073,-0.00836760229604913,0.00277790518712253,0.325638364875753
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.00811694047984059,0.00828086040388834,-0.0243474268714617,0.00811354591178056,0.327002327820766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,0.00476995012894658,0.00487186661446487,-0.00477890843540456,0.0143188086932977,0.327561573256621
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.00441639278055217,0.0045189258830319,-0.0132734875112947,0.00444070195019035,0.328433023078933
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,41843,-0.010250068879773,0.0104893065087604,-0.0308091096369434,0.0103089718773975,0.328491841000251
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.00380108471816946,0.00390314618931132,-0.00384908181288073,0.0114512512492197,0.330147483825726
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,0.00449107490587726,0.00462267503058432,-0.004569368154068,0.0135515179658225,0.331301289036737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00782402555771383,0.00805394274721188,-0.00796170222682147,0.0236097533422491,0.331340492906815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,42262,-0.00480897119415978,0.00495403219138528,-0.0145188742892749,0.00490093190095537,0.331705611894414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,39657,0.0027471346368877,0.00284231472676883,-0.00282380222757919,0.0083180715013546,0.333808595404735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.00336291597639985,0.00348467479196909,-0.00346704661585956,0.0101928785686593,0.334536639002019
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,0.00875745003551833,0.00909149787530635,-0.0090618858000821,0.0265767858711188,0.335439759516046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,0.00322399808541175,0.00335102506670021,-0.00334401104532066,0.00979200721614417,0.336024016168455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,0.00738269117956447,0.00769144734103716,-0.00769254560886837,0.0224579279679973,0.337148208798595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,-0.00796844086378782,0.00830441841509064,-0.0242451009573655,0.00830821922978983,0.337306780492817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.00890000958604839,0.00927575056574957,-0.0270804806949175,0.00928046152282076,0.337328013298155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.00421112971019638,0.00439325473821702,-0.00439964957670898,0.0128219089971017,0.337809274214464
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,39657,0.00436984021172619,0.00458353901448695,-0.00461389625666823,0.0133535766801206,0.340419982600535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0028813429163679,0.00302911630397614,-0.00881841087216114,0.00305572503942534,0.341511716616346
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.00433963702623067,0.00457940837388606,-0.004636003386586,0.0133152774390473,0.343328851883925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.00409239488277874,0.00432245110765558,-0.0125643990537837,0.0043796092882262,0.343773398240775
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.00274608994642941,0.00290717751908907,-0.00844415788384399,0.00295197799098517,0.344885190496461
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,39934,-0.00691660066404262,0.00736061820309366,-0.0213434123421062,0.00751021101402095,0.347403498251803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,41839,-0.00658492473851746,0.00701202702816545,-0.0203284977137217,0.00715864823668681,0.347701650225617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,39586,-0.00486947283067817,0.00520527644804392,-0.0150718146688443,0.00533286900748792,0.349557508323526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.00133068568779186,0.00142259449828568,-0.00145759952884807,0.00411897090443179,0.349605722999021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSC1,Hamartin,39657,0.00734557781427422,0.00785870481861626,-0.00805748363021364,0.0227486392587621,0.3499602939868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,0.00471534043100602,0.00504587352478307,-0.0051745716775688,0.0146052525395808,0.350069495302998
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.00360779145708348,0.00386277705207688,-0.0111788344791542,0.0039632515649872,0.350329485796307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.0076450707632192,0.00818678958521837,-0.0236911783502472,0.0084010368238088,0.350412098231191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,41910,-0.00723687607350682,0.00778470161945891,-0.0224948912476463,0.00802113910063264,0.352580618987717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,39657,0.00565630851302627,0.00610076054841116,-0.0063011821618596,0.0176137991879121,0.353869885310886
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.00394015281377608,0.00425007380454591,-0.00438999184313391,0.0122702974706861,0.353906098854186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,39757,0.00330557660543331,0.00356596490366301,-0.00368371460574618,0.0102948678166128,0.353957194420068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,39649,-0.00606821757700511,0.00654627747716123,-0.0188989214322411,0.00676248627823089,0.353961188623972
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,0.0068208350239326,0.00736785370118785,-0.00762015823039559,0.0212618282782608,0.354593115288487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,41913,-0.00313571157410797,0.00338803610434443,-0.00977626233862306,0.00350483919040711,0.354709744978802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.00715134829678745,0.00773847775294679,-0.0223187646925632,0.00801606809898825,0.355439682431633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,39560,0.0114178886057309,0.0124130655398197,-0.0129117198523158,0.0357474970637775,0.357682751379776
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,0.00988541815392332,0.0107513644061772,-0.011187256082184,0.0309580923900307,0.357876751162934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPGN,Epigen,39919,0.00452606822383569,0.00492333820582047,-0.00512367465957243,0.0141758111072438,0.357953657101464
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,42075,-0.00573505236702292,0.00624638607852047,-0.017977969080923,0.0065078643468772,0.358562390074703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.00253763775306801,0.00276698234531577,-0.00288564764375089,0.00796092314988691,0.359103178915644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.0122786227369532,0.0134088361945036,-0.0385599416781803,0.0140026962042739,0.359838168356143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.00427042802500407,0.00466813376718688,-0.00487911415868222,0.0134199702086904,0.360314594358466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.0035166370858525,0.00384913107440376,-0.00402765981997887,0.0110609339916839,0.360937314640891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.0049015897007633,0.00536773686245119,-0.0154223539511676,0.00561917454964103,0.361179585565248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,42107,-0.00388740244856796,0.00426662330708946,-0.0122499841304633,0.00447517923332739,0.362248826450792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.0046698866842503,0.00513882231974251,-0.00540220506244502,0.0147419784309456,0.363503918888058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,-0.0113484757642899,0.0124905372973596,-0.0358299288671147,0.0131329773385348,0.363599264608487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.00522334019551933,0.00575370394199446,-0.00605391953078981,0.0165005999218285,0.363991949912028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,39657,-0.00421998364444963,0.00465411764927359,-0.0133420542370259,0.00490208694812661,0.364574405797953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.00585759705190325,0.00646348001912601,-0.0185260178893902,0.00681082378558373,0.364817848786726
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,42310,0.00296843718738643,0.00327604129551781,-0.00345260375182847,0.00938947812660134,0.364896236933036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,-0.00597292627701356,0.00659381006111218,-0.0188967939967934,0.00695094144276631,0.365037792507557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.00297766560025175,0.00329557972079317,-0.00943700185300635,0.00348167065250286,0.366258865642013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,-0.00627642168296137,0.00695066369395766,-0.0198997225231184,0.00734687915719563,0.366547823025869
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,-0.00627074861792613,0.00695180837291872,-0.0198962930288468,0.00735479579299455,0.367056569521645
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,42144,0.00229112203075714,0.00254037516819113,-0.00268801329889747,0.00727025736041175,0.36713488218374
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.00621411673821224,0.00689660620845457,-0.0197314649067832,0.00730323143035871,0.367583453587376
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00427567535182288,0.00474691549859627,-0.0135796297290716,0.00502827902542582,0.367753062607463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,39979,0.00246565650003845,0.00274230705714289,-0.00290926533196161,0.00784057833203852,0.368609057616545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.00243897492336093,0.00271930339864817,-0.00289085973798948,0.00776880958471134,0.369785619111008
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,39560,0.00444210318862181,0.00496798961516906,-0.00529515645710955,0.0141793628343532,0.371263936844249
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,42296,0.00403643826626957,0.00452096879233879,-0.00482466056671445,0.0128975370992536,0.37196607284824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.00480883621932151,0.00540042213741919,-0.0057759911700201,0.0153936636086631,0.37324080971471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00447727999532996,0.0050491560298274,-0.0143736258137917,0.00541906582313175,0.37523911703254
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,0.0120563045341902,0.0136350397338686,-0.0146683733441922,0.0387809824125726,0.376595821477101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,39934,-0.00343516956717365,0.00388602941405792,-0.0110517872187272,0.00418144808437987,0.37672613690758
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.003308133708577,0.0037550118384891,-0.0106679569120156,0.00405168949486164,0.378341369702122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.00413667210290807,0.00470204415356383,-0.0133526786438932,0.00507933443807703,0.379004754602253
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.005883775709272,0.00670094483097112,-0.0190176275779754,0.00725007615943139,0.37993459412828
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,39560,0.00285270669991096,0.00325264256134598,-0.00352247272032716,0.00922788612014908,0.380482621294524
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,42189,-0.00422144929586204,0.00481617498618196,-0.0136611522687787,0.0052182536770546,0.380765655933344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,42249,0.00326720514220979,0.00373780634124133,-0.00405889528662322,0.0105933055710428,0.382080834593748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.00479886140756568,0.00550416538455942,-0.00598930274617078,0.0155870255613021,0.383304276410782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.00506552518228254,0.00583653378352447,-0.0165051313979905,0.00637408103342543,0.385468269790925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,39649,-0.00331466274150315,0.00382218471086888,-0.0108061447748062,0.00417681929179986,0.385842073399785
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00337633950973601,0.00390069575003378,-0.0110217031798022,0.00426902416033019,0.386742796962923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-0.00576031713303093,0.00666028802343849,-0.0188144816589704,0.00729384739290851,0.387126286051361
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,41839,-0.00438189414790133,0.00507332070998667,-0.0143256027394752,0.00556181444367254,0.38776109885836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.00262532432763975,0.00304207126359808,-0.00858778400429199,0.0033371353490125,0.38814966060599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,42185,0.00608807303913233,0.0070569473187287,-0.00774354370557592,0.0199196897838406,0.388314186746862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00488825923041142,0.00566789296758853,-0.0062208109860621,0.0159973294468849,0.388459669469797
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.00686774678166755,0.00797273113644968,-0.0224942998091089,0.00875880624577383,0.389034122408686
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,41900,-0.00717694537044614,0.00834102591709387,-0.0235253561679501,0.00917146542705784,0.389562514817307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.00832788079163369,0.00971149849659975,-0.0273624178449692,0.0107066562617018,0.391171959947568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFP,Properdin,39979,0.00214763260061021,0.00251440655090849,-0.00278060423917044,0.00707586944039086,0.393050385668928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.00489631371440014,0.00573612595919439,-0.0161391205944211,0.00634649316562086,0.393349357248449
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.00449782870178378,0.00528574970833669,-0.0148578981301237,0.00586224072655613,0.394820624345028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,39929,-0.00241334782686774,0.00284117112984565,-0.00798204324136522,0.00315534758762973,0.395665529002926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.00548795134961233,0.0064774585547531,-0.00720786741770374,0.0181837701169284,0.396877390620075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,39929,0.00852514591531589,0.0100853726513715,-0.0112421844813722,0.028292476312004,0.397962296715511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.00260408574448091,0.00308802660194324,-0.00865661788428966,0.00344844639532784,0.399084109079362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.00391718893836779,0.00464977816358065,-0.00519637626225029,0.0130307541389859,0.399555905029403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,0.0033502343878238,0.00398083472118054,-0.00445220166569005,0.0111526704413377,0.400035287476169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,41900,-0.00433899955944794,0.00516072888056026,-0.014454028165346,0.00577602904645017,0.40049044168582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00427318048061203,0.00509945936677584,-0.0142681208394927,0.00572175987826862,0.402066988462436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,0.00389480797487513,0.00466371012951243,-0.00524606387896924,0.0130356798287195,0.403658871489039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.00695125906820037,0.00832418658454326,-0.00936414663750441,0.0232666647739052,0.403694674769156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.00261887241646522,0.00313805737646681,-0.00876946487434018,0.00353172004140973,0.403987963700832
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.00409341628139684,0.00490653851968528,-0.01371023177998,0.0055233992171863,0.404142051275824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,-0.00238830741129583,0.00287833019825515,-0.00802983459987593,0.00325321977728428,0.406695138218587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00420064154868566,0.00506878087577999,-0.00573416896784313,0.0141354520652144,0.407273107942862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.0035085098093991,0.0042378905169952,-0.0118147752227097,0.0047977556039115,0.407750139388297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.0041453547044142,0.00501090615321792,-0.00567602135589292,0.0139667307647213,0.408103476906147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,39736,0.00845896064114932,0.0102968114051116,-0.0117227897128694,0.028640710995168,0.411371918709901
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,0.00680611285420813,0.00830176650350868,-0.00946534949266889,0.0230775752010852,0.412322587570077
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.00408754128440425,0.00500265343007678,-0.0138927420073547,0.00571765943854623,0.413902952357835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,39657,0.00223641227074745,0.00274073395652988,-0.00313542628405112,0.00760825082554602,0.414523272466101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,0.00202293766615011,0.00248369856904458,-0.00284511152917726,0.00689098686147748,0.415380998892578
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRL,Prolactin,42249,-0.0063559999467353,0.00780691256026646,-0.0216575485648576,0.00894554867138695,0.415573075505217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,39930,0.00567554237761027,0.00697320097253927,-0.00799193152856669,0.0193430162837872,0.415714900080952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,0.00188618901909122,0.00233007275045283,-0.00268075357179632,0.00645313160997877,0.41824622440579
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,39657,0.003354958713414,0.00414962182702952,-0.00477830006756387,0.0114882174943919,0.418821661578491
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,39657,-0.00464733216970256,0.00574999837281153,-0.0159173289804132,0.00662266464100805,0.418974479435551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,0.00403847820771614,0.00501400417261322,-0.00578896997060577,0.013865926386038,0.420580268260038
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00637868640420674,0.00794330502242132,-0.00919019143973905,0.0219475642481525,0.421976646794554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,39919,0.00300681532448419,0.00374458444761269,-0.00433257019283667,0.0103462008418051,0.422004867300815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,41913,0.00289896456528833,0.00361187470110442,-0.00418030984887634,0.009978238979453,0.422208461624291
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00520178556835299,0.00653152857380651,-0.00760001043630777,0.0180035815730137,0.42580950140908
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.00423062429232402,0.00534544449252578,-0.00624644691302652,0.0147076954976746,0.428701598184243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,42249,0.00252408783837121,0.00319079810385585,-0.00372987644518625,0.00877805212192867,0.428927280170921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,39586,0.00282741280490334,0.00359470993990211,-0.0042182186773048,0.00987304428711148,0.431563330376336
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.004081511379485,0.005208491807799,-0.014290155322771,0.00612713256380103,0.433273413384187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.00270151721525868,0.00344986649709256,-0.00946325554956009,0.00406022111904273,0.433594383081755
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00486838318594679,0.00623724302758477,-0.00735661314811935,0.0170933795200129,0.435093202804022
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.00279266792999054,0.0035828909495496,-0.00981513419110776,0.00422979833112668,0.435731311784176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,-0.00344754063831907,0.00442529312196445,-0.0121211151573694,0.00522603388073125,0.435961746185785
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.005632891871801,0.00724902340791082,-0.0085751940077042,0.0198409777513062,0.437142907779617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,39649,0.00282414666469422,0.00364224401779325,-0.00431465161018055,0.00996294493956898,0.438127933037592
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,0.00607655464767137,0.0078453694939911,-0.00930036956055119,0.0214534788558939,0.438628029320242
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.00459534092987254,0.00595838541459027,-0.0162737763424695,0.00708309448272439,0.4405817367623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.0063169573401584,0.00819816879786955,-0.0223853681839827,0.00975145350366592,0.441000425969215
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,39586,0.00391037820174248,0.00509674952185492,-0.00607925086109317,0.0139000072645781,0.442961375787297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,0.00586006332058355,0.00768007618224318,-0.00919288599661308,0.0209130126377802,0.44546393049099
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.00330481938350467,0.00433143718595879,-0.0117944362679839,0.00518479750097455,0.44548626121282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,42287,-0.00475308973998041,0.00623356459385421,-0.0169708763439347,0.00746469686397385,0.445775095495331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,42016,-0.00454652545191903,0.00596817658939621,-0.0162441515671356,0.00715110066329754,0.44619591956412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_E,,42119,-0.00236388545416095,0.00311124422997945,-0.00846192414492066,0.00373415323659877,0.447394676587564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BSND,Barttin,39560,-0.00269501838139951,0.00356029795409694,-0.00967320237142951,0.00428316560863049,0.449087534124351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,42137,0.00272986185349934,0.00361582280811551,-0.00435715085040707,0.00981687455740574,0.450276116609385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,0.00439757971173464,0.00583982959116927,-0.00704848628695712,0.0158436457104264,0.45144674029212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.00323344389689697,0.00430660908346718,-0.0116743977004926,0.00520750990669871,0.452783284725991
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.00216829605579502,0.00289830798427773,-0.00784897970497937,0.00351238759338934,0.454397779651352
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,39657,0.00453600862830958,0.00606998221657184,-0.00736115651617123,0.0164331737727904,0.454907240179782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.00680443031875929,0.00915688936335526,-0.011143072833417,0.0247519334709356,0.457437663950257
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.00607586650223297,0.00819485048605789,-0.00998604045044049,0.0221377734549064,0.458451745690553
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,0.00199101385202211,0.0026890127061578,-0.00327945105204718,0.0072614787560914,0.45905446839623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,39586,0.00524324006761517,0.0070919092206457,-0.00865690200485041,0.0191433821400807,0.459724245763191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.00312466832522156,0.00424056465498976,-0.00518683839855838,0.0114361750490015,0.461228160766015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00388915216746613,0.00528869539338239,-0.0142549951384956,0.00647669080356336,0.462129413569846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00197881006404281,0.00269205768355312,-0.00725524312380692,0.00329762299572131,0.462321303735361
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,42143,-0.00280506215658662,0.00382471740207913,-0.0103015082646617,0.00469138395148848,0.463324896133131
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,39649,0.0031518697609212,0.00430036660002387,-0.0052768487751256,0.011580588296968,0.463616379668351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,0.00478139763127399,0.00652438107940871,-0.00800638928436708,0.017569184546915,0.463664854300827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00433914666100009,0.00593832326675031,-0.00729996694183052,0.0159782602638307,0.464976573161449
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00213353737265562,0.00292268462196573,-0.00786199923170844,0.0035949244863972,0.465407726556352
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,42196,-0.00271844284434277,0.00372583529895155,-0.0100210800302878,0.00458419434160227,0.465635244740125
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEB,Nebulin,39575,0.00308282236119802,0.00422864308389463,-0.00520531808323546,0.0113709628056315,0.465996742871806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.00316613262597465,0.00434418889247155,-0.0116807428552189,0.0053484776032696,0.466124323239504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,39919,-0.00410527437410133,0.00563582974206825,-0.0151515006685551,0.00694095192035243,0.466369066163227
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.0040565218453681,0.0055727678456538,-0.0149791468228496,0.00686610313211336,0.466676237579659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.00312214212849085,0.00430447413705699,-0.0115589114371225,0.00531462718014085,0.468268104123852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0033495501686426,0.00462995947336284,-0.00572517039914858,0.0124242707364338,0.469415123917843
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,39919,-0.0029865244851765,0.00414766804536626,-0.0111159538540944,0.00514290488374136,0.471509656415627
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,0.00256106815278639,0.00357338380018443,-0.00444276409557509,0.00956490040114787,0.473567582266831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.00252937265677224,0.00354652815670057,-0.00442182253036087,0.00948056784390536,0.475739149239871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,41880,-0.00274689751541466,0.00385524561631886,-0.0103031789233996,0.00480938389257031,0.476162107414232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.00265947953089928,0.00373325267145165,-0.00997665476694451,0.00465769570514594,0.476244120576185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,41780,0.00229056680920039,0.0032285098452333,-0.00403731248745689,0.00861844610585766,0.47803850861913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.00232705378183865,0.00328590728371127,-0.00876743205791273,0.00411332449423544,0.478838126766591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,39586,-0.00323872217616583,0.00457758499052357,-0.012210788757592,0.00573334440526036,0.479259856332628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,39886,0.00213585847590294,0.0030344985864801,-0.00381175875359805,0.00808347570540392,0.481535244272539
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.00516430015681725,0.00735269907331968,-0.0195755903405238,0.00924699002688932,0.482464381674399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,0.00352914945210049,0.00503041747038077,-0.00633046878984582,0.0133887676940468,0.482964724456406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,0.00799200400798795,0.0114166482676203,-0.0143846265965477,0.0303686346125236,0.483922484617338
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,39560,0.00687887945905486,0.0098308901309946,-0.0123896651976946,0.0261474241158043,0.484116461421727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,-0.00380448513530989,0.00543722002372224,-0.0144614363818055,0.0068524661111857,0.484119811355068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,39649,0.00355837253231703,0.0050988916235635,-0.00643545504986742,0.0135522001145015,0.485272074564942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,0.00211301152561325,0.00303213545405082,-0.00382997396432636,0.00805599701555287,0.48589687068099
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,39560,0.00314873492932697,0.00452148914117614,-0.00571338378737828,0.0120108536460322,0.486197300199127
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.00239499580809232,0.00346219864140371,-0.00439091352905895,0.00918090514524359,0.489102862267585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,39657,-0.00344919764364643,0.00501119596071957,-0.0132711417266568,0.00637274643936393,0.491279394041224
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,39575,-0.0042585525218143,0.00621873810282728,-0.0164472792033558,0.00793017415972718,0.493488588084032
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.0043954059887423,0.00651202120774975,-0.0171589675559318,0.00836815557844721,0.499709819752683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,42070,-0.00304321171926694,0.00451653082079852,-0.011895612128032,0.00580918868949816,0.50045380196155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,0.00231829087843978,0.00344088371947601,-0.00442584121173319,0.00906242296861275,0.500483070146279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.00437922416855438,0.0065010652901654,-0.00836286380016979,0.0171213121372786,0.500566742697227
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,0.00188193355687437,0.00279433243612784,-0.0035949580179362,0.00735882513168493,0.500654679604297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,-0.00815859213774428,0.0121273001975148,-0.0319281005248734,0.0156109162493848,0.501122589027541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,41814,-0.00655277642582901,0.00974205818842934,-0.0256472104751505,0.0125416576234925,0.501196051617917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,0.0020844834901783,0.00310093907603664,-0.00399335709885352,0.00816232407921012,0.501461140877457
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,41839,-0.00274299315272588,0.00408550903295142,-0.0107505908573107,0.0052646045518589,0.501980204608288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,42020,0.00498669292921443,0.00744026210104437,-0.00959622078883254,0.0195696066472614,0.50272219590604
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,-0.00234634325816064,0.00350829996507587,-0.00922261118970934,0.00452992467338807,0.503636085295958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,0.00602612082070248,0.00902750818251217,-0.0116677952170214,0.0237200368584263,0.504445918073773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,0.00982517193830867,0.0147259401672436,-0.0190376707894888,0.0386880146661062,0.504656866498545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.0039549761737842,0.00594260103239443,-0.0156024741972773,0.00769252184970887,0.505725443740292
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,39560,0.0046761487841529,0.00703995004768236,-0.00912215330930452,0.0184744508776103,0.506556837387776
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,0.00153770835446139,0.00233472985461282,-0.00303836216057975,0.00611377886950252,0.510151170702635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.00336179614777865,0.0051175115831614,-0.013392118850775,0.00666852655521769,0.511245658351804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,0.00511369728070292,0.00779597519826995,-0.0101664141079062,0.020393808669312,0.511875541405568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,0.00279396752482439,0.00428287365071827,-0.00560046483058341,0.0111883998802322,0.514183818842076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,39649,0.00190546842648676,0.00293714967351507,-0.00385134493360279,0.0076622817865763,0.516515097578928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,42119,-0.00275013910914904,0.00424476614032116,-0.0110698807441785,0.00556960252588043,0.517067471243158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,0.00291638832854791,0.00450841581847657,-0.00592010667566616,0.011752883332762,0.517725392381765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,39919,-0.00357917300417641,0.00554256429471682,-0.0144425990218214,0.00728425301346856,0.51844710581626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.00573099262293073,0.00888312659588542,-0.0231419207508662,0.0116799355050047,0.518837799506154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,0.00326264737115596,0.00506296216948561,-0.00666075848103584,0.0131860532233478,0.519317487804043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,42129,0.00214555426194618,0.00333053372408475,-0.00438229183725992,0.00867340036115228,0.519451914975658
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00411118784403837,0.00641336557623529,-0.0084590086853828,0.0166813843734595,0.521511440567008
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00403870721562689,0.00630462844666956,-0.00831836453984545,0.0163957789710992,0.521799460498219
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,39757,-0.00293388370236747,0.00459735081450219,-0.0119446912987918,0.00607692389405682,0.523377206899667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,42027,0.00312607504975518,0.00491605638919781,-0.00650939547307252,0.0127615455725829,0.52485843494263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,39586,0.00415466661377845,0.0065361904846169,-0.00865626673607067,0.0169655999636276,0.52502408299839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.00372447521427497,0.00588572824330816,-0.00781155214260902,0.015260502571159,0.526878951777731
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.00376204137364993,0.00595542310939109,-0.0154346706680565,0.0079105879207566,0.527595752017286
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.00312389068186018,0.00495932833434724,-0.0128441742171808,0.00659639285346041,0.528771763053971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,0.0029635662710574,0.00471702500910928,-0.0062818027467968,0.0122089352889116,0.529840019762206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,39649,0.00267991923672414,0.00426771290901563,-0.00568479806494649,0.0110446365383948,0.530048304602333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,39649,0.00404099039165179,0.00645128743725899,-0.00860353298537582,0.0166855137686794,0.531075313887805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.00212177658086899,0.00339134974346767,-0.00452526891632765,0.00876882207806562,0.531561607862107
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,39575,0.00548202155219077,0.00876709609052466,-0.0117014867852376,0.0226655298896191,0.531790446801403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,42088,0.00479678982838381,0.0076873336303213,-0.0102703840870459,0.0198639637438136,0.53264722403124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00267083630349475,0.00428940043643636,-0.00573638855192052,0.01107806115891,0.533521182008778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCLN,Nicalin,41913,0.00337478293634829,0.00542547828669722,-0.00725915450557826,0.0140087203782748,0.533936105177459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,0.00275687377282449,0.00444205017909841,-0.0059495445782084,0.0114632921238574,0.534855279500325
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,39657,0.00656579715231051,0.0106434427013276,-0.0142953505422915,0.0274269448469125,0.537322229240292
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,42166,0.00538216971492337,0.00872951876868932,-0.0117276870717077,0.0224920265015544,0.537543068442982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,39586,-0.00255791690492119,0.00415032835616902,-0.0106925604830125,0.00557672667317009,0.537698252516011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,0.00318232642709356,0.00520857816041662,-0.00702648676732302,0.0133911396215101,0.541224664844986
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,39757,0.00230308425099289,0.00377067515019041,-0.00508743904338032,0.0096936075453661,0.541352184724934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.00364611394067138,0.00597091238308105,-0.0153491022115102,0.00805687433016747,0.541446503236556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00313602273194799,0.00513905291833897,-0.00693652098799639,0.0132085664518924,0.541719714181326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.00188797908710854,0.00309473042785382,-0.00795365072570203,0.00417769255148496,0.541832614819356
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,0.0062302545556766,0.0102278159359347,-0.0138162646787554,0.0262767737901087,0.542438820310603
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,0.00313814001803983,0.00518703608773206,-0.00702845071391501,0.0133047307499947,0.545193676091041
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00192028157388,0.00318960485469259,-0.00817190708907747,0.00433134394131748,0.547157078235962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,41839,0.00289454590836151,0.00482842999723469,-0.00656917688621848,0.0123582687029415,0.548863282294323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,39649,-0.00382363619626592,0.00638532752527288,-0.0163388781458008,0.00869160575326892,0.549307877250033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,42264,-0.0013070453839481,0.00218380016447669,-0.00558729370632241,0.00297320293842621,0.549503760915682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,42181,0.0027091824788024,0.00452988399307757,-0.00616939014762965,0.0115877551052344,0.549803971579274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.00144381861913685,0.00242802906165116,-0.00620275557997313,0.00331511834169943,0.552089703848098
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.00355985269162297,0.00598824693704841,-0.00817711130499192,0.0152968166882379,0.552207490751368
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,39575,-0.00245071191750954,0.00413438331596044,-0.010554103216792,0.00565267938177291,0.553351587584257
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.00146069521672408,0.00246517452506809,-0.00337104685240937,0.00629243728585753,0.553506071144178
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,41913,0.00382057768622195,0.00645429727190835,-0.00882984496671843,0.0164710003391623,0.553898644586995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,-0.00254078088991518,0.00429772245461083,-0.0109643169009524,0.00588275512112206,0.554401486449241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,39649,-0.00372908874068241,0.00633991746929058,-0.0161553269804919,0.00869714949912712,0.556415448071706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,39657,-0.00206143677674465,0.00353685699893389,-0.00899367649465507,0.00487080294116577,0.560010037115513
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,42249,-0.00224479524921696,0.00390756395992864,-0.0099036206106771,0.00541403011224318,0.565656323515287
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,42249,0.00195691861524599,0.00341223885820839,-0.00473106954684245,0.00864490677733442,0.566315721361232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,0.0035767466511335,0.0062482211436223,-0.00866976679036621,0.0158232600926332,0.567033942723269
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.00188265847562449,0.00330544169109686,-0.00836132419017434,0.00459600723892537,0.568985456051053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.0038998228915546,0.00684709374798743,-0.01732012663761,0.00952048085450077,0.568988518924466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,39929,-0.00172664508170687,0.00304530706056747,-0.00769544692041911,0.00424215675700536,0.570735236109122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,0.00256306790389389,0.00452697977064202,-0.00630981244656448,0.0114359482543523,0.571285628608474
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,42123,-0.00163407124565459,0.00290245342983448,-0.00732287996813018,0.00405473747682099,0.57344657202659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00381392880151076,0.00681155318047043,-0.0171645730352328,0.00953671543221129,0.575545054354268
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,-0.00568565940455208,0.0101729415359853,-0.0256246248150833,0.0142533060059791,0.576239042584521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,39560,0.00216756287144395,0.00387867386531637,-0.00543463790457612,0.00976976364746403,0.576281499140495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,39657,0.00211076449920689,0.00378236242940371,-0.00530266586242438,0.00952419486083816,0.576818445397113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.00375743296997248,0.0067377609554073,-0.0169634444425708,0.00944857850262584,0.577082574087443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00265905188351681,0.00479646843133381,-0.00674202624189745,0.0120601300089311,0.579332060714175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,41839,0.00324546802752121,0.00586069770330366,-0.00824149947095397,0.0147324355259964,0.57974684523472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,39657,0.00195177479567156,0.00352506417668889,-0.00495735099063867,0.00886090058198179,0.579805709075081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.00220532492599111,0.00398983239909674,-0.0100253964282207,0.0056147465762385,0.580453319790819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00256345329584921,0.00464501938958652,-0.0116676912994388,0.00654078470774037,0.581047698321819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,-0.00216303322621656,0.0039627250383913,-0.00992997430146351,0.00560390784903039,0.585183494707212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,41839,-0.00340340232461215,0.00625317249399827,-0.0156596204128488,0.00885281576362445,0.586266160132052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,41883,-0.00511396824941453,0.00940917011589227,-0.0235559416765634,0.0133280051777343,0.58678854557289
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,39919,0.00198562939770172,0.00365799989337133,-0.00518405039330609,0.00915530918870953,0.587265578429928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.00367493259342835,0.00678412810918392,-0.00962195850057214,0.0169718236874288,0.588039033710291
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,0.00194951206548312,0.00360441493228675,-0.0051151412017989,0.00901416533276514,0.588607724839124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,-0.00155447554359971,0.00288347298150699,-0.00720608258735342,0.004097131500154,0.589829578877275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,39930,0.00175918423781478,0.00328335770709628,-0.00467619686809392,0.00819456534372348,0.592115472021192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00233602699793617,0.00439581047770394,-0.00627976153836355,0.0109518155342359,0.595137659293154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,-0.00293254993525776,0.00552848836361261,-0.0137683871279385,0.00790328725742294,0.595814976648572
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.00489999825373861,0.00925722755613532,-0.0230441642637638,0.0132441677562866,0.596596819736305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,42145,0.00136521553477374,0.00259743465685764,-0.00372575639266723,0.00645618746221472,0.599173722901958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NENF,Neudesin,39919,-0.00627777022753505,0.0119498182050588,-0.0296994139094502,0.0171438734543801,0.599354078625956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,0.00529149330173341,0.0101117098896981,-0.0145274580820749,0.0251104446855417,0.600771627786181
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALB1,Calbindin,42070,-0.00250561387236316,0.00479926247438421,-0.0119121683221562,0.0069009405774299,0.601621051621836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.00195751095978323,0.00375472477246433,-0.00931677151381332,0.00540174959424686,0.602134288417817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPL,Periplakin,39657,-0.0017855230976261,0.00342966788288761,-0.00850767214808582,0.00493662595283361,0.602648154216267
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.00309904174211175,0.00596012187691583,-0.0147808806208668,0.00858279713664327,0.603098147477025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.0042648324564578,0.0082056121651238,-0.0118181673871848,0.0203478323001004,0.603251172600386
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.0015260054145848,0.002942752150173,-0.00729379962892388,0.00424178879975428,0.60407519300356
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.00265419529624647,0.0051457746389624,-0.0127399135886128,0.00743152299611983,0.606003534064512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,-0.00340679608417633,0.00663065907533388,-0.0164028878718307,0.00958929570347807,0.607405711486214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.0022360452854964,0.00436414421990845,-0.00631767738552417,0.010789767956517,0.608404035258313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.00169437782010179,0.00331044442277994,-0.00818284888875046,0.00479409324854689,0.608781773684536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00238614976394511,0.00469752996701403,-0.00682100897140239,0.0115933084992926,0.611490939397509
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.00157786920605249,0.00312109881504667,-0.00453948447143898,0.00769522288354396,0.613181346698079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.00180337082141586,0.00357601597617253,-0.00881236213471403,0.00520562049188231,0.614061616843146
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,39560,0.003238810715208,0.00649821791155252,-0.00949769639143493,0.0159753178218509,0.618201412468075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00221554428540462,0.00445222140638547,-0.0065108096711109,0.0109418982419202,0.618757070726313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,39586,0.00394177262234496,0.00798087218756664,-0.0117007368652856,0.0195842821099756,0.621384922299028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.00163736677650803,0.00331568744834552,-0.00813611417526524,0.00486138062224918,0.621438341558453
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.00176088672600249,0.00356595364614937,-0.00875015587245524,0.00522838242045027,0.621453255094086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.00280165075154387,0.00570570929249626,-0.00838153946174879,0.0139848409648365,0.623416258874092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.00179771650415882,0.00366432943382963,-0.00538436918614726,0.0089798021944649,0.623718027820683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,0.00144458740362043,0.00294837368083046,-0.00433422501080727,0.00722339981804812,0.624169695604882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,0.00242226342580854,0.00495209059716404,-0.00728383414463297,0.01212836099625,0.624752659384279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.00441402520191656,0.00902601368059508,-0.0132769616120498,0.0221050120158829,0.624825745577932
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,0.003092452803966,0.00632570175952729,-0.00930592264470749,0.0154908282526395,0.624942713159349
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,-0.00215627276367916,0.00442604566516647,-0.0108313222674054,0.00651877674004712,0.626141505966039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,0.00222782935686897,0.00458194706275434,-0.00675278688612954,0.0112084455998675,0.62681984224539
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.00167515452644177,0.00344652979101314,-0.00508004386394398,0.00843035291682752,0.626947844525178
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.00387972189063544,0.00801356348361117,-0.0195863063185133,0.0118268625372425,0.628291418831282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,0.00184421552435196,0.00384560202530717,-0.0056931644452501,0.00938159549395402,0.631546117175826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00227635387430155,0.00476598486953665,-0.00706497646999029,0.0116176842185934,0.632924966703337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,-0.0031881695602326,0.00669438191303933,-0.0163091581097897,0.0099328189893245,0.633908610028819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,41913,-0.00291735384949791,0.00613089364609823,-0.0149339053958504,0.00909919769685462,0.634192759782626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,39560,0.00210987250167772,0.00444382368168366,-0.00660002191442224,0.0108197669177777,0.634947812909219
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00148164452442423,0.00312614501286054,-0.00464559970078243,0.00760888874963089,0.635543074422862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.00232493166897916,0.0049070020408626,-0.0119426556690699,0.00729279233111154,0.635651202488871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.00260752873263091,0.00550606099004638,-0.00818435080785999,0.0133994082731218,0.635812970298842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,-0.00266403605864354,0.00563613556416356,-0.0137108617644041,0.00838278964711704,0.636457389948048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,42062,0.00161382293102514,0.00341751066833193,-0.00508449797890544,0.00831214384095571,0.636776157981126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,39709,-0.002581872259008,0.00546757198529035,-0.0132983133501771,0.00813456883216109,0.63678225019301
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.00116296770046085,0.00247255620035415,-0.00600917785315499,0.00368324245223329,0.638112213000946
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,39930,-0.00168457094286795,0.00359680480873092,-0.00873430836798055,0.00536516648224465,0.639541854441796
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.00190860901421398,0.00407825003453655,-0.00990197908190563,0.00608476105347766,0.63979569704302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,0.00268446550983068,0.00574955206227216,-0.00858465653222275,0.0139535875518841,0.640580674872567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.00261397690319757,0.00564066604548204,-0.00844172854594723,0.0136696823523424,0.643073444681835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,-0.00169219201942334,0.00367298508202992,-0.00889124278020199,0.00550685874135531,0.645013637892267
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.00340211943727027,0.00742989390868964,-0.0111604726237614,0.017964711498302,0.647034346362744
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,39757,0.00133863472941663,0.0029295223517304,-0.00440322907997495,0.0070804985388082,0.647718459108206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,42083,0.00169986870414348,0.00372868776392731,-0.00560835931315405,0.00900809672144101,0.64847695543487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,0.00198198068479554,0.00435611359281863,-0.00655600195712899,0.0105199633267201,0.649124912052122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,39657,-0.00224276295105753,0.00498180136750744,-0.0120070936313721,0.00752156772925704,0.652581433886931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.00138543585380522,0.00308705933650447,-0.00743607215335397,0.00466520044574354,0.653591629472281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,42119,-0.00262584057473417,0.00586878279929809,-0.0141286548613584,0.00887697371189008,0.654575344075235
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,41913,-0.00202738462564283,0.00453131059202873,-0.0109087533860191,0.00685398413473348,0.654581404895624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.00229336005061612,0.00513503472375273,-0.0123580281091715,0.00777130800793924,0.655163681271299
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,39575,0.00151783622572693,0.00339921941390123,-0.00514463382551949,0.00818030627697335,0.655226915487121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,42015,0.00277897709082769,0.00624643780959107,-0.00946404101597081,0.0150219951976262,0.65640649987858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,39586,0.0043023172570968,0.00969370305650764,-0.0146973407336582,0.0233019752478518,0.657177144686182
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.00243051909845085,0.00552279393833862,-0.0132551952175945,0.00839415702069284,0.659879832075749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.00170789962971133,0.00390545846073319,-0.00594679895332571,0.00936259821274838,0.661892971008063
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00272828009685875,0.00624491122111212,-0.009511745896521,0.0149683060902385,0.66220658233136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.00245082331317311,0.00566827001626632,-0.00865898591870887,0.0135606325450551,0.665476682360982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,0.00229246359606509,0.00530801079622195,-0.00811123756452993,0.0126961647566601,0.665830000919514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.00213427565426336,0.00495261321020265,-0.0118413975462606,0.00757284623773384,0.666520972457545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,42070,0.00303756204817425,0.0070579643042818,-0.0107960479882181,0.0168711720845666,0.666930725839866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,39958,0.00302602459872096,0.0070338036088856,-0.0107602304746948,0.0168122796721367,0.667049815139367
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,0.00134444795848639,0.00313689657095879,-0.00480386932059283,0.00749276523756562,0.668228706893064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.0024825503587669,0.00585044168362985,-0.00898431534114759,0.0139494160586814,0.671329429187784
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_A,,39934,0.00147935232283673,0.00348798073659254,-0.00535708992088465,0.00831579456655812,0.671480091537219
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,39757,-0.00260968929371433,0.00620021888466427,-0.0147621183076563,0.00954273972022763,0.673834190810008
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,0.00139385394438894,0.00333215142768974,-0.00513716285388296,0.00792487074266083,0.675731252125117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,39966,0.0011494275871063,0.00275741627200829,-0.00425510830602995,0.00655396348024254,0.67679636742834
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00275577822337684,0.00667817769739328,-0.010333450063514,0.0158450065102677,0.679868029464018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,39657,0.00198085476258424,0.00481489608307405,-0.0074563415602409,0.0114180510854094,0.680786235726422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,39657,0.00182084650844203,0.00444501744432182,-0.00689138768242873,0.0105330806993128,0.68207970797473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.0035601659051319,0.00874720275304566,-0.0207046833011014,0.0135843514908376,0.684011351057575
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,0.00103322861759609,0.00256688112202961,-0.00399785838158194,0.00606431561677412,0.68730677698669
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,41913,-0.00587998318885039,0.0146356646278278,-0.0345658858593928,0.022805919481692,0.687869195442097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,0.00280433408638231,0.00701699026016433,-0.0109489668235398,0.0165576349963044,0.689422680711229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00147689034474504,0.00374245296963372,-0.00585831747573705,0.00881209816522713,0.693121116214359
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.00453730352196379,0.0115107619635302,-0.0180237899265555,0.0270983969704831,0.693456469343462
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.00183356428878758,0.00469309489237903,-0.00736490170027532,0.0110320302778505,0.696030931367211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.00110183097086232,0.00282930131254261,-0.00664726154344583,0.00444359960172119,0.696961358739864
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00219195348455211,0.00572165244197432,-0.0134063922708218,0.00902248530171755,0.701654548208853
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,42145,0.00336322817589337,0.00881675838261288,-0.0139176182540279,0.0206440746058146,0.702868980028874
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.00118097443406002,0.003101287389176,-0.00725949771684498,0.00489754884872494,0.703357918985614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,-0.00214469675364206,0.00564829751345348,-0.0132153598800109,0.00892596637272676,0.704169189586661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.00208715576697066,0.00554066080655218,-0.0129468509478129,0.00877253941387161,0.706405352159668
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.00248840961406777,0.00661773337985543,-0.0154591670385844,0.0104823478104489,0.706907066030043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,0.000916855588044697,0.00243961815732424,-0.00386479600031082,0.00569850717640021,0.707058262896933
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,42070,0.00760006112117668,0.0202474490305071,-0.0320849389786173,0.0472850612209707,0.707399443296063
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,0.00259301218559574,0.00694157762772177,-0.0110124799647389,0.0161985043359304,0.708747752197799
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00139079016956079,0.00372379295939125,-0.00868942436996764,0.00590784403084606,0.708792844257239
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,-0.0038185183340591,0.0102469666803725,-0.0239025730275892,0.016265536359471,0.709416927202407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.001594057081885,0.00428181859187565,-0.00679830735819128,0.00998642152196128,0.709687803542824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,0.00361655606408876,0.00972901818084914,-0.0154523195703755,0.0226854316985531,0.710101917467026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.00335546326328123,0.00913274548694066,-0.0212556444176849,0.0145447178911225,0.713320143731179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,0.0018988342127505,0.00517118548282749,-0.00823668933359138,0.0120343577590924,0.713480300178462
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,0.00245027504660055,0.00669194274363135,-0.0106659327309169,0.015566482824118,0.714257953613823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.00142458718556256,0.00389945686027673,-0.00621834826057983,0.00906752263170495,0.71487234586722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.00101630527065211,0.00278419402364233,-0.00647332555699108,0.00444071501568685,0.715098377122414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,0.00136854999216795,0.0038258326234623,-0.00613008194981817,0.00886718193415406,0.720564778627024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,42119,-0.00211573866734373,0.00595700692097236,-0.0137914722324495,0.00955999489776209,0.722469222502411
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F2,Prothrombin,39979,0.000558966350388392,0.0015790825364817,-0.00253603542111574,0.00365396812189253,0.723359142275417
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,39930,-0.00234027093613311,0.00662438002911874,-0.0153240557932058,0.0106435139209396,0.723883983454649
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.00110134036505773,0.00315041139304563,-0.00507346596531171,0.00727614669542716,0.726655762160658
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.00183894794835433,0.00527507411242794,-0.0121780932087131,0.00850019731200442,0.727388135803774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00112528103603985,0.00323466807091002,-0.0074652304550235,0.00521466838294379,0.727934742037126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,42208,0.00410088738896861,0.0118630428515358,-0.0191506766000415,0.0273524513779787,0.729584078411281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,0.00103628917080039,0.00300425777835694,-0.00485205607477922,0.00692463441638,0.730144804209416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,-0.00169289809962153,0.00493593246289039,-0.0113673257268867,0.00798152952764363,0.731623220248521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,0.00205610463998579,0.00599539155422305,-0.00969486280629138,0.013807072086263,0.731644816443818
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2,Complement C2,42199,0.000819520238442015,0.00239492742924341,-0.00387453752287508,0.00551357799975911,0.732213191693854
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,0.000739886240402329,0.00216731187799509,-0.00350804504046805,0.00498781752127271,0.732820782607185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTTG1,Securin,39757,-0.00150861242075235,0.00442275473518902,-0.0101772117017228,0.00715998686021813,0.733032889419768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.00223049846835768,0.0065745674014068,-0.0106556536383996,0.015116650575115,0.734419128122852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,41913,0.00170474412111507,0.00502575337479116,-0.00814573249347561,0.0115552207357057,0.734463134010832
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.00315384443669305,0.00931395096631979,-0.0214091883306798,0.0151014994572937,0.734905988954554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.00430623528419012,0.0127483770859965,-0.0206805838043631,0.0292930543727433,0.735530010491112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.000959920710876792,0.0028528968974152,-0.00655159862981059,0.004631757208057,0.736519995679951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,41913,0.00171798167014993,0.00510883281359411,-0.00829533064449452,0.0117312939847944,0.736667484445933
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,-0.00110067418153956,0.00327445969485957,-0.00751861518346431,0.00531726682038519,0.736771215291367
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.00118378957491369,0.00353078771897749,-0.00573655435428219,0.00810413350410956,0.737421833964566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,-0.00104647187723306,0.00314379363288539,-0.00720830739768842,0.00511536364322231,0.739238283119371
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.00286287611929768,0.0086046551120224,-0.0197280001388616,0.0140022479002662,0.739357642249258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00142120071723823,0.00427465963728225,-0.00979953360631144,0.00695713217183499,0.73953981790308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,0.00110280048138305,0.00332661103351893,-0.00541735714431405,0.00762295810708016,0.740265376172907
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00245631526364695,0.00742595706682975,-0.0120985605873394,0.0170111911146333,0.740821296495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.00442342415733904,0.0133841882983673,-0.0306564332221389,0.0218095849074608,0.741030247417837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,39575,0.00195153874409599,0.00592157554154464,-0.0096547493173315,0.0135578268055235,0.741735637916614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,-0.00123542385683807,0.00375167711663266,-0.00858871100543808,0.00611786329176195,0.7419348418591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.00122726483783234,0.00373918345479066,-0.00855606440922202,0.00610153473355735,0.742753411018672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,39560,0.00173640102606427,0.00530265072109738,-0.00865679438728658,0.0121295964394151,0.743326956383315
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,0.00185464367541553,0.00567330662261097,-0.00926503730490197,0.012974324655733,0.743743362265491
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,39638,0.000632361153424455,0.00193842159731643,-0.00316694517731575,0.00443166748416467,0.74426048115376
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,39586,0.00200574470448693,0.0062221681753233,-0.0101897049191467,0.0142011943281206,0.747190187022811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.00182341648279584,0.00567276075522791,-0.0129420275630425,0.00929519459745086,0.747887662195018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,39638,-0.00300533794495855,0.00937008837443976,-0.0213707111588605,0.0153600352689434,0.748415461077343
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,39649,0.00239288118528759,0.00746559151836593,-0.0122396781907096,0.0170254405612848,0.748579238889983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,39657,0.00125127549460464,0.0039055818950866,-0.00640366501976509,0.00890621600897437,0.748685336208212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,-0.00284545657152597,0.0089291415463238,-0.0203465740023206,0.0146556608592687,0.749981194093729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.000935594348553614,0.00295040353989755,-0.00671838528675282,0.00484719658964559,0.751167225378575
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.000795440080466579,0.002508909534943,-0.00412202260802171,0.00571290276895487,0.751214589312969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.00101073045569052,0.00322136946711968,-0.00530315369986406,0.0073246146112451,0.753709645977867
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,39649,0.00214170205419368,0.00689257051776027,-0.0113677361606165,0.0156511402690038,0.756014660155908
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,41913,0.00127943482390505,0.00417914643479548,-0.00691169218829409,0.00947056183610418,0.75949720507354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.00131230388953924,0.00429980979196067,-0.00973993108178216,0.00711532330270369,0.760219237568686
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00205303045908975,0.00672967180410319,-0.0111371262769525,0.015243187195132,0.760317456936284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,-0.0017464735216638,0.00574802409467883,-0.0130126007472343,0.00951965370390672,0.761256369779881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,41913,0.00109030621952876,0.00361153286160597,-0.00598829818921894,0.00816891062827645,0.762736294127331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,0.000772938077752809,0.00261323442794301,-0.0043490014010155,0.00589487755652112,0.767404804452827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,0.00261654111244362,0.00887459906885458,-0.0147776730625114,0.0200107552873986,0.768125536388507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,0.00106378773169119,0.00361243803181208,-0.00601659081066048,0.00814416627404286,0.768397314777156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAYN,Layilin,41997,0.00111478049174242,0.00379070220901983,-0.00631499583793644,0.00854455682142128,0.768699154948625
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,39934,-0.00138323882050439,0.00470988158892755,-0.0106146067348024,0.0078481290937936,0.769001196610514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00144983589392311,0.00495375755880479,-0.00825952892133427,0.0111592007091805,0.769775816480613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,0.00226257180718084,0.00780428339091536,-0.0130338236390133,0.0175589672533749,0.771886342109321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,0.000795265827633949,0.00276639494374226,-0.00462686826210088,0.00621739991736878,0.7737548673188
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,0.00243706956548283,0.00850880720912736,-0.0142401925644068,0.0191143316953725,0.774563846005762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0032014572894084,0.0112174956268998,-0.025187748718132,0.0187848341393152,0.775344147246863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,41900,-0.00141437301205298,0.00495910781038494,-0.0111342243204075,0.00830547829630149,0.775489882822875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,39919,-0.00129427853574587,0.00453851589179568,-0.0101897696836654,0.00760121261217366,0.775514063725444
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,0.00160924572100293,0.00571089780600392,-0.00958411397876476,0.0128026054207706,0.778113473347669
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,42070,-0.000569980756908814,0.00202798740313049,-0.00454483606704457,0.00340487455322694,0.778670732947036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.00140744286063983,0.00502293955205492,-0.0112524043826675,0.00843751866138782,0.779326122026824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.0010754545199849,0.00384668872032228,-0.00861496441181657,0.00646405537184678,0.779805531174406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,42070,0.000887439678865966,0.0031779188042102,-0.00534128117738603,0.00711616053511796,0.780055848701837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,41843,-0.00215534199303933,0.00777414053405812,-0.0173926574397933,0.0130819734537146,0.781596276126511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,0.00143596755734461,0.00520569740440342,-0.00876719935528609,0.0116391344699753,0.782672023833111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,-0.00198283830144353,0.00727298226668694,-0.0162378835441499,0.0122722069412629,0.785142150031252
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.00112166024909196,0.00411881845777856,-0.00919454442633793,0.00695122392815401,0.785376695803442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00143305680498361,0.0052783319612549,-0.008912473839076,0.0117785874490432,0.786013110054569
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.00474643560664635,0.0176390297168291,-0.0298260626383387,0.0393189338516314,0.787867545863536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,0.00117431717378409,0.00438258637441129,-0.00741555212006205,0.00976418646763023,0.788742258676323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,41913,0.00136746108645029,0.00510479829075757,-0.00863794356343455,0.0113728657363351,0.788797690646769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,-0.000798976704523272,0.00299821955437269,-0.00667548703109375,0.0050775336220472,0.789871667464826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.00168610562090351,0.00637934795155251,-0.0141896276059464,0.0108174163641394,0.791547428914084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,0.000793872100286436,0.00302082799185097,-0.00512695076374146,0.00671469496431434,0.792709145420793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.000743059116917525,0.00282986809813863,-0.00480348235543419,0.00628960058926924,0.792881335541653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,39720,0.00101387679924458,0.00387389319932201,-0.00657895387142656,0.00860670746991573,0.793541874662238
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRN,Progranulin,42077,0.000693762973621966,0.00266146804826341,-0.00452271440097432,0.00591024034821825,0.794351536850172
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0012939942351495,0.00498713633560105,-0.00848079298262855,0.0110687814529276,0.795279455396971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.00274861294821453,0.0106020664939438,-0.0235286632763444,0.0180314373799153,0.795445237331079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',39575,-0.00118057637907844,0.00457180355911929,-0.0101413113549522,0.00778015859679536,0.796234324934573
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,39560,0.0011695819031864,0.00455092452963099,-0.00775023017489033,0.0100893939812631,0.797184564362921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,0.00239934506580023,0.00934906420290437,-0.0159248207718923,0.0207235109034928,0.797461375003624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,39930,0.00695356338910186,0.0275979142737892,-0.047138348587525,0.0610454753657288,0.801076750553079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.000796467791998509,0.00320756682933681,-0.00549036319350164,0.00708329877749866,0.803899168013087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,0.0009678987564557,0.00392154970644131,-0.00671833866816926,0.00865413618108066,0.805055560111307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,39966,-0.00242794773301338,0.00985464950257063,-0.0217430607580518,0.0168871652920251,0.805395741508501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,-0.000901999465809512,0.00368225526914166,-0.00811921979332716,0.00631522086170814,0.80649306026746
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.00155422555565687,0.00638319886161728,-0.0140652953244267,0.010956844213113,0.807631956672912
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,0.0010099941861523,0.0042343037774932,-0.00728924121773438,0.00930922959003898,0.81147635976548
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,-0.000980037844110845,0.00414432999178727,-0.00910292462801389,0.0071428489397922,0.813067136371614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAG,S-arrestin,39586,0.00131172101962205,0.00555795071436111,-0.00958186238052573,0.0122053044197698,0.813430835782291
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.00145673104180973,0.00618236776874026,-0.0106607097849212,0.0135741718685406,0.81372596520916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,0.00212722333167501,0.00912167330645715,-0.015751256348981,0.020005703012331,0.815605530167289
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,0.00247724815697386,0.0106760975887704,-0.0184479031170161,0.0234023994309639,0.816513643504394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,41865,0.00183313906800382,0.00790906138500462,-0.0136686212466052,0.0173348993826129,0.816714743425572
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,0.00211315386239304,0.00915756356511719,-0.0158356707252367,0.0200619784500227,0.817509349660968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.00135758566077814,0.00589196916982248,-0.0101906739120739,0.0129058452336302,0.817775168101777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.00115495899700664,0.00501574930799607,-0.0109858276406789,0.00867590964666565,0.817888193421451
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,0.000872714405542761,0.00380944224541776,-0.00659379239547606,0.00833922120656158,0.818801312139574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,42200,-0.000970008011030188,0.00424901794804109,-0.00929808318919073,0.00735806716713036,0.819424284564291
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,-0.00110705667738309,0.00492475479532243,-0.010759576076215,0.00854546272144887,0.822143505972792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,-0.00249712839106747,0.0111138216250516,-0.0242802187761686,0.0192859619940336,0.822227129796069
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,0.00155034671288355,0.00698382550719238,-0.0121379512812135,0.0152386447069806,0.824324279643097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,-0.0013990655418375,0.00632816529027676,-0.01380226951078,0.0110041384271049,0.825029848408503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,41976,-0.00152413468281137,0.00690538051340666,-0.0150586804890884,0.0120104111234657,0.825316183714502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,39929,-0.0005089124296222,0.00232101846789969,-0.0050581086267056,0.0040402837674612,0.826449482296405
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.000742228638629405,0.00341394719645478,-0.00743356514368077,0.00594910786642196,0.827891645141742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,39539,0.000826947185803871,0.00383081906590723,-0.0066814581833743,0.00833535255498204,0.8290954931335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.00156358217295449,0.00734627829806845,-0.0159622876371686,0.0128351232912597,0.831455657684106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.000482117447490575,0.00227341616302416,-0.00493801312701793,0.00397377823203678,0.832057663442707
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.000858263281177166,0.00406774568523236,-0.0088310448242326,0.00711451826187827,0.832897031933351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,42107,-0.00063270716804889,0.00303739359029649,-0.00658599860503001,0.00532058426893223,0.834993224192888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.001522200490624,0.00732901994761405,-0.0158870795879475,0.0128426786066995,0.835470945498878
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.000949298809408647,0.00468901341307559,-0.0101397650990368,0.00824116748021952,0.839567240807167
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.00071409860739174,0.00355704257586741,-0.00625770484130839,0.00768590205609187,0.84089214491517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.00103630899286152,0.00516490978679985,-0.0111595321749892,0.00908691418926619,0.840979842654508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,0.00092269311312609,0.0046386679015001,-0.00816909597381411,0.0100144822000663,0.842334072074334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.00129306561275491,0.00658678709468806,-0.0142031683183435,0.0116170370928337,0.844369577748811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00108174487415361,0.00553030060548844,-0.00975764431260373,0.0119211340609109,0.844924327909315
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,39822,0.000652497727320425,0.00334012513513411,-0.00589414753754242,0.00719914299218327,0.845121489773428
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,42217,-0.000962615523830815,0.00494538222588961,-0.0106555646865744,0.00873033363891281,0.845670356072903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.000857806747673953,0.00448268771945988,-0.00792826118246741,0.00964387467781532,0.84824710385117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.000828588415715344,0.00433211814626008,-0.0093195399823851,0.00766236315095441,0.848320436825056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.00113365290891278,0.00602787770253318,-0.0129482932058778,0.0106809873880523,0.850826566732489
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.000905558601948064,0.00482128294543541,-0.0103552731750015,0.00854415597110535,0.851016484042688
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,0.00106188399997942,0.00572186331058207,-0.0101529680887614,0.0122767360887203,0.852774740450826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00104992655959475,0.00570298394691427,-0.0122277750955467,0.0101279219763572,0.853937411900441
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.000543507077778356,0.00296568110667,-0.00635624204685156,0.00526922789129484,0.854592403500988
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,39575,-0.00127010106665252,0.0069405621046228,-0.0148736027917132,0.0123334006584082,0.854803863194908
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,-0.000935705794178642,0.00511784936254652,-0.0109666905447698,0.00909527895641253,0.854933342002902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,0.000989274807924947,0.00555412027626257,-0.00989680093354969,0.0118753505493996,0.858635567942748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,39736,0.000652300894064077,0.00367484710788139,-0.00655039943738344,0.0078550012255116,0.85911557392272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,0.00074134890395922,0.00418481068879363,-0.00746088004607629,0.00894357785399473,0.859392018843982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,0.00132861701543384,0.00753669953667096,-0.0134433140764412,0.0161005481073089,0.860072259270443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,39657,0.000812083435361332,0.00464410593295661,-0.00829036419323362,0.00991453106395629,0.861190292850369
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEO1,Neogenin,39934,0.000419677247824631,0.0024009055765947,-0.00428609768230097,0.00512545217795023,0.861240253252497
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.0013620362405457,0.00803612741972501,-0.0171128459832067,0.0143887735021153,0.865414511657068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.00155587220298619,0.0093302118725347,-0.0198430874731542,0.0167313430671818,0.867564809178813
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.000582532783551441,0.00350025154799314,-0.007443025817618,0.00627796025051512,0.867824798129618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,39575,-0.000694075371453718,0.00420447433301324,-0.00893484506415967,0.00754669432125224,0.868883914941259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,39586,-0.000997199791568205,0.00605768808914168,-0.0128702684462859,0.0108758688631495,0.86924830267818
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,0.000816649769537547,0.00503355354741027,-0.00904911518338659,0.0106824147224617,0.871118903138164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.000856623193659759,0.00530848014512719,-0.00954799789078954,0.0112612442781091,0.871805381978684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.000819286663355759,0.00513025823801128,-0.0108745928098579,0.00923601948314635,0.873122740767804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,39959,-0.000377955640330734,0.00238677566938994,-0.00505603595233502,0.00430012467167355,0.87418061921559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,39657,0.00101131200846317,0.00639443432305095,-0.0115217792647167,0.013544403281643,0.874337519755797
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,39510,0.000576222503125422,0.0036466382779288,-0.00657118852161502,0.00772363352786586,0.874448128989943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,0.000555659386098871,0.00361082814955193,-0.0065215637870229,0.00763288255922064,0.877701601657104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,39657,0.000991450770247021,0.00655165817650046,-0.0118497992556939,0.0138327007961879,0.87971956992792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.00131564660382894,0.00876019606968709,-0.0184856309004156,0.0158543376927578,0.880621735135284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,-0.00110245818268555,0.00745681437306519,-0.0157178143538933,0.0135128979885222,0.88246715191394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,0.00082726024083299,0.00571585493133753,-0.0103758154245886,0.0120303359062545,0.884925629798943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,0.000705048315143608,0.00488647934593661,-0.00887245120289215,0.0102825478331794,0.885277142168455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALB2,Calretinin,41839,0.000450536649812275,0.00312355500036365,-0.00567163115090048,0.00657270445052503,0.885314395854119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.00103876043130332,0.00734118869395682,-0.0154274902714587,0.013349969408852,0.887478988052549
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.00102397819780598,0.00729142657126199,-0.0132672178818675,0.0153151742774795,0.888317715567052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.000273096555997427,0.00194869864421531,-0.00409254589865943,0.00354635278666458,0.888549453932835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,39990,0.000339854496604366,0.00242528094783474,-0.00441369616115173,0.00509340515436046,0.888559795601485
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,0.000453937535452578,0.00333481760454481,-0.00608230496945526,0.00699018004036042,0.891728384050063
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,39736,0.000551605339788725,0.0041772002889587,-0.00763570722657032,0.00873891790614777,0.894945985379214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.000422427673869136,0.00321445286052539,-0.00672275528049891,0.00587789993276064,0.895449262800872
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,0.000702576874399724,0.00539144384955725,-0.00986465307073249,0.0112698068195319,0.89632092512376
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,41913,0.000422879398367537,0.00325508156345865,-0.00595708046601142,0.0068028392627465,0.89663673865155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,39575,0.000653106405208986,0.00505674530234655,-0.00925811438739025,0.0105643271978082,0.897236983588531
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.000851269400797305,0.00659996326886006,-0.0120846586061684,0.013787197407763,0.897374637009763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,0.000537048682301222,0.00418783012934178,-0.00767109837120867,0.00874519573581111,0.897961102867607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,41843,-0.00180863094611971,0.0141397058213773,-0.0295224543560193,0.0259051924637798,0.898220954288614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,0.000885494094192357,0.00698289062834624,-0.0128009715373663,0.014571959725751,0.89909377621319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,39919,-0.000529861793325467,0.00424595502788944,-0.00885193364798877,0.00779221006133783,0.900690330097888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,-0.00143089042764635,0.0116433290223318,-0.0242518153114166,0.0213900344561239,0.902193185182696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.000476276631942858,0.00388627277031361,-0.00809337126175752,0.00714081799787181,0.902462845759526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,42145,-0.000874116776039417,0.00713856597117297,-0.0148657060795384,0.0131174725274596,0.902544528317978
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.00110475681354598,0.00917735826573316,-0.019092379014383,0.016882865387291,0.904185492720248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,42207,0.00198113277564697,0.0166099809458197,-0.0305744298781597,0.0345366954294536,0.905060332751672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,39575,-0.000636067975110268,0.00534297296639578,-0.011108294989246,0.00983615903902545,0.905239843167512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,0.000741080859374388,0.00624153222686775,-0.0114923223052864,0.0129744840240352,0.905488056268715
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,41967,0.00130568209965344,0.0111802110843765,-0.0206075316257244,0.0232188958250313,0.907032103779979
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,0.00055086792323496,0.00471918603017727,-0.00869873669591248,0.0098004725423824,0.907076564253043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,-0.000324262299119485,0.00277904107106242,-0.00577118279840182,0.00512265820016285,0.907114627866644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,42296,0.00103090897258245,0.00917312632718519,-0.0169484186287005,0.0190102365738654,0.910520904153085
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.00078655748276936,0.00700056593698547,-0.0129345517537222,0.0145076667192609,0.910542573086567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,0.000483234797041393,0.00431980482093532,-0.00798358265199184,0.00895005224607463,0.910932511420718
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.00123149924869985,0.0110253670169129,-0.0203782201044495,0.0228412186018492,0.91106577125262
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.000563378901246811,0.00505962028856029,-0.010480234666825,0.00935347686433136,0.911341980805203
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,42296,0.000470584894302667,0.00424474801867625,-0.00784912122230279,0.00879029101090812,0.911726723931412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,0.000228037769683777,0.00213313088022411,-0.00395289875555548,0.00440897429492303,0.914867946552657
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,41839,0.000438747977791172,0.00412320303313893,-0.00764272996716113,0.00852022592274348,0.915259067321118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,42119,-0.000764358736891084,0.00719220694974411,-0.0148610843583895,0.0133323668846074,0.915364977271237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,42137,0.000855459448348635,0.0080524813305155,-0.0149274039594617,0.016638322856159,0.915397072835278
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,39750,0.00111653327593129,0.0105314178623874,-0.0195250457343481,0.0217581122862107,0.91556896714237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,41900,0.000784394431414803,0.00744967562555584,-0.0138169697946746,0.0153857586575042,0.916145359303571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.00188677128568244,0.0182805435749735,-0.0339430941212656,0.0377166366926305,0.917796550560056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,41900,0.00150048596114064,0.0148657891948715,-0.0276364608608074,0.0306374327830887,0.919603178409332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,0.00257005788027172,0.0256180268241132,-0.0476412746949902,0.0527813904555336,0.92009027539187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,39934,-0.000319604325387194,0.0032080079118019,-0.00660729983251891,0.00596809118174452,0.920642189566952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,-0.000258007795006909,0.0026078108179192,-0.00536931699812854,0.00485330140811472,0.921190445203445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.000424707547660439,0.00432680658689343,-0.00805583336265068,0.00890524845797156,0.92180887828375
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,-0.000414427128203125,0.004592002548985,-0.00941475212421373,0.00858589786780748,0.92809033968649
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.000682294212439093,0.00764381453025786,-0.0142995822668663,0.0156641706917445,0.928875863383652
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.000226502376700183,0.00254622005087917,-0.00476408892302299,0.00521709367642335,0.929117956347223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,39560,-0.00067816966960886,0.0077560119628766,-0.015879953116847,0.0145236137776293,0.930325014483111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,41913,0.000253291759120571,0.00289836962106454,-0.00542751269816592,0.00593409621640706,0.930361944203672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,-0.000386077595726152,0.0044619005700828,-0.00913140271308844,0.00835924752163614,0.931048588812927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,41843,-0.000718011392414449,0.00830006761967997,-0.0169861439269872,0.0155501211421583,0.931064944472834
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.000230648103250384,0.00269623999950084,-0.00551527850227203,0.00505398229577126,0.931830199523392
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.000607177666385393,0.00716151267409248,-0.0146437425076067,0.0134293871748359,0.932435058072766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.000431111322339731,0.00523704908452646,-0.0106957275280116,0.00983350488333214,0.934393855501546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.000244255761319709,0.00299936744711855,-0.00612301595767207,0.00563450443503266,0.935096607139271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,-0.000211820404801334,0.00260591713169494,-0.00531941798292342,0.00489577717332076,0.935216983342569
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,39934,-0.000320357404054934,0.00397698333740286,-0.00811524474536455,0.00747452993725468,0.935798974412653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.000453300340984828,0.00573382274149602,-0.0107849922323474,0.011691592914317,0.936988472593086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.000252076367447112,0.00324428457360645,-0.00661087413171575,0.00610672139682152,0.938068948001398
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.000473421541420258,0.00625154698032829,-0.0117796105400232,0.0127264536228637,0.939636320551103
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,42110,-0.000231382694423247,0.00312824000714185,-0.00636273310842128,0.00589996771957478,0.941038713809351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.00026112538327199,0.00356011182567539,-0.00671669379505177,0.00723894456159575,0.941530914273694
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,0.00082857182811335,0.0115493737019836,-0.0218082006277746,0.0234653442840013,0.942808767169407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,39966,0.000328196086942972,0.00461120216948192,-0.00870976016524158,0.00936615233912753,0.943260805100168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.00035704073755715,0.0050878467360356,-0.00961513886507263,0.0103292203401869,0.944055479959068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.000193723432513346,0.00288516997432605,-0.0058486565821924,0.00546120971716571,0.946467618180803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,39934,0.00108081359995914,0.0165987767602966,-0.0314527888502223,0.0336144160501405,0.94808434130357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.000342647257614369,0.0053221344559721,-0.0100887362760909,0.0107740307913197,0.948667593072558
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,-0.000242019629138396,0.00385532001061284,-0.00779844684993957,0.00731440759166278,0.949946412763601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,41839,0.000320665137064605,0.00538266792143253,-0.0102293639889432,0.0108706942630724,0.952496110095951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.000544419538212761,0.00947404118373646,-0.0191135402583362,0.0180247011819107,0.954176341491499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,39657,0.000257603243979673,0.00453080204474718,-0.00862276876372479,0.00913797525168414,0.954660938351563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,0.000266042365131137,0.00486150205004464,-0.00926250165295635,0.00979458638321862,0.956359063083415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,-0.000227431437670603,0.00426893002585563,-0.00859453428834764,0.00813967141300644,0.957512986547713
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.000359144471174683,0.00678740387890279,-0.0136624560738242,0.0129441671314748,0.957801882285655
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,39575,0.000253526906119428,0.00505546355465669,-0.00965518166100769,0.0101622354732465,0.960004491885958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.000303709373244872,0.00622388495806682,-0.0118951051445661,0.0125025238910558,0.961081639480471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.000423468302460547,0.00876714790125821,-0.0176070781889266,0.0167601415840055,0.961476499181378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,42145,0.000389975857939122,0.00809828769486031,-0.0154826680239871,0.0162626197398653,0.961593146398611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,-0.00022709704788526,0.00474109484910686,-0.00951964295213471,0.00906544885636419,0.961797031303505
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.000253692861421001,0.00539989216747877,-0.0108374815096794,0.0103300957868374,0.96252914184132
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,0.000249883339711308,0.00544343047530081,-0.0104192403918783,0.0109190070713009,0.963386254759383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.000396664681979232,0.00895802970154088,-0.0179544028969994,0.0171610735330409,0.964681610345708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,39959,-6.72560814838938e-05,0.00153625843389822,-0.00307832261192441,0.00294381044895662,0.965081220150031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,42246,0.000196843384414666,0.00464031081667366,-0.00889816581626572,0.00929185258509505,0.966164265201619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,39586,0.000450428389183833,0.0112678613081811,-0.021634579774851,0.0225354365532187,0.96811409280653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,42181,-0.000146467093733989,0.00407563857403023,-0.00813471869883324,0.00784178451136527,0.971332951073702
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C3,Complement C3,39445,0.000169266623241052,0.00490235836672792,-0.00943935577554566,0.00977788902202777,0.972457076683007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.000226886072996152,0.00664952394179091,-0.0132599529989063,0.012806180852914,0.972781558379069
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,39958,0.000353476595469119,0.0105093431412168,-0.0202448359613158,0.0209517891522541,0.973169194723369
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.000172321829318115,0.00515574348962209,-0.0102775790689774,0.00993293541034118,0.973337656946153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.000352254604245531,0.0115741128733223,-0.0230375158359573,0.0223330066274662,0.975720824961829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGMN,Legumain,42185,-0.000108640546892749,0.00384824411861677,-0.00765119901938163,0.00743391792559613,0.977478168331374
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,9.10467857274246e-05,0.00334391658422471,-0.00646302971935301,0.00664512329080786,0.978278703396512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.000158812953890876,0.00622934981505529,-0.0120507126836175,0.0123683385913992,0.979661068859742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.000120040276394965,0.00493581860534841,-0.00979424474287785,0.00955416419008792,0.980597613562977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,42145,0.000153545139356685,0.00722725481198317,-0.0140118742921303,0.0143189645708437,0.983050297513513
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,0.000131514466706963,0.00638478872235837,-0.0123826714291154,0.0126457003625294,0.983566625423863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-8.36600113342294e-05,0.00413906260441836,-0.00819622271599422,0.00802890269332576,0.983874313426963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.000112562625363206,0.00571492530121302,-0.0110886909650143,0.0113138162157407,0.984286030577916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,39736,7.49091513588664e-05,0.00388402533750511,-0.00753778051015115,0.00768759881286889,0.984612920110778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.000125344666640734,0.00661628991671111,-0.0130932729033945,0.012842583570113,0.984885437032501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,39757,8.00269049241241e-05,0.00424779301988865,-0.00824564741405764,0.00840570122390588,0.984969365601322
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRN1,Neuritin,39934,6.20355097738677e-05,0.00369591227105621,-0.0071819525414963,0.00730602356104403,0.986608513447129
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,9.63619040603123e-05,0.00604100023797083,-0.0117439985623625,0.0119367223704831,0.987273469939711
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,-0.000114757008790357,0.00941667766741075,-0.0185714452369154,0.0183419312193347,0.990276983869016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,-2.82259855073061e-05,0.00308401647472091,-0.00607289827596029,0.00601644630494567,0.992697724369905
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,39919,3.97863365577593e-05,0.00477884056663705,-0.00932674117405086,0.00940631384716638,0.993357418950535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFB,Complement factor B,39794,-1.98700854631417e-05,0.00347949668576938,-0.00683968358957112,0.00679994341864484,0.995443710513615
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,39624,3.2290573977525e-05,0.00713296257405228,-0.013948316071165,0.01401289721912,0.996388109723444
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-1.3352588532304e-05,0.00523650872076423,-0.0102769096812302,0.0102502045041656,0.997965518962268
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,-4.90340036019774e-06,0.00358270746437759,-0.00702701003054028,0.00701720322981988,0.998908011967672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,41900,5.11086681722043e-06,0.00527730007230968,-0.0103383972749098,0.0103486190085442,0.999227293430121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,42132,-8.44092716909609e-06,0.0203529012470297,-0.0399001273713474,0.0398832455170092,0.999669100696346
